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Foreword: What is a chemical biology approach? 
 
The frontiers between chemistry and biology disciplines are dynamic. The term biochemistry 
was coined in the early 20th century to describe the field studying chemical processes in living 
organisms, although the discipline roots back earlier (its birth is often related to the synthesis 
of urea by Wöhler in 1828)1. Biochemistry in its original sense relates to the characterization, 
purification and reconstitution of biological components. The molecular biology emergence in 
the second part of the 20th century2
 
 enabled to close the gap with others biological fields such 
as physiology in a coherent vision of biological processes, so that biochemistry now diverges 
with the latter only by the studied scales. 
Chemical biology emerged over the last twenty 
years as a specific research field at the 
chemistry/ biology interface, as illustrated in 
Fig. 0 with the numbers of references in 
Pubmed3
a research field. This culminated in 2015 with the interview of thirty researchers in the field 
about the meaning of chemical biology
 database. However, despite its rapid 
emergence, and the constitution of a chemical 
biology community of researchers, several 
articles have lined out the difficulty to give an 
actual positive definition of chemical biology as  
4
                                                 
1 Morisson K., Weiss G. The origins of chemical biology Nature Chem. Biol., 2 (1), 3-6 (2006). 
. Several characteristics are lined out by 
commentators to define the chemical biology field, such as interdisciplinary research, synergy 
between chemistry and biology or horizontal focus to study biological questions at the 
molecular level. Alternatively, other definitions list significant achievements of chemical 
biology over the last fifteen years. Eventually, many definitions insist on tools and analytical 
 
2 Morange, M., Histoire de la Biologie Moléculaire, La Découverte/Poche. 
 
3Alternative clues arguing for the constitution of chemical biology as a specific field are the creation- or change 
in name- of research journals or research departments explicitly referring to chemical biology, the 
implementation of chemical biology degrees in university or the occurrence of chemical biology conferences. 
 
4 Though our panelists voiced diverse opinions on how chemical biology should be defined, there was a general 
consensus that modern chemical biology is a distinct discipline by virtue of unique heritage and its subsequent 
evolution within a dynamic scientific era. Voices of chemical biology, Nature Chem. Biol., v. 11, June 2015. See 
also: a) A decade of chemical biology, Nature Chem. Biol., v. 6, December 2010, b) Five years of Nature 
Chemical Biology Nature Chem. Biol., v. 6, June 2010, c) Chemical biology is, Chem. Cent. J., 1:5 (2007). 
Fig. 0: Number of articles reported in Pubmed             
from 1992 referring to chemical biology. 
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frameworks. Chemical biology is often characterized by its methodologies: commentators 
listed techniques developed using a chemical biology approach to be applied to biological 
systems as alternatives to routine biochemical assays5
 
. From these definitions, one can retain 
that an invariant of chemical biology approaches is that they are goal-directed: the 
experimenter defines a purpose, such as perturbing a specific physiological function with an 
artifact that he purposefully implements in a living system. This process contrasts with 
biochemistry, which, in a strict sense relates to the description of biological mechanisms.  
A common inaccuracy in molecular biology description is finalism that is to attribute a final 
cause to living organisms and to describe biological processes as goal-directed. However, 
these were constituted by evolution, consisting in natural selection of pre-occurring variants 
optimizing fitness in relation to their environment. To address this contradiction between 
apparent purpose and ''blind'' evolutionary mechanisms, the concept of teleonomy was 
introduced6, in contrast to teleology, in which an agent intentionally models purposed 
alternatives. Teleonomy was particularly developed by François Jacob in his essay Chance 
and Necessity
 
 (see quote page 135). 
We thus propose to describe chemical biology as a teleologic approach of biological studies, 
to be compared with the teleonomic nature of biological processes. In chemical biology 
approaches, the experimenter is an external agent who introduces purpose (obtain given 
characteristics in a physiological function) to purposeless biological systems. In this 
dissertation, we propose to illustrate this proposed definition with our work on the 
implementation of a light-induced protein degradation platform that was published this year 
(Delacour, 2015). This teleologic approach (the experimenters defines the goal) was 
implemented by hijacking endogenous components of a protein degradation pathway. In this 
prospect, we will describe the implementation of light-induced degradation in relation to the 
subjacent biological processes resulting from teleonomic evolution. 
                                                 
5 Chemical biology is focused on the development of new molecules or approaches that are purposefully and 
intentionally designed to address specific gaps in biological knowledge. In other words, ‘tool making’ occurs 
hand in hand with ‘tool using’. Gestwicki J.,  Voices of chemical biology, Nature Chem. Biol., vol.11, June 2015. 
 
6The biologists long-standing confusion would be removed if all end-directed systems were described by some 
other term, e.g., ‘teleonomic,’ in order to emphasize that recognition and description of end-directedness do not 
carry a commitment to teleology as an efficient causal principle.  Pittendrigh C. S., Adaptation, natural selection, 
and behavior in Behavior and Evolution, ed. A. Roe and G. G. Simpson, University Press, 1958, 390-416. 
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PART A 
INTRODUCTION 
 
 
 
 
 
 
Evolution behaves like a tinkerer who, during eons upon eons, would slowly modify his work, 
unceasingly retouching it, cutting here, lengthening there, seizing the opportunities to adapt it 
progressively to its new use. […]Evolution does not produce novelties from scratch. It works on 
what already exists, either transforming a system to give it new functions or combining several 
systems to produce a more elaborate one.  
Francois Jacob, Evolution and Tinkering
 
, Science, 196-4295 (1977) 
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Chapter 1 
Strategies for the control of protein degradation 
 
1.0 Motivation: development of a generic perturbation method 
 
The study of the specific role played by a given Protein of Interest (POI) in biological processes 
relies on perturbative techniques that interfere, at some point, in the gene expression process. An 
overview of this scheme is proposed on Fig.1. Some specifications for the development of such 
methods are particularly desirable: 
• genericity : the method should be applicable to any POI, requiring no prior knowledge, and 
specifically perturbating the POI 
• temporal resolution : the perturbation timescale should be compatible with the timescale of 
the biological phenomenon 
• spatial resolution : down to the single cell or the subcellular level 
• biocompatibility : applicable in vivo, and non toxic 
 
Much of the knowledge about specific POI originates from genetic perturbation studies: 
introduction of mutations (natural or induced by mutagenesis) modifies the gene expression, either 
quantitatively (knock-out models, over-expression) or qualitatively (mutants). However, long 
timescale is necessary for the introduction or isolation of mutations, and subsequent genetic 
expression; moreover, many mutations on essential genes have important downstream effects1
 
, and 
some are lethal in embryonic development. Introduction of genomic targeted techniques such as the 
CRISPR/Cas9 methodology has been however a significant step forward (Park, 2014). 
                                                 
1 Compensatory mechanisms resulting from protein redundancy might also oppose visible effects of the depletion. 
[PART A : INTRODUCTION] 
 
20 
 
The discovery and description of gene silencing by interferent RNAs led to the development of 
siRNA (Novina, 2004). This generic method is currently widespread in molecular and cellular 
biology as a particularly potent perturbative tool for genetic inactivation (Jankovics 2014). Generic 
control of RNA synthesis can also be achieved by modulatable transcription promoter (Ouyang, 
2010). However, these methods are not fully generic: the knock-out might not be complete, and 
does not affect preexistent proteins. They are also unavailable to for the yeast model (Carthew, 
2001). Moreover, the temporal resolution is limited as these techniques are often used on a 24 hours 
timescale (Schneeckloth, 2005). 
 
Therefore, perturbation of the protein activity at the protein-level itself is promising for better time-
resolved methodologies. Pharmacological inhibitors, which target a POI and modify its activities 
with variable efficacy and specificity, have been long used in a therapeutic, but also fundamental 
perspective (Skaar, 2014). However, the drug-discovery process is partly chance-driven, although it 
is more and more rationalized by chemical biology approaches. Moreover, about 80% of the 
proteome has no described enzymatic activity (Raina, 2010); these features make the subsequent 
development of a generic perturbation technique difficult. 
 
 
 
 
Fig. 1.1: (a) Typical timescales of biological processes. Many mechanisms controlling POI activity range between the 
minute and the hour. (b) Overview of processes that can be targeted for perturbing the activity of a POI. Perturbation 
can be implemented (1) at the genetic level, to control transcription or mRNA stability. Alternatively, POI degradation 
(2), subcellular localization (3), interaction with binding partners that can sequestrate or activate the POI (4) would 
enable to control the active POI availability. The activity of the POI itself can be rapidly controlled by post-translational 
modifications (5) or allosteric changes that can be triggered by small-effectors (6) (adapted from (Gautier, 2014)). 
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Other features of gene expression (Fig. 1.1.) that can be targeted to perturb protein activity include: 
• Covalent modifications, such as phosphorylation or methylation states 
• Interaction with protein partners, homo-dimerization, and aggregation (Skwarczynska, 2012) 
• Protein folding and conformational changes 
• Cellular localization: for example, conditional addressing of a constitutively cytoplasmic 
POI to the nucleus or the membrane, where it can interact with an effector partner 
 
Over the last few years, several reported techniques, which will be described in this manuscript, 
drew attention on the opportunities of hijacking the Ubiquitin Proteasome System (UPS), a 
ubiquitous protein degradation pathway, to specifically deplete a POI. Such conditional degradation 
by the UPS would constitute an interesting step towards a generic On/Off perturbation method 
meeting the specifications described earlier. 
 
The possibility of implementing such a technique by using a chemical biology approach in this 
perspective will be addressed in this work. We will consider the endogenous cellular pathways as 
functional modules that can be hijacked to trigger designed perturbation. Thus, we propose in this 
first part a functional description of the UPS in eukaryotes and the implications for a chemical 
biology process, with top-down perspective towards the specific conditional control of degradation 
of a POI. We will restrict ourselves to a parsimonious yet generic description of the biological 
features necessary at each step to implement a functional module for conditional POI degradation. 
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1.1 The Ubiquitin-Proteasome System (UPS) allows the selective 
degradation of protein substrates 
 
The control of protein level (proteostasis), along the cell-cycle and in response to variations of the 
cellular environment, is an essential process for living systems. This control depends on the rates of 
protein synthesis and folding, protein activity, sequestration, but also protein degradation. In this 
work, we focus on specific ATP-dependent proteolysis, although protein degradation can be realized 
by various mechanisms such as lysosomal-dependent mechanisms, which will not be described here. 
 
1.1.1 The Proteasome is an efficient proteolytic complex in eukaryotes 
 
1.1.1.1 The Proteasome is a protein complex with differentiated catalytic/regulatory subunits 
ATP-dependent proteases are ubiquitous (present in bacteria 2
– A cylindrical 20S catalytic core, digesting proteins into short peptides of about twenty 
amino-acids long (Fig. 1.2). This core is composed of four stacked heptameric ring, surrounding a 
central cavity with three different proteolytic sites. This geometry prevents unwanted proteolytic 
activation, as the catalytic site is isolated from the cytosol. 
, archae and eukaryotes), highly 
conserved proteolytic protein complexes, allowing both Quality Control in protein turnover and 
specific process regulation (Inobe, 2014). In eukaryotes, a single type is present in the cytoplasm 
and the nucleus: the 26S Proteasome, a complex of up to fifty subunits and 2.4 MDa, composed of: 
– One or two 19S regulatory particles (RP), for substrate recognition and transport to the inner 
core. The base is composed of a ring of six ATPases that unfold and linearize substrates in an ATP-
consuming process. It also controls the access to the inner proteolytic site by encapsulating them: 
only unfolded proteins can pass through the narrow entry channel, excluding globular proteins. 
– Two large subunits, Rpn1 and Rpn2 which organize facultative receptors Rpn10 and Rpn13. 
These additional modules can recognize substrate proteins addressed with a degradation tag3
The proteolytic activity of the 20S Proteasome discriminates specific substrates. The question 
whether the degradation of a protein is only induced by physical interaction with the proteasome, or 
whether it necessitates specific addressing signaling, long remained open.   
. 
                                                 
2 Several ATPases (ClpYQ, ClpXP, and ClpAP) functionally related to eukaryotic Proteasome exist in eubacteria. 
3 Several supplementary subunits can be associated for substrate recognition, like protein chaperone Cdc48.     
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Fig. 1.2: Overview of the substrate degradation mechanism by the proteasome. A poly-ubiquitinated substrate binds 
with Rpn subunits at the 19S Regulatory Particle. Consequently, the substrate is unfolded and translocated to proteolytic 
core particle in an active ATP-consuming process, where it is degraded into short peptides. 
 
1.1.1.2 Interaction with proteasome is sufficient for proteolysis: a chemical biology approach 
To demonstrate that interaction with the proteasome is sufficient for proteolysis, target reporter 
proteins were artificially addressed to the proteasome by the rapamycin-heterodimerization system4
FKBP fused to different non-catalytic subunits of the proteasome was co-expressed with FRB fused 
to a POI in yeast. Addition of Rapamycin conditionally induces the interaction between the two 
chimeric proteins. This was sufficient to trigger the proteasomal degradation of the FRB-POI, 
depending on the identity of the proteasomal subunit fused to FKBP. Ubiquitin binding protein 
Rpn10 displayed the fastest degradation with a half-life of 20 min. 
 
(Janse, 2004). Rapamycin allows the control of the interaction between two proteins FKBP and 
FRB with high affinity, as detailed in Fig.1.3. 
 
Fig. 1.3: Overview of the proteasome addressing approach reported in (Church, 2014). A POI fused to FRB 
heterodimerizes with FKBP fused to proteasome regulatory particle Rpn10 upon rapamycin addition. This addressing is 
sufficient to initiate the unfolding and translocation of the FRB-POI to the proteolytic core where it is degraded. 
                                                 
4 Rapamycin, a 31 member, 912 Da macrolide antibiotic binds with high affinity (KD=0.2 nM) to the FK506 Binding 
Protein (FKBP) and to the mammalian protein Target of Rapamycin (mTOR), which can be restricted to its binding 
domain called FRB. FRB/FKBP is widely used as a dimerization module, associated with different partner proteins such 
as Calcineurin 1, or modified Rapamycin ligand. Another dimerization platform is the Coumermycin-induced 
homodimerization of GyraseB (Farrar, 2000). Other examples based on phytohormones will be described in part 7.2.1. 
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It is likely that the physical interaction of the FRB-POI is sufficient for their unfolding by 
Proteasome ATPase units, a necessary step to access the narrow 20S proteolytic core. 5
 
 This 
approach confirmed that controlled addressing to the proteasome can be sufficient to degrade a 
stable POI.   
1.1.1.3 Conclusion 
The proteasome itself is active for protein degradation, which indicates that substrate selectivity has 
to be achieved by complementary associated mechanisms, such as polyubiquitin conjugation. 
Therefore, we will now describe the Ubiquitin-Proteasome System (UPS) to see whether 
conditional hijacking can be achieved. 
 
1.1.2 Polyubiquitination of protein substrates is a proteasomal degradation 
addressing tag6
 
 
The Ubiquitin (Ub)-Proteasome system (UPS) is an essential eukaryotic post-translational 
regulation pathway. Ub and Ub-like proteins (such as Nedd8 and SUMO) conjugated to protein 
substrates are able to regulate a broad range of cellular processes such as degradation, control of 
protein activity or subcellular localization (Novatchkova, 2010). 
 
1.1.2.1 Ubiquitin conjugation is an important post-translational modification mechanism 
Ub is a small and highly conserved protein (76 a.a., 8.5 kDa), which can be attached by its Gly76  
C-ter to a ε-amino group of Lys residues in a substrate protein. Further addition of Ub residues 
(polyubiquitination) can take place at one of the seven Lys present in Ub, as detailed on Fig. 1.4.a. 
 
Mono- or polyubiquitination of substrate proteins are recognized as signaling tags by specific 
receptor proteins containing Ubiquitin-Binding Domains (UBD). These receptors can discriminate 
not only the number of Ubiquitin residues attached, but also their branching mode; this determines 
the cellular fate of a protein. Much is still to be learned on the regulation of ubiquitination, which 
involve a complex recognition process; however, in this work, we will focus on the Lys 48                      
polyubiquitination7
                                                 
5 Similar approach led to the rapamycin-controlled degradation of POI by ClpX protease in bacteria (Davis, 2011). 
, a cellular signal for proteasomal degradation (Zhou, 2013). 
6 From now on, the proteasome will be considered as a «black box»: once the substrate protein is polyubiquitinated, it is 
considered to be recognized by the proteasome and degraded. 
7 At least a 4-mer polyubiquitin tag is necessary; other Lys residues such as Lys29 can be involved. 
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1.1.2.2 Polyubiquitination controls the degradation of protein substrates 
Lys48-Polyubiquitination couples a series of post-translational modifications in a substrate protein, 
which finely tune the degradation rates by the Proteasome. The Ubiquitin-Proteasome System (UPS) 
is a highly conserved pathway common to all eukaryotic species, tightly controlled by a subset of 
protein through a cascade of transfer of Ubiquitin monomers (Nagy, 2010). This process is 
summarized in Fig. 1.4.b/c.  
 
 
 
Fig. 1.4: (a) Crystallographic structure of Ubiquitin (PDB ref.:1UBQ, adapted from (Dikic, 2009)). (b-c) Overview of 
the UPS degradation pathway. (b) An ubiquitin moiety is activated by a thioester link with Ubiquitin Activating 
Enzyme (UAE) E1, and transferred to an Ubiquitin Conjugating Enzyme (UCE) E2. (c) Activated-Ub is conjugated to 
Lys-residues of a substrate by an ubiquitin ligase, resulting in different cellular outcomes. Polyubiquitinated proteins 
can be recognized by the Proteasome and degraded. 
 
a) Activation of Ubiquitin transfer by E1 and E2 enzymes8
In a first, ATP-dependent step, a thioester linkage is made between Ub at its C-ter and an active site 
Cys of the Ubiquitin Activating Enzyme (UAE) E1. A trans-thiolation reaction transfers Ub to 
Ubiquitin Conjugating Enzyme (UCE) E2, through a Cys residue of the conserved Ubiquitin 
Conjugating Domain (UCD). While there is a single Ub-Activating E1 enzyme in human, 40 UCE 
E2 variants have been identified, with different structural properties. This variability is seemingly 
important for the specification of the ubiquitin linkage generated (Metzger, 2014). 
 
                                                 
8 A first chemical biology application to the specific targeting of protein substrates by genetically harnessing the UPS 
components was reported in 1995 (Gosink, 1995). In this approach, different Protein Binding Domains (PBD) were 
fused to the C-ter of UCE E2. Interaction between the chimeric UCE E2 and the substrate recognized by the PBD (e.g. 
RNAse A) enhanced the ubiquitination and degradation of the latter in cell lysates in vitro. Although the extent of 
depletion was limited (10% in 4 h), this constituted a proof of principle that interaction with UCE E2 can be sufficient 
to control the ubiquitination of a substrate. 
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The last step involves an ubiquitin ligase E3 which catalyses the transfer of activated thio-ubiquitin 
E2 to a Lys residue of a target protein
b) Conjugation of Ubiquitin to Protein substrates by E3 enzymes 
9. The typology of E3 ubiquitin ligase distinguishes two 
ubiquitination mechanisms10
• In a first mechanism, the E3 acts as a catalytic intermediate: activated ubiquitin is 
transferred from E2 to E3, which transfers the ubiquitin to an interacting target protein. This type of 
ubiquitination is specific of HECT9 E3 ligases (Marin, 2010). 
 (Metzger, 2014), as explained on Fig. 1.5: 
• Alternatively, the E3 lacks a functional catalytic center, but mediates the close spatial 
interaction between thio-ubiquitin E2 and the target protein, which authorizes the direct transfer of 
ubiquitin from E2 to the target protein. This mechanism is present in RING-type E3. 
 
 
Fig. 1.5: Overview of the two classes of E3 Ubiquitin Ligase mechanisms. (Top) Activated Ub-moiety is transferred to 
a Cys residue of HECT Ubiquitin Ligase, and to Lys residue of a substrate in a second-time. (Bottom) In RING 
ubiquitin ligase, activated-Ub is directly transferred from E2 to substrate, due to the spatial proximity mediated by E3. 
 
 
In an increasing complexity, 600 to 1,000 E3 ubiquitin ligases have been identified in human. This 
dramatic variability is associated with high regulation potential. E3 ubiquitin ligases fundamentally 
allow homeostasis of the concentration of specific proteins. They are involved in many essential 
regulation processes such as development, genome maintenance and response to cellular signals 
(Lipkovitz, 2013). In numerous examples, E3 ubiquitin ligases dysfunctions are associated with 
human diseases. This is especially true for cancer: for example, specific mutations in the E3 
ubiquitin ligase BRCA1 are a hallmark of breast cancer (Nakayama, 2006). 
c) Final ubiquitination steps allow a complex regulation mechanism 
                                                 
9 Other ubiquitination positions exist, such as the N-ter of the substrate protein. 
10 HECT: Homologous to E6-AP C-ter; RING: Really Interesting New Gene. In some classifications, two more families, 
the U-box and PHD-finger, are singularized; in this work, we associate the U-box described on part 1.2.2.1 with RINGs, 
whereas the PHD finger will not be involved. 
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Lys48-polyubiquitinated proteins then diffuse before being recognized by the proteasome and 
degraded 11
 
. DeUbiquitinating (Dub) Enzymes recognize and remove ubiquitin moieties from 
ubiquitinated proteins, a process which offers a further level of regulation. (Eletr, 2014) 
 
1.1.3 Perturbation of the UPS pathway by small molecules, a chemical biology 
approach 
 
1.1.3.1 Motivation 
A first approach to perturb the UPS is to develop small molecules inhibiting specific components of 
this pathway. This pharmacological approach relies on the identification of a specific POI drug 
target, and might therefore seem incompatible with the development of a generic perturbation 
pathway. However, important therapeutic stakes, such as p53 are associated with this perspective. 
Moreover, this is an important requirement for the technology of PROTACs detailed on part 1.3.2.3. 
Last, these can constitute interesting examples of chemical biology application for small molecule 
drug-design. We develop here examples of perturbation at each level of the UPS, as detailed on Fig. 
1.6. Complete reviews analyze further the associated potentialities ((Bedford, 2011), (Buckley, 
2014)). 
 
1.1.3.2 Perturbation of the Proteasome activity globally impairs the UPS     
Proteasome inhibition would result in a global impairment of the UPS by preventing the final 
common step of protein degradation. Paradoxically, the first FDA-approved drugs targeting the UPS 
were developed against the proteasome. Peptide aldehydes, such as MG 132 12
 
 are proteasome 
inhibitors widely used in biological studies (see chapter 3) to monitor proteasome-dependent 
degradation, despite poor selectivity and rapid reversibility. These drawbacks were compensated by 
the conversion into a boronic acid peptide, which led to the development of the more stable and 
highly specific MG262, which was developed into Bortezomib/Velcade in 2003, a FDA-approved 
drug for the treatment of multiple myeloma. 
                                                 
11 In some cases, polyubiquitination might increase the activity of the protein, which might be a strategy to generate 
short-lived high signals. Alternatively, the E3 Ub ligase can be physically associated with the proteasome. 
  
12 MG 132 covalently inhibits (Ki= 4 nM) the chymotryptic-like activity of the β5 subunit of the proteasome. Other 
proteasome inhibitors target the caspase-like (β1) or trypsin-like (β2) activities. 
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1.1.3.3 Perturbation of the activity of UPS enzymes: from broad impairment to fine control 
Inhibition at the E1 level prevents ubiquitin-dependent proteasomal degradation and thus globally 
impairs the UPS13
Targeting one of the 40 E2 enzymes introduces an additional step of regulation as these proteins 
largely determine the ubiquitination chain topology, controlling the fate of target ubiquitinated 
substrates. This complex regulation process is however widely unknown and few E2 inhibitors have 
been identified. The first described CC0651 example was selected in a high-throughput screen of 
inhibitors of p27Kip1 ubiquitination, in a cell-free assay reconstituting all components of the 
ubiquitin machinery. CC0651 inhibits the proliferation of cancer cells by accumulation of the cell-
cycle regulatory protein p27Kip1. 
. Pyrazone PYR-41 was the first inhibitor described to covalently inhibit UAE E1 
in vivo, preventing global degradation of UPS targets such as P53.                 
 
1.1.3.4 Targeting E3 ubiquitin ligases can trigger specific substrate degradation 
With up to 1,000 different genes, E3 ubiquitin ligases exhibit high substrate specificity. This feature 
renders them highly attractive targets for the selective development of small molecule-based 
perturbation of the UPS (see Goldenberg, 2010 for identification platform methodology). As most 
E3 ubiquitin ligases lack an enzymatic activity14, the inhibition of their activity is mostly achieved 
by perturbing the surface of interaction between an E3 ubiquitin ligase and its substrate.15
However, other mechanisms for E3 ubiquitin ligase perturbation exist
 This is 
the case in the first described example: cis-imidazoline-based Nutlins targets interaction between an 
E3 ubiquitin ligase MDM2 and its p53 tumor repressor substrate, which is stabilized in vivo. 
16
                                                 
13 Another orientation is the development of specific inhibitors of the 7 other E1 proteins in human, which share similar 
structures and mechanisms for activation of Ub-like proteins such as Nedd8. Neddylation being an important regulatory 
step of Cul-based RING E3 (Duda, 2008), targeting Nedd8-Activating E1 would impair the ubiquitination process. 
:    
  (a) inhibition of the E3-substrate interaction with the proteasome   
             (b) inhibition of the insertion of the substrate adapter into core ubiquitin ligase     
  (c) perturbation of the core ubiquitin ligase assembly                   
  (d) allosteric change in the substrate adapter protein altering affinity for its substrate 
14 With the notable exception of HECT E3, see part 1.1.2.2.  
15 Another attractive target for UPS drug inhibition are the nearly 100 De-Ubiquitin Enzymes (DUB) identified in 
mammals, which can stabilize substrates by removing Ubiquitin residues. 
16 (a) tryptamine JNJ-26854165 blocks the interaction between p53-MDM2 and the Proteasome, (b) chromone-based 
SMER3 blocks the insertion of the F-Box protein Met30 in the SCF (Aghajan, 2010); TAME inhibits the insertion of  
WD40-D-Box-Cdc20 protein into APC Ubiquitin Ligase Complex (Zeng, 2012) (c) thalidomide associates with CRBN, 
part of  Cul4 CRL (d) allosteric change induced by binding of SCFI2 in the WD40 domain of Cdc4, excluding Sic1. 
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Fig 1.6: Examples of molecules inhibiting specific enzymes of the UPS pathway: Pyrazone PYR-41 inhibits globally 
E1 activating enzyme, CC0651 inhibits E2 Ubiquitin conjugating enzyme, Nutlin-3 inhibits interaction between E3 
Ubiquitin ligase MDM2 and p53, MG132 targets the Proteasome. 
 
1.1.4 Complementary signaling can implement substrate selection for 
proteasomal degradation    
 
It was long thought that polyubiquitin was a necessary tag for proteasomal addressing and 
degradation initiation. This description has evolved since the identification of ubiquitin-independent 
degradation substrates, such as Ornithine decarboxylase (ODC) or the emerging field of 
intrinsically disordered proteins. The current model describes polyubiquitin as a particularly potent 
adaptor tag, although other signals addressing to the Proteasome might be sufficient to induce 
degradation (Inobe, 2011), (Asher, 2005). 
Consistently, while eukaryotic and archeal proteasomal 20S core proteins present a sequence and 
structure homology indicating that this process emerged early in evolution, archeal proteasome lack 
the regulatory 19S RP (Bathelme, 2012). This might indicate that degradation control by ubiquitin 
conjugation evolved later as substrate selection strategy in eukaryotes (Hagai, 2012), (Zuin, 2014)17
                                                 
17 Although the UPS can be related to prokaryotic antecedents with Ub-like β grasp domains (Iyer, 2006). 
. 
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A working analogy can be made between this substrate selectivity in living systems, and our 
chemical biology approach for conditional degradation of a POI ; in both cases, selectivity of 
substrate necessitates the implementation of addressing strategies to the degradation effector, the 
proteasome. In the next two sections, we will thus explore further the two functionalities associated 
with the UPS: Protein Quality Control and selective regulation, to see whether substrate selectivity 
can be implemented by hijacking the substrate recognition pathways. 
 
1.2 The UPS Protein Quality Control (PQC) pathway allows the 
degradation of defective protein substrates 
 
Elimination of misfolded or abherent proteins and homeostasis of available amino-acid pools are 
essential functions in cells. (Bennett, 2005), (Suraweera, 2012) Moreover, the maintenance of a 
pool of short-lived proteins in cells also appears as a potent strategy for the rapid generation of 
spatial gradients or adjusting of the protein composition. We will now describe Protein Quality 
Control processes associated with the UPS, and their implications for chemical biology approaches.   
 
1.2.1 The N-end rule pathway: lessons from a destabilization pathway 
 
1.2.1.1 The N-end rule pathway: from instability observations to chimeric POI destabilization 
The lifetime of a protein molecule in vivo ranges from one minute to several days; this discrepancy 
between different peptidic sequences was phenomenologically characterized by the universal N-end 
rule, relating the lifetime of a protein to its N-terminal amino-acid identity18
 
 (Bachmair, 1986). 
Proteins exposing a residue other than Met are degraded with various rates (Dougan, 2012). 
The eukaryotic N-end rule pathway is related to the UPS, with two sub-divisions: the Arg/N-end 
rule involving N-terminal arginylation and the Ac/N-end rule, targeting N-terminally acetylated 
proteins. The N-end rule variations have been widely detailed in recent reviews (Sriram, 2011). In a 
functional description to implement N-end rule instability in eukaryotes, we only summarize on Fig. 
1.7 the mammalian Arg/N-end rule. A functional N-terminal degron associates an unstructured N-
a) The N-end rule pathway in eukaryotes: overview 
                                                 
18 Interestingly, the first discovery of the N-end rule pathway resulted from the work by Varshavsky et al. in 1986, 
described below, on the metabolic stability of an engineered Ub-fused protein. This illustrates the fertile interplay that 
can exist between fundamental description and applied methodology. 
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terminal extension with internal Lys and a destabilizing N-terminal residue. These features allow 
protein recognition by E3 RING Ubiquitin Ligases called N-recognins, such as Ubr1 in yeast and 
Ubr in mammals, which ubiquitinate substrates and target them for degradation19
 
 (Dougan, 2012). 
 
Fig. 1.7: Overview of the “classic” Arg/N-end rule pathway in eukaryotes. The half-life of a Protein is correlated to the 
identity of its N-terminal residue. At the primary level, some residues are stabilizing (top left), whereas others are 
destabilizing (top right). At a secondary level, D and E residues are modified by Arginylation, a destabilizing signal. A 
tertiary level exists as Q and N-terminal residues can be deamidated, resulting in resp. D and E exposition. Alternatively, 
oxidized N-ter Cys residues are also arginylated. Destabilized residues are processed by a specific class of proteins 
called N-Recognins (Adapted from (Dougan, 2012)). 
 
Chemical biology applications originate from a single paper published in 1986 by Varshavsky et al. 
which shed light on the N-end rule (Bachmair, 1986). Instability can be conferred by destabilizing 
residues (X) located at the N-end terminus of a β-galactosidase protein fused to Ub (chimeric Ub-X-
β-Gal). Most of the time, the Ub moiety is rapidly processed by DeUBiquitin enzymes (DUB). This 
liberates X-β-Gal proteins which are constitutively degraded by the Proteasome at a rate depending 
on X identity. In particular, N-ter residues Phe, Leu, Asp, Lys, and Arg dramatically reduce the half-
life time to a few minutes in yeast. However, introducing a proline residue prevents the DUB 
cleavage. The mono-ubiquitinated protein is recognized by a TRIP12 HECT E3 ubiquitin ligase 
(Park, 2009), which processes it by further addition of Ub residues leading to degradation by the 
proteasome. 
b) Application of the N-end rule: implementation of constitutively-degraded variants of a protein 
                                                 
19 HECT-type Ufd4 ubiquitin ligase also mediates polyubiquitination by associating with Ubr1 (Hwang, 2010). 
c) Instability can be conferred to a POI by destabilizing N- and C-terminal cassettes 
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Consequently, shorter protein degron sequences, with a destabilizing N-ter residue and internal Lys 
residue for ubiquitination, were developed to create N-ter proteins tags that can be fused to any POI 
to create conditionally unstable variants. 
 
The first example was developed with a 45 residue from an 
internal sequence of lac repressor (lacI) and was extended to 
several POI in yeast as a generic and portable destabilization 
cassette (Park, 1992). This methodology led to the 
development of short-lived GFP reporters, as explained on Fig. 
1.8. These constitute an interesting tool for monitoring UPS 
degradation of instable proteins (Dantuma, 2000), (Houser, 
2013). 
Fig. 1.8: Targeting of GFP reporters for proteasomal degradation reported 
by (Dantuma, 2000). The outcome of a GFP fused to an N-ter Ub tag 
depends on the amino-acid identity of the linker. The Ub tag can either be 
processed by DUB enzymes (bottom), liberating an N-end sequence 
driving either polyubiquitination on specific Lys sequence (right) or 
stabilization (left). Alternatively, the Ub moiety is stable and initiates 
polyubiquitination, resulting in proteasomal degradation. 
 
Destabilizing C-ter tags, which do not rely on the N-end rule pathway exist, such as sequence 
derived from Ornithine decarboxylase (mODC) (Li, 1998) or CL1, a 16 amino-acid derived from a 
ER associated-degradation protein (Gilon, 1998), (Neefjes, 2004). Although the molecular features 
of their proteasome-dependent degradation might be partially unknown (mODC is degraded in an 
ubiquitin-independent pathway), these sequences can be used as known destabilizing tags in a 
chemical biology approach. 
Constitutive unstable proteins allow transcriptional pulse-chase experiments, where either 
transcriptional activation (with an inducible promoter) or repression (with cycloheximide), or global 
UPS impairment with proteasome inhibitors create a perturbation of the protein content whose 
proteasomal decay can be monitored. This approach allows however poor temporal resolution due 
to the transcription and protein folding time, and can be perturbative for other cellular processes. 
Therefore, a technique to expose conditionally a destabilizing residue would be interesting. 
 
 
1.2.1.2 Towards the conditional degradation of a POI by N-end rule application 
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Taxis et al. developed the Tobacco-Etch virus (TEV) protease induced protein inactivation (TIPI) 
degron-system (Taxis, 2009), summarized on fig. 1.10.b. In this system, an N-end degron is 
inactivated by GFP blocker moiety placed at the N-ter, separated by a TEV protease recognition site. 
a) Genetic induction of a protease can trigger the N-end rule dependent degradation of a POI 
Conditional expression of the TEV protease results in the cleavage of the recognition site and the 
exposure of destabilizing reside of the N-degron. POI is then degraded by the Ubr1-dependent N-
end rule pathway. Although this system relies on genetic induction, the timescale for protein 
degradation is very rapid (1-3 h) 20
A TIPI-degron derived from Ornithine decarboxylase (mODC), completed this approach by 
allowing the degradation of C-ter tagged POI
. A chemical biology approach optimized this system by 
enhancing the bonding and cleavage efficiency of variant TEV proteases (Taxis, 2009). 
21 (Jungbluth, 2010). Together, these two systems 
provide a bidirectional degron which can be placed at both N- and C-ter, or internally, for creation 
of conditional mutants of essential protein in yeast.       
  
b) A temperature-sensitive (ts) degron triggers temperature destabilization of a POI in yeast
 
  
Another example of inducible degradation by the conditional N-end rule destabilization is the 
development of temperature sensitive (ts) degrons, detailed on Fig. 1.10.a. A ts-variant of human 
DHFR (DHFRts) was developed in yeast (Dohmen, 1994). This module can be fused at the N-ter of 
a POI and an Ub moiety (Ub- DHFRts -POI). The Ub moiety is cleaved by DUB, as previously 
described, exposing a normally-destabilizing Arg residue at the N-end. The N-end ts-degron POI is 
stable at a permissive 24°C temperature, whereas shifting to 37°C results in the partial unfolding of 
tsDHFR, leading to a higher exposure of N-end Arg or internal Lys. This results in the rapid (30 min) 
proteasomal degradation of the N-end ts-degron-tagged POI through Ubr1-dependent ubiquitination. 
This N-end ts-degron can be easily fused to any POI enabling a very fast and specific degradation. 
This generic depletion methodology has been widely used for depletion studies in yeast (Kearsey, 
2008). A chemical biology approach optimized this system by over-expression of Ubr1 E3 ubiquitin 
                                                 
20 This might be due to the fact that the TEV protease acts as a catalyst, sequentially proceeding cleavage sites, 
requiring a very low amount of maturated protein after induction. 
21 It is however to note that the mODC protein is degraded in a proteasome-dependent, but ubiquitin-independent 
pathway by recognition of its C-ter (Asher, 2005, see part 1.1.4). This illustrates once again a key principle in chemical 
biology approaches: the endogenous mechanisms are considered as functional modules unless their deeper 
comprehension is necessary for the process implementation. 
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ligase. However, it is limited to species that support a high temperature shift, which is not the case 
for mammalian cells. Application of this technique in chicken DT40 cells growing at temperature 
from 35 to 42°C has been reported (Su, 2008). 
It was also reported that methotrexate, a high affinity ligand of mammalian DHFR, partially 
blocked this temperature dependent degradation. This was an interesting step towards the control of 
protein degradation by small molecules in cells (Prakash, 2009).  
c) Small-molecule control of the destabilization of a POI by the N-end rule pathway
An interesting combination of split-Ub, DUB enzymes and N-end rule led to the development of the 
SURF (Split-Ubiquitin for the rescue of Function) methodology detailed on Fig. 1.9, which allows 
the conditional stabilization of a POI by rapamycin in mammalian culture cells. N-ter and C-ter Ub 
fragments are fused respectively to FKBP and FRB. The POI is fused to C-ter-Ub-FRB together 
with a degron sequence. In the absence of rapamycin, the degron addresses the POI to proteasomal 
degradation, whereas the rapamycin-induced dimerization mediates the complementation of the 
split-Ub, which is recognized and cleaved by DUB, liberating the POI under its native state, a 
highly attractive feature (Pratt, 2007). 
        
Conditional cleavage of Ub residues can be introduced by split-Ubiquitin technologies: N- and C-
terminal modified fragments of Ubiquitin protein will complement and fold only if they are fused to 
partner proteins which can dimerize. The functional reconstituted Ub residue is then cleaved by 
DUB (Johnsson, 1995), (Lin, 2014). 
 
Fig. 1.9: Overview of SURF (Split-Ubiquitin for rescue of Function) methodology. A POI fused to C-ter part of split Ub 
and FRB is constitutively degraded by a C-ter degron, unless it interacts with N-ter split ubiquitin fused to FKBP in a 
rapamycin-dependent interaction. Reconstitution of the full-Ub enables processing by DUB, liberating the native POI. 
 
d) Comparison                      
These methodologies allow the conditional depletion of POI with two different effectors: small 
molecule can be a simple and efficient way to induce a perturbation. A refinement of this is the 
genetic induction, where a small molecule addition results in transcription initiation. However, 
spatial selectivity is poor due to diffusion, and temporal resolution is often affected by the cell-
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delivery issue. On the other-hand, temperature-shift is a physical perturbation that can be 
implemented with excellent spatio-temporal selectivity. However, it can be perturbative for living 
systems. As an alternative, light-sensitive tools for conditional degron presentation were developed 
in yeast and mammals (Fig. 1.10.d). These methodologies will be presented and discussed on part 
7.1.2. 
 
Fig. 1.10: Overview of the strategies to control the stability of a POI by a conditional perturbation (adapted from 
(Kanemaki, 2013)): a) Constitutive N-ter Ubiquitin removal by DUB liberates a POI fused N-end degron which is 
stable at 24°C in yeasts. Thermal shift from 24°C to 37°C induces a denaturation of the DHFRts-degron, which is 
recognized as a N-end rule degron and degraded (1.2.1.2.b)  b) Genetic activation of TEV protease leads to the cleavage 
of a specific TEV site and the exposition of an N-end rule degron fused to a POI (1.2.1.2.a) c) A POI fused to an 
unstable FRB variant is constitutively degraded unless it is stabilized by FKBP in presence of Rapamycin (1.2.2.2.a) d) 
blue-light illumination controls the conditional exposure of a degron fused to LOV domain (7.1.2). 
 
In this part, we have seen that functional understanding of the N-end rule pathway can lead to the 
development of constitutively and conditionally unstable proteins. We will now extend this approach 
to misfolded protein degradation, another PQC process. 
 
1.2.2 Misfolded proteins can be degraded by the PQC pathway 
 
The correct folding of proteins is a crucial issue in vivo, as misfolded proteins tend to aggregate, or 
exhibit a detrimental activity for cells (Bennett, 2005). Several human diseases are associated with a 
mutation inducing misfolding and causing rapid depletion of an essential protein, such as 
haemoglobin in haemoglobinopathies (Goldberg, 2003). Conversely, neurodegenerative diseases 
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such as Parkinson disease can be associated to failure of an E3 ubiquitin ligase Parkin to degrade 
misfolded protein that aggregate into amyloid plaques (Kitada, 1998). 
 
1.2.2.1 Misfolded proteins are addressed by the UPS pathway in vivo 
 
Several strategies are present in eukaryotes to address misfolded proteins: a first set of mechanisms 
involve the repair of misfolded proteins by protein chaperones, while a second strategy is to remove 
them from the cell
a) The misfolded protein response involves a finely regulated process 
22
 
, by the UPS (or autophagy) (Dantuma, 2010). PQC ubiquitin ligases E3 are 
able to ubiquitinate misfolded proteins, addressing them for proteasomal degradation (Fig 1.11). 
This process is evolutionary essential for the cells: the UPS being an efficient tool for protein 
degradation, it must be only activated on misfolded or damaged proteins, without non-specific 
destruction of constitutive cell proteins. In eukaryotes, a subcellular compartimentation of the PQC 
exists: each compartment presents a distinct set of PQC proteins, (see Fredrickson, 2013) for review. 
 
 
Fig. 1.11: Overview of the misfolded protein addressing in eukaryotes. Misfolded proteins, resulting from denaturation 
of folded protein or improper folding of nascent peptides are recognized by Heat-Shock proteins (Hsp), and 
polyubiquitinated by specific RING E3, resulting in eventual proteasomal degradation. This prevents cellular damages 
associated to unfolded protein aggregation (adapted from (Goldberg, 2003)). 
 
                                                 
22 Historically, this cellular misfolded protein degradation was demonstrated 40 years ago. Incorporation of unnatural 
Val analogs in Globin proteins in reticulocytes dramatically reduced the lifespan of this normally stable protein. 
b) The misfolded protein response associates specific E3 ubiquitin ligases to protein chaperones 
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We here describe briefly the cytoplasmic components for recognition of unfolded proteins. In yeast, 
the RING-domain Ubiquitin Ligase Ubr1 mediates cytoplasmic PQC degradation, independently of 
its role in the N-end rule pathway (see part 1.2.1.1), assisted by Hsp70 and 110 chaperones. In 
addition, mammalian CHIP (carboxyl terminus of Hsp70-interacting protein) is a U-box E3 which 
ubiquitinates client protein through direct interaction with Hsp70 and 90 chaperones, which are able 
to specifically accommodate hundreds of substrates (Taipale, 2012). Other ubiquitin ligases have 
been described (Fredrickson, 2012). 
 
However, in a chemical biology approach, the simple knowledge that a misfolded protein can be 
recognized and degraded by endogenous cellular components can be sufficient to implement a 
controlled degradation, by the conditional destabilization of a protein domain, although the 
downstream processing mechanism is not fully known. 
 
1.2.2.2 A chemical biology approach: conditional control of POI stability by small molecules 
 
In a first application of the PQC processes in vivo detailed on Fig. 1.10.c, a POI can be fused to 
FRB*, an unstable mutant of FRB. This induces the constitutive degradation by the proteasome, 
unless FRB* is stabilized through a ternary interaction with endogenous FKBP and conditionally-
added rapamycin (Stankunas, 2003). 
a) Small-molecule mediated stabilization of a constitutively unstable POI 
Alternatively, the group of Wandless proposed a single-ligand single-domain strategy where a small 
molecule controls the stability of protein. By a directed-evolution approach, they engineered a 
mutant version of the human FKBP which is conditionally stabilized by the presence of Shield1 
(Banaszynski, 2006). In absence of Shield1, the constitutively unstable protein is recognized by the 
PQC pathway, and degraded by the proteasome. This protein sequence thus constitutes a 
Destabilizing Degron (DD) that can be genetically fused to any POI to confer a small-molecule 
dependent conditional stability. For example, predictable changes in NIH3T3 culture cells can be 
observed by the Shield1-induced stabilization of heterologous constitutively active small GTPases. 
This DD has been widely applied in cell culture and animal studies (Leong, 2012), (Rodriguez, 
2012) and constitutes a generic23
This potent approach was developed to engineer other DDs for control of fused proteins. Mutants of 
 method of destabilizing a POI by addition of a tag (Fig.1.12.b). 
                                                 
23  However, limitations are observed in certain intracellular contexts: cytoplasmic and nuclear DD fusions are 
efficiently degraded in mammalian cells; whereas fusions to the mitochondrial matrix or ER lumen lead to constitutive 
accumulation (Sellmyer, 2012). 
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E. coli dihydrofolate reductase (ecDHFR) that are stabilized by trimethoprim (TMP), a known low-
cost inhibitor of the human DHFR were genetically engineered in a DD (Iwamoto, 2010). Besides 
being an orthogonal alternative, this DD is more efficient for C-ter POI fusion, transmembrane 
target and nervous system applications compared to Shield1-induced DD. 
 
This method however requires the continuous presence of the stabilizing ligand at a constant 
concentration, which can be an issue for delivery, for example for the long-term study of a POI in a 
developing organism.  Addition, rather than removal of a ligand would allow a better control of the 
degradation of a POI. 
 
Two reverse approaches, in which addition of a small molecule destabilizes a constitutively stable 
protein, were developed by the group of T. Wandless in 2011. In a first strategy (Bonger, 2011), an 
engineered-variant of FKBP fused to destabilizing 19-residue C-ter sequence constitutes a cryptic 
degron which is destabilized by the addition of Shield1 (Fig. 1.12.a). 
b) Small molecule-induced destabilization of a stable POI 
 
In the second strategy (Neklesa, 2011), a hydrophobic adamantyl-ligand can be added to a HaloTag 
dehalogenase (a commercial fusion domain recognizing a specific substrate) fused to a specific POI. 
This hydrophobic group mimics the partially denatured state of a protein, which is recognized by 
the PQC pathway and degraded (Fig. 1.12.c). 
 
Table 1.1 summarizes the properties of the methodologies for small molecule conditional stability. 
 
 Halo Tag destabilization Shield destabilization Shield stabilization ecDHFR stabilization 
Reversibility Partly (50%) Fully Fully Fully 
Half-life time 1.5 h 1 h after addition 1 h after removal several hours 
Cellular toxicity 20 µM None None None 
IC50  21 nM 3.3 nM 100 nM 90 nM 
Working concentration 1 µM 1 µM 1 µM 1-10 µM 
Maximal  depletion 84% 80% 99% 99% 
Tag size 34 kDa 13 kDa 13 kDa 27 kDa 
Ref. Neklesa, 2011 Bonger, 2011 Banaszynski, 2010 Iwamoto, 2010 
 
Table 1.1: Compared characteristics of the methodologies for the control of POI stability by small molecules described 
on section 1.2.2.2. IC50 = half-maximum inhibitory concentration. 
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Fig. 1.12: Overview of the methodologies for the control of POI stability by small-molecules (adapted from (Kanemaki, 
2013)). Engineered FKBP variants are either (a) destabilized (Bonger, 2011) or (b) stabilized by the addition of the 
FKBP ligand Shield1. Alternatively (c), a hydrophobic tag such as adamantate can be addressed to a POI fused to a 
Halo-tag. Conditional destabilization leads to the recognition of POI by endogenous E3, leading to its proteasomal 
degradation. 
 
 
Functional description of Protein Quality Control (PQC) led to the development of POI depletion 
methodologies, confirming the potentialities coming along this chemical biology approach. 
However, these PQC processes differ from the regulated ubiquitination of fully folded proteins 
which acts as a regulation process in cell physiology. A fully-controlled process that does not rely 
on the introduction of a PQC-recognized module (which can be perturbative for POI function) 
would be highly interesting. We need now to explore further specific regulation processes associated 
with E3 Ubiquitin Ligases for selective subsequent developments in POI depletion. 
 
 
 
 
 
 
1.3 The UPS allows the selective regulation of functional proteins 
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1.3.1 Cullin-Ring Ligases (CRL) present a generic, yet modulable strategy for 
selective degradation of protein substrates 
 
1.3.1.1 CRL is a common strategy for substrate ubiquitination in eukaryotes 
Multi-subunit ubiquitin Ligases (E3) assembled on a cullin scaffold were identified in 1997 with 
protein Cdc4 in S. cerevisiae as a substrate archetype for polyubiquitination and proteasomal 
degradation (Feldman, 1997). This superfamily of Cullin-Ring Ligases (CRL) is widely found in 
eukaryotes, where it controls a wide range of cellular and physiological processes, and exhibits a 
high plasticity in substrate specificity (see Fig. 1.13) (Cardazo, 2004), (Petroski, 2005). 
 
As the first identified type of RING E3 ubiquitin Ligases, Cul1-based ligases (also called SCF for 
Skp1, Cul1, F-box) forms an archetypal example on which we will mainly focus. Although some 
variations can be observed, Cul1 illustrates the common features of Cullins (Fig. 1. 13): 
a) CRL present a common architecture for selective substrate recognition 
• at the C-ter, a highly conserved globular cullin-homology domain, mediating the insertion of 
a RING subunit, docking the E2 ubiquitin transferase24
• at the N-ter, a domain
. 
25
 
 allowing the insertion of an adaptor protein for the recognition of a 
substrate protein (Schulman, 2000). 
 
Fig. 1.13: Overview of the specific degradation of protein by SCF pathway. Skp1, Cullin1 and Rbx1 form a common 
core on which F-box adapters can associate. These bipartite proteins are composed of a conserved F-box domain that 
associates with Skp1 and a variable Adapter which can specifically recognize target proteins through degron sequence. 
The association between the substrate and the F-box adapter mediates the physical proximity with activated E2 inserted 
on the RING Rbx1 protein, which can be sufficient for substrate Lys-polyubiquitination. 
In the canonical Cul1 description, substrate receptors are recruited at the N-terminus of Cul1 by the 
                                                 
24 This interaction seems necessary for the activation of the E2 catalytic activity. 
25 A three repeat of five helix bundle CR domain. 
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adaptor protein Skp1. This bipartite protein is able to bind the N-ter domain of Cul1 and to integrate 
a substrate receptor containing a conserved N-ter motif of about 60 amino-acids called the F-box26
 
.  
F-Box, Skp1 and the N-terminal region of Cullin1 binding Skp1 share a high homology with 
respective orthologs through eukaryotic species, which denotes the importance of the conservation 
of these substrate-recognition modules (Fig. 1. 13). 
This whole protein forms a rigid, yet curved structure, acting as a scaffold that spatially connects 
the Ub-charged catalytic E2 and the substrate protein. This close proximity
b) CRL control substrate protein ubiquitination by proximity with E2 enzymes 
27
 
 allows the transfer of 
Ub moieties to accessible Lys residues of the nearby substrate. This paradigmatic model of a rigid 
scaffold was however tempered by the structural flexibility, which is necessary to accommodate 
substrates of variable size and conformation (Qian, 2009). No consensus sequence of ubiquitination 
on the substrate is necessary, although Lys residues must be accessible for the ubiquitin transfer. 
The activity of CRL complexes is tightly regulated in cells
c) Several versions of CRL are concomitantly present in eukaryotic cells 
28
                                                 
26 This name comes from Cyclin F where this motif was first identified. 
. Each CRL can be referred by its 
Cullin core component. The N-ter regions of the seven homologs Cul proteins in human are not 
conserved in sequence, but exhibit structural similarities. The Cul1 scaffold enabling the 
recognition of substrate through conserved adapters seems a common architecture for other Cullin 
based CRLs, although they have been less studied. Without being exhaustive, we present two 
alternative models of CRLs in Fig. 1.14. 
 
27 An intriguing feature in the « classical » Cullin scaffold model was the gap space of ~ 50 Å between the substrate 
adapter and the E2 docked to the Rbx1 domain. A crystallographic structure (Saha, 2008) showed that a small Ub-like 
protein Nedd8 addition to a conserved Lys residue at the C ter of the Cul induces a major conformational change, 
displacing the E2-binding RING domain from the Cullin. This illustrates first that Ub and Ub-like modifications can 
largely modify the structure of a protein, but also that polyubiquitin addition can be regulated by post-translational 
regulation of E3 Ubiquitin Ligases, cycling between different states. 
 
28 Homo- or hetero-oligomerization has been described for some F-box protein, which might finely tune the recognition 
mechanism. A second level of regulation is observed with the instability of the substrate-receptors themselves (de Bie, 
2011). In yeast cells, the half-life time for functional F-box proteins is below 30 min. This destabilization might be a 
consequence of the close proximity of the substrate-receptor to E2-Ubiquitin transferase process, which might transfer 
ubiquitin moieties to the receptor instead of the substrate in an « auto-ubiquitination » process, although E3 ubiquitin 
Ligases specifically targeting F-box proteins have been described in mammals. A complex network of interaction exists, 
as one CRL can ubiquitinate several substrates, but reversely, one substrate can be targeted by several CRLs. This 
global interactome is still widely unknown. 
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• in Cul3-based CRLs, substrates are recruited by a single BTB29 domain, sharing a common 
fold with Skp1. This BTB domain protein acts both as substrate receptor and adaptor, conjugating 
the roles played by Skp1 and F-box protein in Cul1 (Genshik, 2013)30
• Cul4a-based CRLs recruit substrates by a large adaptor protein DDB1, although the 
interaction domain is still unclear. Putative substrate receptors are also discussed. These CRLs are 
associated with UV-lesions detection in the genome (Schrima, 2011). 
. 
 
 
Fig. 1.14: Three CRL complexes architectures. (a) Cul1-based CRLs recruit substrates by a Skp1 adapter inserting a 
substrate adapter by a conserved F-box sequence. (b) Cul3-based CRLs recruit substrates by a BTB receptor (c) Cul3-
based CRLs recruit substrates by a DDB1 adapter inserting a substrate receptor. PID = Protein Insertion Domain. 
 
1.3.1.2 SCF strategy rely on specific substrate recognition 
 
Substrate recognition F-box domains form one of the largest multigene superfamilies
a) SCF specificity rely on F-box adapter diversity: the example of plants 
31 in plants, 
where they are associated with multiple and important developmental functions. At least 694 F-box 
genes have been identified in A. Thaliana, and up to 858 in rice, a number largely exceeding other 
eukaryotic species, such as budding yeast and human (resp. 14 and 24 genes). This abundance and 
diversification of F-box genes appears as a plant evolutionary strategy32
 
. 
                                                 
29 BTB: Broad Complex, Tramtrack, Bric-à-Brac, DDB1:  DNA-Damage-Binding Protein-1. 
30 Up to 439 BTB domain adaptor protein have been identified in human (but only 3 in budding yeast), but it is still 
unclear whether these might form as many distinct functional E3 ubiquitin Ligases, as BTB-box (like F-box) domains 
might have other functions in cells. However, as this model was confirmed on various candidate proteins, one can 
expect this combinatorial sensing to be relevant for cellular processes. 
31  Multigene family proteins are often associated with important morphological aspects in developmental and 
evolutionary biology. In these processes, proteasome-dependant protein degradation is an effective mechanism for the 
cellular responses to different external and internal inputs along the development and the life of an organism.      
 
32 It would however be difficult to presume a general trend of F-box specification in plants; the number of F-Box genes 
is variable from species to species: 337 F-box genes have been reported in the nematode C. elegans. 
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An F-Box protein can be generally modeled as a bi-modular protein with an F-box domain at its N-
term and a Substrate Binding Domain. A genome-wide analysis in plants (Xu, 2009) identified 
many F-box candidates with others domains in the C-terminal region. Most abundant domains are
b) Plant F-box are bipartite proteins for substrate recognition 
33
• WD40-Repeat domain: a β propeller structure able to recognize Ser/Thr phosphorylation site 
 : 
• Leucine-Rich-Repeat Domain (LRR), an arc-shaped α/β repeat structure found in many 
protein binding contexts as it seems to offer a high modularity for wide substrate recognition.      
This modular nature allows the specific recognition of a wide range of substrates (Fig. 1.15). 
 
 
 
Fig. 1.15: Examples of F-box proteins in A. thaliana composed of a common N-ter F-box domain and proteins domains 
for substrate recognition. These domains vary by their composition, their repetition and their distance to the F-box 
domain. For each type, a representative example is displayed, along with the numbers of occurrence of this motif in 
Arabidopsis (adapted from (Xu, 2009)). 
 
  
F-box proteins allow a generic, yet adaptable strategy for the degradation of protein substrates by 
SCF multi-domain complexes. The selectivity of substrate selection is permitted by their modular 
nature, which is essentially bipartite
c) Towards a chemical biology approach 
34
 
, as illustrated on Fig. 1.20 for plant F-box proteins: 
• the F-box domain (about 50 a.a., although lacking a strict consensus sequence (Kipreos, 
2000)) binds to Skp1, mediating the recruitment by the core component of the SCF 
• a variable protein-protein interaction domain for specific recognition of distinct substrates 
 
These observations opened the way to chemical biology approaches: selective depletion of specific 
endogenous POI by combining the activity of E3 ubiquitin Ligases with designer binding proteins. 
                                                 
33 Mammalian F-box proteins are often denominated by their binding domains: FBWs for F-box with WD-40 Repeat, 
FBLs for F-box with Leucine-Rich-Repeat (Jin, 2004). 
 
34 This bipartite nature is comparable with transcription factors decoupling DNA binding and transcription modulation 
domains which can be derivatized, for example in Yeast Two-Hydrids for monitoring protein interactions. 
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1.3.2 A chemical biology approach to POI depletion: hijacking the UPS 
selectivity by chimeric bipartite molecules 
 
1.3.2.1 Chimeric bipartite F-box proteins target POI degradation 
Chimeric F-box proteins can insert endogenous SCF complexes through interaction with Skp1 to 
form functional ubiquitin ligases (Su, 2003). Thus, selective depletion of POI can be induced by 
genetic engineering of a bipartite chimeric protein, by fusing an F-box protein with a peptide or a 
protein sequence that is able to bind to a target POI35
 
. Harnessing the POI to the artificial E3 leads 
to its ubiquitination and subsequent proteasomal degradation. 
This strategy was first developed for the specific degradation of pRB (Retino Blastoma Protein) in 
yeast (Zhou, 2000). We present here (Fig. 1.16) the example of depletion of β-catenin, which was 
implemented by hijacking its SCF-degradation pathway mediated βTrCP (Cong et al., 2003). This 
F-box protein normally recognizes phosphorylated β-catenin and IκB through WD40 repeats. 
a) Example of application: endogenous β-catenin is ubiquitinated by a chimeric β-TrCP F-box 
 
 
Fig. 1.16: Example of a chimeric F-box strategy for constitutive degradation of an endogenous POI. (a) In vivo, the 
phosphorylated β-catenin (β-cat) is recognized by SCFβ-TrCP and degraded. (b) A chimeric protein associates the N-ter β-
TrCP F-Box and an E-cadherin (E-cad) domain that recognizes unphosphorylated β-cat and targets it for degradation. 
 
A chimeric F-box protein was engineered by fusion of the C-ter of β-TrCP (containing the F-box) 
with the β-catenin binding domain of E-cadherin (90 a.a.) separated by a Gly-Ser linker preventing 
the steric hindrance. Expression of this chimera induced a protein knock-out of unphosphorylated β-
Catenin in mice, allowing a model to study the effect of β-Catenin silencing in some cancers.  
                                                 
35 This approach has also been realized with HECT E3 ubiquitin ligase (Colas, 2000). A PBD aptamer with high affinity 
for Cdk2, selected from yeast-two hybrids combinatorial libraries, was fused to the catalytic domain of a HECT E3 
ubiquitin Ligase. This chimeric protein expressed in yeast induced the polyubiquitination of the target Cdk2 protein. 
This did not however lead to proteasomal degradation, but rather to changes in the subcellular localization. This 
outcome might be explained by the fact that endogenous Cdk2 is not subject to ubiquitin dependent proteolysis; 
addition of an Ub residue might not therefore be sufficient to destabilize the Cdk2 proteins (Colas, 2000). 
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Optimization of the chimeric F-Box protein for improved interaction included elimination of the 
binding sites of endogenous substrates in the F-Box domain protein, a minimal POI binding domain 
to prevent unspecific interaction and adaptation of the linker length for increased flexibility. 
 
The hijacking of the multimeric SCF Ubiquitin Ligase system raised concern that over-expression 
of engineered F-box proteins might overwhelm the endogenous SCF machinery, inhibiting the 
ubiquitination process (Zhou, 2005). As an alternative, Portnoff et al. proposed the use of the single 
chain U-box type E3 derived from CHIP (see part 1.2.2.1), with a broad substrate activity. This U-
box protein fused to a PBD forms a functional E3 ubiquitin ligase without needing endogenous 
partner adapters (Portnoff, 2013). 
b) Extension to chimeric U-box proteins as an optimization strategy 
 
1.3.2.2 Chimeric bipartite adapter proteins rely on specific POI binding domains 
The first generations of engineered E3s necessitated natural protein domains that were known to 
specifically interact with the target protein; consequently, the example set were limited and did not 
allow a generic technique for the depletion of any POI. 
 
An approach to overcome this problem is the use of single-chain antibody fragments called 
nanobodies
a) Single-Domain Antibody fragments 
36
 
. A chimeric F-box protein was engineered by fusing the N-ter of an endogenous F-box 
to single-domain GFP antibody fragment VhhGFP4 (Fig. 1.17) (Caussinus, 2011).  
 
 
 
Fig. 1.17: Overview of the strategy described in (Caussinus, 2012) for the constitutive degradation of a POI fused to a 
GFP. A chimeric protein associates an F-Box and a GFP antibody fragment that recognizes GFP tagged proteins and 
targets them for degradation. 
 
                                                 
36The nanobody development addressed the limitations of antibodies fragments in cells, which cannot fold in the 
cytoplasm due to disulfide oxidation. They often use single-domain antibody derived from immunized llamas. 
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This method (deGradFP) allowed the degradation of GFP-tagged histones in mammalian cells and 
fruit flies. Temporal-controlled expression with a region-specific promoter in Drosophila confirmed 
the specificity37
 
 and the fast kinetics (2-3 hours) of the degradation. Although this method was 
developed against a chimeric fusion protein, the wide use of GFP as a fusion reporter tag makes the 
depletion of GFP- POI promising (Morin, 2001). 
Another possibility to implement POI binding domain is the development of DARPins, which are 
engineered ankyrin-repeat proteins selected from randomized libraries, allowing the development of 
small Designer Binding Proteins (DBP) with high specificity for any target POI. Brauchle et al. 
adapted the deGradFP technique to engineer a chimeric F-box protein fused to an anti-GFP DARPin 
which reproduces the characteristics of DeGradFP (Brauchle, 2014). 
b) DARPins 
 
Peptide aptamers, which are affinity binders composed of short stretches of variable peptide regions 
constrained within a protein scaffold constitute a third alternative. A chimeric F-box protein 
containing a peptide aptamer selected against β-catenin was able to significantly deplete this protein 
(Yeh, 2013). This constituted an important step towards a generic, fully encoded method to deplete 
any POI. This was confirmed later by Portnoff et al. who developed chimeric proteins called 
ubiquibodies by fusioning Chip U-Box to DARPins DBP, which can degrade endogenous proteins 
in various cell lines (Portnoff, 2013). 
c) Peptide aptamers 
 
These examples show the potentialities coming along the development of fully-encoded and generic 
techniques to induce knock-out of any POI38
 
. This requires the expression of a chimeric adaptor 
protein, which can be either constitutively expressed, or induced by a conditional promoter. This 
limits however the time resolution of this protein depletion technique. A small-molecule 
methodology, PROTACs, offer an alternative strategy for depletion of endogenous proteins. 
 
                                                 
37It is notable however that deGradFP could not degrade GFP alone, indicating that this adaptor-mediated depletion 
were not completely generic for small protein substrates. 
 
38 This methodology can be combined with RNAi silencing, or genomic edition with CRISPR/Cas9 (Park, 2014) for 
faster and complete protein depletion. 
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1.3.2.3 PROTACs: a small-molecule approach to conditional POI depletion 
 
Proteolysis-targeting chimeric molecules (PROTACs) are bifunctional heterodimeric molecules 
composed of two ligand-recognition motifs separated by a linker sequence. A first ligand, mostly a 
peptide, is known to interact with an E3 ubiquitin ligase complex, whereas the second ligand targets 
a specific POI (Sakamoto, 2001). PROTAC molecule mediates the formation of a ternary complex 
with the POI and the E3 ubiquitin ligase. This induced-colocalization can mediate the 
polyubiquitination of the POI by the ubiquitin ligase and its eventual degradation by the proteasome 
(Raina 2010). 
a) Overview of the bipartite molecule approach 
The first described PROTAC conjugated ovalacin, a covalent MetAP-2 covalent binder to a 
phosphopeptide derived from lκBa binding the mammalian F-box SCFβ-TrCP (transducin repeat-
containing protein, see section 1.3.2.1) 39
 
. MetAP-2 is recruited by the SCFβ-TrCP in vitro, 
polyubiquitinated and degraded by the proteasome (Carmony 2012) (Fig 1.18). 
 
Fig. 1.18: Overview of PROTAC strategy for conditional degradation of an endogenous POI. A bipartite molecule with 
ligand-recognition motifs mediates the heterodimerization between a POI and a functional F-box protein part of an SCF 
complex.  This interaction can be sufficient to target the POI for proteasomal degradation. This principle is illustrated 
with artificial addressing of MetAP2 to SCFβ-TrCP by a PROTAC molecule associating ovalacin and a specific peptide 
targeting SCFβ-TrCP.  
 
An essential condition for the development of PROTAC against a specific POI is to have a 
described high-affinity ligand, which limits the field of target POI. It also requires the design and 
synthesis of the PROTAC molecule, however with no molecular biology manipulations needed, as 
b) Implications of the PROTAC strategy for a small-molecule based perturbation of a POI 
                                                 
39 A subclass of PROTACs, SNIPER, relies on the bestatin esters, which recruit the E3 Ubiquitin Ligase cellular 
Inhibitor of Apoptosis Protein 1 (cIAP1). However, this molecule is rather unstable and not very specific. Alternatively, 
many PROTAC molecules target  Von-Hippel Lindau protein (VHL), a Cullin 2-based E3 ubiquitin-ligase. 
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it targets endogenous proteins. One drawback of PROTACs is their poor cell-penetrability40
 
, which 
initially limited their applications to cell extracts or necessitated microinjection. Introduction of a 
Cell-Penetrating-Peptide sequence (CPP) allowed in vivo delivery. 
Interestingly, an example of ligand-induced modulation of a PROTAC platform was reported with 
the development of PhosphoPROTACs. In this case, the POI-targeting ligand is a peptidic sequence 
phosphorylated by membrane receptors in response to external stimulus by growth factor, which 
modifies the affinity of the PROTAC for the POI
c) Possible modulation of a PROTAC activity 
41
PROTACs constitute an interesting example of perturbative technologies using small molecules (a 
field sometimes called chemical genetics). Due to its elegant approach, which hijacks the 
endogenous degradation machinery, they offer a robust platform for protein knock-outs which could 
be developed by chemical libraries screenings. The described examples offer highly potential 
candidates for therapeutic applications. 
 (Hines, 2013). 
 
However, as PROTACs rely on specific artificial POI ligand, they do not present a fully generic 
method for POI depletion. Natural small molecule-mediated modulation of the activity of a SCF E3 
ubiquitin ligase has been described in metal homeostasis (Salahudeen, 2009), (Kobayashi, 2011). 
Identification of these processes might be a significant step towards the development of fully generic 
POI depletion. We will now detail this process for the Auxin-Induced Degradation. 
 
 
 
 
 
 
                                                 
40However, PROTAC molecules are still permeable, in contrast to RNAi, which require a transfection agent to be 
efficiently delivered in vivo. They also present a dose-dependent knockdown. Another advantage is that PROTAC 
specifically target a three-dimensional protein conformation. This theoretically allows to specifically target 
conformational subpopulations of a protein, which can be difficult achieved by either RNAi or small drugs relying on 
functional inhibition of the enzymatic activity. It can also target non-enzymatic proteins. 
41 For example, NGF (nerve growth factor) selectively stimulates the TrkA-dependant phosphorylation of a PROTAC 
containing the TrkA phosphorylation-sequence. This modification enhances the affinity of the PhosphoPROTAC for 
PI3K, recruited at a VHL E3 ubiquitin Ligase and degraded within 6 hours (Hines, 2013). 
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1.4 Auxin-induced degradation, a conditional small-molecule system 
for specific protein depletion 
 
1.4.1 Nuclear Auxin-Response in plant involves controlled degradation strategies 
 
1.4.1.1 The phytohormone auxin regulates genetic expression by controlled degradation 
 
The plant hormone auxin, a small tryptophan-derived indole molecule, is involved in almost all 
developmental processes in plants, promoting different cellular processes in a tissue-dependent 
concentration response
a) Nuclear Auxin Response is a transcriptional switch mediated by auxin 
42
 
. Auxin has been identified as a regulator of the stability of a family of 
transcriptional repression factors Aux/IAA (dubbed so relative to the expression in presence of 
auxin IAA), with 29 members in Arabidopsis Thaliana (At). These Aux/IAA proteins bind to and 
repress the activity of DNA-binding transcriptional activators ARF (Auxin-Response Factors) 
through a conserved dimerization domain (Wright, 2015). In the presence of auxin, degradation 
Aux/IAA proteins are degraded by the Proteasome in a few minutes, leading to a de-repression of 
ARF-mediated transcription (Fig. 1.19) (DeRybel, 2009). 
SCF Ubiquitin Ligase had been reported as responsible for the ubiquitination of Aux/IAA. More 
accurately, the F-box protein TIR1 (Transport Inhibition Response 1) was identified in 2005 as an 
auxin receptor, which evoked a direct link between auxin perception and its protein degradation 
response, excluding intermediate transmission pathways: 
b) Nuclear Auxin Response involves the SCFTIR1 E3 Ubiquitin Ligase 
• auxin promotes the interaction between TIR1 and Aux/IAA in a pull-down reaction 43
• competitive binding experiments showed that auxin directly binds to TIR1 
, 
independent of temperature, and without involving a stable modification of either protein; 
• interaction between synthetic protein in cell-free expression system (Dharmasiri, 2003), or 
in insects cells extracts could be induced by auxin. (Dharmasiri, 2005). 
 
                                                 
42 Historically, the existence of auxin was postulated by Charles Darwin in 1881 to explain phototropism in plants, but 
it was isolated and its structure was solved only some fifty years later (DeRybel, 2009). 
 
43 A 17 amino-acid peptide from the core of domain II in Aux-IAA, corresponding to a region identified with mutations 
disrupting the interaction with TIR1, is sufficient to pull-down TIR1 in presence of auxin (Kepinski, 2005). 
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1.4.1.2 Auxin directly mediates heterodimerization of TIR1 and Aux/IAA 
A crystallographic structure of AtTIR1 in the presence of auxin and a 13-amino-acid peptide from 
Domain II of Aux/IAA protein AtIAA7 (Tan, 2007), lighted-up the mechanism of perception of 
auxin: the eighteen Leu-rich repeat (LRR) domains at the C terminus of TIR1 form a mushroom-
like pocket binding auxin. This small molecule acts as “molecular glue”, enhancing the interaction 
between the two partners, through docking of a hydrophobic pocket 44
 
. Surprisingly, another 
molecule, inositol hexakisphosphate (InsP6) is bound at the interaction core of TIR1. Several 
synthetic auxins, such as 1-Naphalene-Acetic Acid (NAA) or 2, 4-Dichlorophenoxyacetic Acid (2, 
4-D) can also trigger this dimerization. This auxin-mediated interaction leads to the poly-
ubiquitination of Aux/IAA through conserved Lys residues, and its fast proteasomal degradation. 
Fig. 1.19: Overview of the Nuclear-Auxin Response in plants. The expression of ARF genes is regulated by ARF 
transcriptional activators. The phytohormone auxin activates ARF expression by inducing the proteasomal degradation 
of ARF-repressors Aux/IAA. Auxin mediates the direct heterodimerization between Aux-IAA and SCFTIR1, leading to 
the polyubiquitination and eventual proteasomal degradation of Aux/IAA. 
 
In conclusion, auxin directly regulates the interaction between an F-box and its substrate45
                                                 
44 A recent paper highlighted the role of nitric oxide NO in the auxin-dependent degradation: NO enhances TIR1- 
Aux/IAA interaction, while NO depletion blocks Aux/IAA protein degradation. This modulation is mediated by the S-
nitrosylation of critical Cys residues localized on the LRR loops. These finding suggest that auxin sensing might be 
finely regulated by small molecules other than auxin, and post-transcriptional mechanisms (Terrile, 2013). 
 (and not 
by allosteric conformation change). This would constitute an interesting platform for a small 
molecule conditional protein degradation. 
 
45 This direct interaction constitutes an interesting example of natural ligand-induced dimerization, to compare with the 
widely used artificial rapamycin dimerization system. Would it be possible to make a dimerization system with TIR1 
and Aux/IAA? In the original biological context, as well as in heterologous yeast or mammalian system, TIR1 is 
associated with endogenous Skp1 to form a functional E3 through its F-Box ; auxin-induced association between TIR1 
and Aux/IAA results in the polyubiquitination and proteasomal degradation of IAA as the F-Box sequence is implicated 
in the interaction with Aux/IAA (Dharmasiri, 2005), it is difficult to have a stable association with no degradation ; this 
system might be possible in a system where TIR1 does not associate with endogenous ubiquitin Ligase proteins, such as 
bacterial or cell-free expression system, or to engineer TIR1 to prevent association with Skp1. 
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1.4.2 Auxin-Inducible-Degron (AID), a chemical biology methodology for 
conditional protein degradation 
 
This feature was derivatized by the team of Kanemaki (Nishimura, 2009) to elaborate an elegant 
strategy to control the degradation of POI by a chemical biology approach. This exploits the 
universality of ubiquitination and proteasomal degradation processes in eukaryotes, the genericity 
of the SCF E3 ubiquitin ligase and the specificity of phytohormone perception in plants (Fig. 1.20). 
 
1.4.2.1 The auxin-inducible degron allows conditional degradation in yeast 
 
Heterologous F-box protein AtTIR1 expressed in yeast can associate with endogenous Skp1 (see 
part 1.3.1.1), due to the high conservation of Skp1 and F-box sequences through eukaryotes, to form 
a functional RING SCF ubiquitin ligase, as was confirmed by immunoprecipitation. As TIR1 
possesses no orthologs in non-plant cells, this artificial ubiquitin Ligase is orthogonal to yeast; it 
can however interact with and ubiquitinate a heterologous Aux/IAA protein in an auxin-dependent 
manner (Fig. 1.20). AtAux/IAA17 protein was selected among the 29 members of the Aux/IAA 
family (presenting a differential affinity to auxin-dependant TIR1 binding) for its short life-time 
(about 10 min in presence of auxin).  
a) AID methodology relies on heterologous expression of plant proteins in yeast 
 
 
 
Fig. 1.20: Overview of the Auxin-Inducible Degradation depletion method. In plants, the transcriptional repressors 
Aux/IAA are degraded by SCFTIR1 in presence of auxin which mediates direct heterodimerization. AtTIR1 
heterologously expressed in yeast or mammalian cells associates with endogenous SCF components to form a 
functional artificial Ubiquitin Ligase E3, which associates to an AID-tagged POI in an auxin-dependent fashion. 
Consequently, the AID-POI is degraded by the proteasome. 
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The complete sequence of AtAux/IAA17, which will later be called the AID for Auxin Inducible 
Degron, can be fused to POI. Addition of 500 µM auxin in yeast cells heterologously expressing 
AtTIR1 and nuclear AID fused to a reporter GFP (AID-GFP-NLS) led to the rapid (30 min) and 
complete (97%) proteasomal degradation of the AID-GFP-NLS (Nishimura, 2009). 
b) AID allows auxin-dependent POI depletion 
 
The AID methodology presents several interesting features for the development of a perturbation 
technique. First, degradation is reversible, as auxin removal (by change of medium) disrupts the 
TIR1-AID interaction and thus stops the AID degradation, which is re-expressed within one hour. 
Another interesting feature for the development of a generic method is that the AID tag can be 
incorporated either at the N- or C-ter of the target POI. Last, the extent of depletion is finely tunable, 
as the depletion process is a direct auxin-dose response. 
c) AID is a generic POI depletion methodology 
 
Over the six years following the publication of this strategy, the AID protocol has been widely 
exploited in yeast cells (more than 50 reported applications in Pubmed) as a perturbation technique 
to explore the function of POI. It is often used to confirm the predicted role previously postulated 
with other molecular biology methods such as siRNA or immunoprecipitation.                      
Several methodological papers have reported improvements of this technique in yeasts, such as 
subcellular addressing, fusion with endogenous ubiquitin ligase components, or optimization by 
using mutants and orthologs variants of TIR1 and IAA. These methods will be presented and 
discussed on chapter 3. 
 
One of the characteristics of the AID approach is that it necessitates the expression of two proteins, 
contrary to the techniques evoked in part 1.2 (where expression of a single POI fused to a 
destabilizing domain is sufficient to induce degradation, relying on endogenous machinery). A main 
issue of this heterodimerization system is to control stoichiometry of the two heterologous proteins: 
d) AID requires the co-expression of two heterologous proteins 
• Overexpression of TIR1 would saturate insertion of TIR1 in endogenous SCF 
• Overexpression of AID-POI would saturate the SCF-TIR1 ubiquitin Ligase, therefore               
slowing down the kinetics of degradation. 
Kanemaki et al. proposed the use of IRES (internal ribosome entry site)-based bicistronic plasmid 
for the co-expression of the two proteins46
                                                 
46 The stoichiometry of expression can be adjusted by regulation of the strength of the IRES. 
. 
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1.4.2.2 The AID methodology can be extended to mammalian culture cells 
The application of perturbative techniques from yeast to mammalian culture cells is highly desirable, 
but not always possible, as illustrated by the ts-degron methodology (see part 1.2.1.2). 
 
 
a) Optimization of the F-box protein TIR1 is needed for AID application to mammalian cells 
Indeed, heterologous expression AtTIR1 and AID-GFP-NLS did not lead to notable auxin-
dependent degradation in mammalian cells at 37°C (Nishimura, 2009). The authors postulated that 
AtTIR1, normally functioning at 24°C was temperature sensitive, and introduced OsTIR1 isolated 
from rice species (Oryza sativa) growing at warmer temperature47. Heterologous OsTIR1 efficiently 
induced the proteasome-dependent degradation of AID-GFP-NLS at 37°C in variable mammalian 
culture cell lines by addition of 500 µM auxin.48
 
 The authors claimed a half-life as low as 10 min in 
Human Embryonic Kidney (HEK) cells. 
In 2012, the team of D. Cleveland confirmed the potentiality of this approach by conditionally 
depleting various protein targets in different cellular contexts, in mammalian culture cells, as 
summarized on Table 2 (Holland, 2012). Although application to mammalian cells have been 
associated with particularly interesting kinetics, few applications have been reported to this day. 
b) Mammalian AID is a generic protein depletion platform 
Protein identity Plk4 CENP-A TRF2 Cyclin B1 H2B 
Localization nuclear cytoplasmic nuclear cytoplasmic nuclear 
Localisation centrosomic centromeric telomeric diffuse diffuse 
Half-life (min) 9 18 13 17 40 
 
Table 1.2: Reported POI targets for AID-degradation in (Holland, 2012). For each example, the localization of the 
heterologous POI-AID is reported with the half-life upon 500 µM auxin addition. 
  
1.4.2.3 Fine regulation of auxin-mediated response by combinatorial auxin-sensing variants 
 
TIR1 is a member of the AFB gene family where four members have been recognized as auxin 
receptors
a) A complex regulation of nuclear-signal proteins is associated with fine auxin sensing 
49
                                                 
47 This was not true however for the GhTIR1 from tropical cotton (Gossypium Hirsutum) closely related to AtTIR1. 
. A complex regulation of the Aux/IAA genes exists, showing that a fine tuning and 
 
48 Natural Auxin (Indole Acetic Acid, IAA) or artificial Auxin (Naphtalene Acetic Acid, NAA). 
 
49 Members of the AFB family share homology with the Jasmonic acid receptor COI, which might indicate a common 
hormone sensing which evolved to specific perception of different molecules. 
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plasticity exists in the AFB-dependent auxin reception (Parry, 2009). In particular, the TIR1 and 
AFB1 proteins share a 70% homology; both exhibit variable affinity to Aux/IAA proteins 
conditioned by the presence of auxin at very variable ranges. 
Combinations of pairs taken among the 4 AFB receptors and the 29 Aux/IAA proteins in 
Arabidopsis assemble at different auxin concentrations, as monitored in yeast two-hybrids assays 
(Villalobos, 2012). This feature allows a large dynamic range of auxin sensing by differential 
sensitivity of co-receptor pairs. These characteristics have been exploited to develop quantitative 
ratiometric assays to measure auxin dynamics with large and adaptable ranges (Wend, 2013). 
 
As an illustration of the potentiality associated to this chemical biology approach (expressing 
ectopic proteins as functional modules in model system), the entire Arabidopsis nuclear auxin signal 
has been recapitulated in yeast (Pierre-Jerome, 2014), by expressing the modular elements of auxin-
reception pathway (Fig. 1.21): 
b) The whole plant auxin-response pathway can be functionally expressed in yeast 
• an auxin receptor of the AFB family (6 members) 
• a transcriptional repressor of the Aux/IAA family (29 members) 
• an Auxin-Response transcription Factor (23 members) associated with a plant ARF promoter 
 
 
Fig.1.21: Overview of the strategy reported by (Pierre-Jerome, 2014). The Arabidopsis nuclear auxin response can be 
recapitulated in yeasts by a heterologous expression of a combination of three components taken among the variants 
existing in A. thaliana: an ARF transcriptional activator, an Aux/IAA transcriptional repressor and an AFB F-box 
protein. These heterologous plants proteins associate with endogenous transcription and UPS systems due to high 
conservation of specific association sequence among eukaryotes to form functional artificial systems. 
 
These ectopic proteins inserted into the UPS and transcriptional machinery, due to conservation of 
common features through eukaryotes, specificity of interaction and orthogonality of the 
heterologous proteins. Combined with a mathematical model, this allowed a fine evaluation of the 
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combinatorial constants of interaction of the core elements of the Auxin Response Components. 
This reconstituted system might allow better understanding of how a simple pathway orchestrates a 
large number of responses in response to auxin, depending on cellular context. 
 
1.5 Conclusion 
 
In this chapter, we described the mechanisms controlling the stability of a given protein by 
regulation of the UPS-dependent degradation in eukaryotes. This allowed first the development of 
constitutive unstable versions of POI; but subsequently, several examples of conditional degradation 
were described, relying on a perturbational actuation method. As mentioned on section 1.2.1.2.d, 
both chemical and temperature-shift strategies suffer from intrinsic limitations50
 
 which prevent the 
development a specific and generic degradation methods. 
Light activation is a relatively non-invasive and specific perturbation. The wavelength and intensity 
of illumination can be finely tuned. Moreover, precise patterns of illumination can be controlled in 
time and space with lasers, down to a subcellular resolution. Light appears therefore as a promising 
method for specific control of degradation. In the next chapter, we will thus describe strategies for 
the photocontrol of protein activity. 
 
 
 
 
 
 
 
 
 
                                                 
50 Chemical strategies imply addition or removal of a small molecule.  Alternatively, temperature-shift is highly-specific, 
but can only be applied to a limited number of eukaryotes and is highly perturbative. 
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Chapter 2 
Strategies for the photocontrol of protein activity in vivo 
 
On Chapter 1, we described the mechanisms controlling the stability of a given protein by 
regulation of the UPS-dependent degradation in eukaryotes. In this chapter, we will thus describe 
strategies to control the activity of POI in vivo, with a specific perspective for the implementation of 
a light-controlled proteasomal degradation. We will first describe photosensing protein modules 
existing in living systems, for the subsequent development of optogenetic actuation tools51
 
. Then, in 
a second part, we will present chemical tools enabling light-control. 
2.1. Photosensible protein modules trigger effector responses upon 
light illumination 
 
2.1.1. Description of photosensible protein modules 
 
Photochemical reactions in cells take place in protein complexes converting the incoming radiation 
in either energy (photosynthesis), or information through an ontology of proteins called 
photoreceptors, distributed in all kingdoms, including non-photosynthetic organisms (Miesenbock, 
2011). These proteins can be described as a combination of a receptor (sensing light-variation in the 
environment), and an effector module. 
 
                                                 
51 In a restricted sense, optogenetics refer to the control of physiological activity by genetically encoded light-sensitive 
proteins. A strict application of the definition might exclude some important achievement, such as the development of 
caged-neurotransmitters, as it does not correspond to a genetically encoded technique. In this work, we will rather use 
photoactuation, as the control of physiological function in vivo by light illumination (Deisseroth, 2011). 
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UV and visible light quanta are associated with energies up to 400 kJ/mol, comparable in magnitude 
to the strength of a single or a double bond. Photon absorption by an extended conjugated π electron 
systems52 can trigger a photochemical reaction: cis-trans isomerisation, bond cleavage (photolysis) 
or bond formation, or charge dissociation (Moglich, 2010). This results in transmission of a global 
conformational change in the holoprotein, which either alters directly the activity of an endogenous 
effector domain, or modifies the affinity of the photoreceptor protein for a binding partner. In both 
cases, a discrepancy in activity exists between the dark ground and the light-activated state. This 
process is reversed in the dark by thermal return53
 
 (Tischer, 2014). 
Consequently, these photosensitive domains offer interesting opportunities for light-actuation that 
can be fused to POI for the control of a physiological pathway by light. This led to the blooming 
development of optogenetics54
 
 over the last few years, which have been extensively described in 
complete reviews (Goguen, 2011), (Kim, 2013), (Gautier, 2014). We will give next a short 
description of four existing light-sensitive proteins adapted into optogenetic methodologies. 
2.1.2. Examples of photosensible protein modules 
 
2.1.2.1 LOV-domain modules 
The light-oxygen-voltage (LOV) domain55
                                                 
52  Generally a chromophore cofactor is bound to the protein; however, receptors in UVR8 are endogenous Trp residues 
mediating the switch from dimeric to monomeric state upon activation, in absence of cofactor (Tischer, 2014). 
 proteins are blue-light sensing modules, associated to 
phototropic responses in plants (Krauss, 2009). The LOV module consists of a core domain of about 
110 a.a. binding a photoreactive cofactor flavin mononucleotide (FMN). Illumination with blue 
light leads to the formation of a covalent bond between the flavin and a conserved Cys residue. This 
conserved mechanism triggers however various conformational changes at N-or C-termini, resulting 
in different outputs (Zoltowski, 2009). Thermal hydrolysis of the cysteinyl-flavin bond allows the 
 
53 An inherent limitation of light-sensitive domains is that equilibrium exists between dark and activated states due to 
thermodynamic properties: a fraction of protein is active in dark, resulting in background activity (Vendrusolo, 2008). 
 
54  The most dramatic methodologic developments are undoubtly channelrhodopsin-based tools, enabling the 
photocontrol of ionic fluxes and membrane polarization, with applications in neurophysiology.  As it is not directly 
relevant for our approach, it will not be described in this dissertation. An example of review is found in (Dugué, 2012). 
 
55 LOV domains are part of a larger class of PAS (PER-ARNT-SIM) sensory domains, which can be associated with 
various multi-domains effector proteins, including DNA-binding proteins or histidine-kinases. Four major LOV families 
are currently identified in Plants and fungi (Krauss, 2009). 
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return to dark-state. This diversity of conformational modulations is associated with an extended 
library of LOV variants and mutants exhibiting different kinetic and thermodynamic properties. 
Therefore, LOV-domains were identified as promising candidates for the development of 
optogenetic tools (Pathak, 2013). Possible implementations described on Fig. 2.1 include (a) photo-
controlled homodimerization (Zoltowski, 2009), (b) light-dependent unfolding modulating the 
activity of a fused POI (for example, DHFR in (Lee, 2008)), or (c) conditional exposition of a fused 
sequence by unfolding of the Jα-helix (for example controlling the sequestration of an addressing 
peptide) (Strickland, 2012). 
 
 
Fig. 2.1: LOV-domain based light-sensitive modules for implementation of optogenetic process in vivo: (a) Light-
dependent homodimerization; (b) Light-dependent conformational change of POI (DHFR) fused to a LOV-domain. (c) 
Light-dependent heterodimerization  by differential sequestration of a PDZ recognition peptide fused to a LOV-domain. 
 
2.1.2.2 Cryptochrome-based modules 
Cryptochromes are a class of proteins binding a FAD cofactor, which are implicated in circadian 
clock regulation in animals, and in growth control in plants; in these systems, blue-light absorption 
induces reduction of the FAD chromophore, inducing a reversible conformational change in the C-
terminal helical domain56
                                                 
56 This mechanism however also involves a triad of conserved Trp residues. 
, which thermally returns to the ground state in minutes (Kim, 2013). 
Interestingly, blue-light mediates differential affinity of AtCry2 to a binding partner CIB1 (calcium 
and integrin-binding protein). This was derivatized in a photoactivatable dimerization platform 
(Kennedy, 2010) that has since been validating on multiple approaches (Pathak, 2013) (Fig. 2.2.a). 
Interestingly, aggregation of Cry-fusion proteins was observed in certain conditions (Tischer, 2014). 
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2.1.2.3 Phytochrome-based modules 
Plant phytochromes are a class of light-responsive proteins with N-terminal sensory module binding 
a linear tetrapyrole chromophore, which undergoes cis-trans isomerisation induced by red-light, 
resulting in a global conformational change in the protein, from red-absorbing (Pr) at 650 nm to far-
red absorbing (Pfr) state. Either thermal return or far-red illumination at 750 nm converts Pfr back 
to its red state (Kim, 2013). Pfr differentially bind to PIFs (phytochrome-interacting factors). 
Photoactivatable tools for heterodimerization of POI were implemented with PIF3 and PIF6 (Fig. 
2.2.b) (Pathak, 2013). Development of red-absorbing photoactuators is highly desirable because of 
the low toxicity and high tissue-penetration of red-light; however, they require addition of 
exogenous chromophore, and exhibit slower kinetics than blue light-based systems (Tischer, 2014). 
 
2.1.2.4 FP Dronpa monomeric state is reversibly controllable by light 
The group of Lin designed variants of the photoswitchable fluorescent protein Dronpa whose 
oligomerization state is light-dependent (Zhou, 2013). 145N Dronpa variants associate into a 
fluorescently-active tetramer, which dissociate upon cyan (500 nm) illumination. Variants 145N and 
145K associate into a dimer. This dimer also dissociates upon 500 nm illumination, but is reformed 
by thermal return or 400 nm illumination (Fig. 2.2). This propriety was derivatized for the light-
control of protein activity: Dronpa monomers fused to a POI associate into a dimer (or tetramers 
with POI dimerization) which can mask (« cage ») an active site, activated by a 500 nm illumination. 
This elegant approach allows reversible photoactivation process, although protein engineering with 
Dronpa can be challenging 57
 
. 
Fig 2.2: Light-sensitive modules for implementation of light-controlled heterodimerization of POI in vivo: (a) Blue-
light-dependent interaction of Cry and CIB. (b) Red-light-dependent interaction of PhyB and PIF, reversed by far red-
light (c) Blue-light-dependent interaction of Dronpa variants 145N and 145K can hinder a POI active site. 
                                                 
57Another plant protein UVR8 (UV-B resistance), stably dimeric in the dark, dissociates upon UV illumination, 
enhancing its affinity for COP1 (Constitutively Morphogenic 1) (Kim, 2013). UVR8-COP1-based photo controlled 
dimerization platform have been implemented in mammalian cells, although prolonged use of UV light can be an issue. 
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2.1.3 Classification of optogenetic systems based on photosensible protein 
modules 
 
2.1.3.1 By physiological function target 
Development of the photosensing proteins described above led to numerous applications for POI 
control in vivo, that we cannot extensively describe here. We identified ten classes of cellular 
functions that can be controlled by optogenetic tools, presented on Fig 2.4. 
 
Fig. 2.3: Overview of the light-controlled physiological processes implemented by optogenetics for in eukaryotes 
• Subcellular localization (green): nuclear addressing (1), membrane addressing (2) or  sequestration (3) 
• POI activity (red): either controlled by conformational change (4) or heterodimerization (5) 
• POI turnover (violet): proteasomal degradation (6), transcription initiation (7), or small-RNA control (8) 
• Membrane protein control (Blue), including ion channel activation (9) or membrane receptor activation (10). 
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Table 2.1 proposes reference examples for each physiological function and photosensor type: 
# LOV domains Cryptochrome Phytochrome Others
1 Nuclear Import Niopek, 2014 Crefcoeur, 2013 (UVR8)
2 Membrane addressing Strickland, 2012 Kennedy, 2010 Levskaia, 2009 Zhou, 2012 (Dronpa)
3 Sequestration Taslimi, 2015 Yang, 2013 Chen, 2013 (UVR8)
4 Protein Activity Wu, 2009 Idevall, 2012 Folcher, 2014 Zhou, 2012 (Dronpa)
5 Heterodimerization Strickland, 2012 Kennedy, 2010 Levskaia, 2009 Zhou, 2012 (Dronpa)
6 Proteasomal degradation Renicke, 2013
7 Transcription activation Polstein, 2012 Kennedy, 2010 Shimizu, 2002 Muller, 2013 (UVR8)  
 
Table 2.1: Reference examples of light-sensitive modules applications for the light control of physiological processes.  
 
2.1.3.2 By actuation mechanism 
Photoactuation with light sensing domains involves two mains classes of mechanisms. : 
• Fusion of POI to a LOV domain can result in the allosteric modulation of protein activity by 
light illumination (Strickland, 2012). Alternatively, a short domain fused to AsLOV2-Jα can be 
cryptic in the dark due to cryptic docking, whereas illumination leads to the dissociation of Jα from 
the LOV core and the presentation of the functional domain (Lee, 2008). 
• Optical dimerization systems, based on the light-induced differential affinity to binding 
protein (Fig. 2.2). An efficient dimerization method would control the functional accumulation or 
depletion of POI in space, controlling therefore the function. Alternatively, the activity of a split 
protein can be controlled by complementation dependent on fused dimerizers. As a general trend, 
these systems allow fast-kinetics of dimerization, within the minute time-scale (Tischer, 2014). 
 
2.1.4 Conclusion 
 
Photosensing modules exhibit thus high potential for the light-control of physiological functions, 
with growing use. The possibility to implement light-controlled proteolysis by inserting 
photosensing modules will be discussed on chapters 7 and 8. However, the implementation of light-
sensitivity by genetic manipulation can be difficult. 
 
In multicellular organisms such as metazoan or higher plants, physiological activity can be 
controlled by small molecules. For example, in section 1.4.2.1, we described the plant 
transcriptional switch mediated by the small molecule auxin, which mediates protein 
heterodimerization and proteasomal degradation. Therefore, a simple strategy for the control of 
physiological processes by modulating the disponibility of effector molecules by light would be 
valuable. We will next present strategies for the photo-activation of small molecules. 
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2.2- Chemical actuators enable photocontrol of physiological activities 
 
2.2.1 Classification of chemical actuators 
Small chemical actuators combine light-sensing and effector parts on physically distinct chemical 
entities. Two classes of molecules can be distinguished by the reaction resulting from photon 
absorption by the chromophore: either cis-trans isomerization; or bond-cleavage of the 
chromophore; in both cases, this process results in a differential accessibility of an active effector 
molecule (Shao, 2009), (Ahmed, 2013). Synthetic photoactuators molecules are attractive, as a 
variety of chromophores with diverse photochemical properties can be conjugated to a molecule of 
interest, using reasonably simple synthetic approaches. 
 
2.2.1.1 Photoswitchable effectors  
In the first case, photoisomerization can enable the presentation of a hindered active molecule. 
Azobenzene is a widely used example of small-molecule modulation with light. The stable trans-
conformation can be converted to a cis geometry upon 360-400 nm light-illumination. This process 
is reversible, longer wavelength converts the azobenzene back to its trans conformation, and can be 
repeated many times (Shao, 2009). We present in Fig. 2.5 an example of azobenzene-based module 
for pH modulation previously developed in our group. Alternatively, conjugation of proteasome 
inhibitors with azobenzene led to the development of platforms for photo-controlled impairment of 
the UPS (Hansen, 2014). 
Further development led to hybrid approaches that combine genetic encoding with synthetic 
photoactive compound. For example, azobenzene moieties conjugated to accessible endogenous 
Cys residues of endogenous porines allowed light-control of permeability as photoisomerizable 
tethered ligands (PTL) (Kramer, 2005). 
 
 
Fig. 2.4: Example of azobenzene-based photoswitchable effector developed in our group. pKA of an azobenzene-based  
platform is modulated by light-illumination (Emond, 2011). 
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2.2.1.2 Caged effectors  
In the second case, the chromophore is cleaved by photolysis, leading to the liberation of an active 
diffusible protein effector. This defines the class of caged molecules (Deiters, 2010). 
Photocaging of bioactive molecule has been introduced by the pioneer work on deoxy-nucleotide 
phosphate protection by o-nitrobenzyl caging group (Engels, 1976), (Kaplan, 1977). Many 
biological effectors have since been caged, along with commercial availability (Corrie, 2005). For 
example, glutamate and γ-aminobutyric acid (GABA) are highly-interesting candidates to 
interrogate spatial control of neurotransmission (Matsuzaki, 2010). 
Caged-compounds combine practical advantages of small-molecule addition, but enable spatio-
temporal control by light illumination. Moreover, caging strategy can be applied to many types of 
biological effectors, including oligonucleotides, metabolites, or peptides, a feature which is 
inaccessible to photosensible protein modules methodologies (Riggsbee, 2010). For example, this 
strategy allows light-control of RNA interference (Chaulk, 2007). We present in Fig. 2.6 two 
examples of caged biological effectors developed in our group. 
 
 
 
Fig 2.5: Example of caged effector molecules developed in our group. (a) Retinoic acid, an important morphogenetic 
regulator was caged with Dimethoxy-nitrobenzene (DMNB) or Coumarin caging group. One-(365 nm) or two-photon 
(750 nm) liberation could trigger visible alteration phenotype in zebrafish eye development (Neveu, 2008). (b) 
cyclofen-OH, a photochemically stable inducer of the receptor specific for 4-hydroxy-tamoxifen (ER(T2)), was caged 
with various caging groups for photoinducing the nuclear translocation of proteins in zebrafish embryos (Sinha, 2010). 
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2.2.1.3 Genetically encoded caged proteins: chemical genetics approaches 
Unnatural mutagenesis allows the incorporation of caged amino-acids (such as Tyr, Cys, Ser and 
Lys) at specific positions (Riggsbee, 2010). This can be realized in mammalian cells by engineering 
orthogonal pairs of aminoacyl-tRNA synthetase/tRNA enabling the site-specific incorporation of a 
caged amino-acid into a heterologous POI gene where the codon for a critical residue has been 
replaced by a non-sense codon58
 
. Although it relies on a complex heterologous co-expression, this 
constitutes a fully-encoded method to implement conditional POI control with high spatio-temporal 
resolution. Interestingly, light-illumination liberates the native functional protein, a highly desirable 
feature. This strategy was used, for example, for the fast (< 1 min) photocontrol nuclear 
translocation by caging a key Lys residue in a Nuclear Localization Signal (NLS) sequence (Gautier, 
2010). Alternative physiological targets of caged proteins and caged small molecules effectors are 
listed in Table 2.2:  
Caged proteins Caged molecules
Nuclear Import Gautier, 2010 Sinha, 2010
Membrane addressing Umeda, 2011
Sequestration Robinson,2010
Protein Activity Gautier, 2011 Veldhuizen, 2003
Heterodimerization DeRose, 2013
Proteasomal degradation This work
Transcription activation Pinheiro, 2008 Neveu, 2008
si RNA activation Chaulk, 2007   Cryptochrome Phytochrome Others Caged proteins Caged molecule 
 
Table 2.2: Reference examples of caged proteins and caged small molecules applications for the light control of 
physiological processes displayed on Fig. 2.4. 
 
 
2.2.2 Specification of a good caged compound 
 
The desirable characteristics of a caged compound can be listed (adapted from (Bochet, 2002), 
(Corrie, 2005), (Kao, 2008), (Gurney, 2010), (Civillico, 2011). Ideally, a caged compound is 
inactive in the dark, whereas light-illumination restores the biological activity. 
 
                                                 
58 As an example, we describe the caged lysine unnatural amino-acid (UAA) incorporation strategy used in (Gautier, 
2010). The pyrrolysyl-tRNA synthetase of M. barkeri (a methanogenic bacterium) and its cognate amber codon tRNA 
are functional and orthogonal to the endogenous translational machinery in mammalian cells (Chen, 2009). A chemical 
biology approach by directed evolution of the active site of the synthetase led to a selective synthetase/tRNA pair 
enabling to incorporate a caged Lys UAA in the POI. 
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2.2.2.1 The caged compound must be inactive in the dark 
 
A first requirement is that the caged compound is not affected by hydrolysis in water. Esters are 
more sensitive to hydrolysis than ethers or carbamates, resulting in spontaneous release of the active 
compound (Fedoriak, 2005). For example, cAMP caged with 2-nitrobenzyl are sensitive to 
hydrolysis, resulting in steady-low level release of free cAMP (Lester, 1982). 
a) chemical stability 
 
Endogenous enzymes such as esterases can potentially recognize and hydrolyze caged-substrates in 
vivo. This issue will be addressed with the development of caged auxins in plants in Chapter 4. 
b) in vivo stability 
 
c) Inactivity in the dark
Some potent effectors, such as glutamate are biologically active at very low concentrations. 
Therefore, high purity in caged-molecule is necessary to prevent residual active compound to 
prevent background activation in the dark. Although the caged-molecules are relatively stable, 
manipulators should handle these products with special care to prevent activation by ambient light. 
For example, a reported caged-version of the small inducer of gene expression doxycyclin presents 
background activation when used at usual concentration of free-doxycyclin activation, 
hypothetically due to mild-affinity with the effector protein Tet (Cambridge, 2006). 
  
  
2.2.2.2 The caged compound must be activatable upon light illumination59
 
  
Two important parameters characterize the overall caged compound efficiency: first, the absorption 
coefficient ε (M-1.cm-1), quantifies the ability of a molecule to absorb light (according to Beer-
Lambert's law)
a) Efficiency of photoliberation  
60, the first-step of the uncaging process. Second, the quantum-yield of uncaging φ is 
defined as the ratio of the numbers of absorbed photons leading to an efficient photochemical 
release 61
                                                 
59The intensity is either quantified by surfacic power (in W.m-2), or by the photon flux (in mol photons.m-2.s-1). Typical 
surfacic power of 10−1–103 mW.cm-2 is obtained with violet light in epifluorescence microscopy. 
 compared to the total numbers of photons absorbed. Both these numbers need to be 
 
60 Alternatively, the single-photon absoption cross-section σ (in cm2 or Å2) caracterizes the effective capture area of a 
molecule is proportional to ε. 
 
61 Dissipation can however occur via other photophysical processes, such as quenching, non-radiative transfer or 
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maximized, to prevent light damage associated with high-illumination. Therefore, the product ε.φ, 
called action cross-section, can be used to characterize the system. 
 
b) Kinetics of photoliberation
Ideally, photolysis should be triggered by a short pulse, and the photochemical reaction post-
illumination should be fast in comparison to the biological phenomenon studied; however, fast and 
efficient release are not always compatible. As photorelease is a sequential process of reactions with 
possible by-products, fast photochemical reactions do not necessarily lead to the expected active 
product. Assuming a global single-exponential decay, the actual rate of uncaging k (or alternatively, 
the typical time constant τ, or the half-life time t1/2) has been reported for several caged bioactive 
molecules, with typical range from 102 to 107 s-1. Therefore, a compromise has to be made 
according to desired specifications. 
  
 
The caged compound must be evenly distributed through the system of interest. Light allows highly 
precise patterns of activation. In one-photon activation, a beam of near-UV light triggers, with 
maximal release at the focal plane. Higher spatial selectivity can be obtained by two-photon 
excitation. 
c) Photoliberation can be highly-localized 
 
2.2.2.3 The caged compound must be compatible with cellular physiology 
 
a) Biological toxicity
The caged compound must be biologically inert and non-toxic: DMNPE caged ATP (Nichols, 1990) 
addressed the instability of previous caged-ATP candidates with 2-nitrobenzyl (section 2.2.2.1.a), 
but inhibited ATP-sensitive K+ channels. 
  
 
 UV-light-illumination can also be toxic, especially below 350 nm, a range at which o-nitrobenzyl 
uncaging is the most efficient, due to strong absorption by endogenous cellular components. 
However, this issue can be addressed by the introduction of electron-donating substituents enabling 
red-shifted absorption. Two-photon excitation is another strategy for efficient uncaging in the 
« therapeutic optical window », between 700 nm and 900 nm, where both light-absorption and 
scattering are minimal. Photolysis can generate toxic side products, such as nitrosobenzaldehyde, 
b) Light toxicity 
                                                                                                                                                                  
fluorescence. Competition between these phenomena and efficient photolysis is quantified globally by quantum-yield. 
[PART A : INTRODUCTION] 
 
68 
 
the photoilluminated product of o-nitrobenzyl caging group. Introduction of methyl alpha 
substituent results in a less-toxic ketone by-product. 
Addition of a hydrophobic caging chromophore to a molecule that is itself moderately soluble, such 
as serotonin or cAMP can be a challenge when the caged molecule has to be delivered at high 
concentrations. The introduction of a large caging group can be an issue for biological uptake. 
However, the protecting cage can also confer membrane permeability to hydrophilic molecules. 
c) Intracellular uptake 
The choice of a photocaging group relies on a compromise, depending on the specifications for 
photoactivation, as reported caging groups exhibit different photochemical, stability, and delivery 
issues. Nitroaryl- derivatives, especially 6-nitroveratryloxycarbonyl (NVOC), and 2-4 dimethoxy-
nitrobenzyl (DMNB) are commonly used in reported photoactivation examples. 
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PART B 
RESULTS 
 
“We must, therefore, conclude that when seedlings are freely exposed to a lateral light, some 
influence is transmitted from the upper to the lower part, causing the latter to bend.” 1
 
 
Charles Darwin, The Power of Movement in Plants (1880)  
 
 
‘‘Au début de l’enquête, on est dans le noir, on tâtonne... ’’ 
      Georges Simenon, Maigret et les témoins récalcitrants 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
1 Light perception by plant shoots triggers a differential growth response, a process called phototropism. This led 
Charles Darwin who studied this phenomenon to propose that the origin of this light-driven asymmetry was a diffusible 
factor, which was purified fifty years later and named auxin. Interaction of auxin with light roots thus back in the very 
initial phytohormone observations (Abel, 2010). 
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Presentation of part B 
 
In chapter 1, we reviewed the existing methodologies for controlling the stability of a Protein of 
Interest (POI) by hijacking the Ubiquitin-Proteasome System (UPS). This led to the development of 
the Auxin-Inducible Degradation (AID) methodology, which enables to deplete heterologous POI in 
yeast or mammalian cells by conditional addition of a small molecule auxin (natural IAA, or 
synthetic NAA). This perturbation is easy to implement, but allows poor spatio-temporal resolution, 
whereas homogenous distribution or intracellular delivery can be an issue. In chapter 2, we 
described the existing methods for the light-control of physiological processes. In particular, the 
availability of small effectors can be modulated by light using a caging methodology.  
 
In this work, we propose to implement light-control on the AID methodology by a photoactivable 
caged version of the effector of degradation, auxin, as summarized on Fig. B. Light illumination 
would liberate the inactive caged auxin. This would lead to the heterodimerization of heterologous 
POI tagged with an AID degron and F-Box protein OsTIR1, resulting in polyubiquitination and 
eventual proteasomal degradation of AID-POI. 
 
 
 
Fig. B: Overview of a light-controlled AID for conditional depletion of POI in mammalian cells. Caged auxin is 
inactive in the dark, whereas its photolysis by UV illumination mediates the direct interaction between heterologous 
POI-AID and F-box OsTIR1, leading to the subsequent polyubiquitination and degradation of the POI-AID. 
 
We will describe in chapter 3 the optimization process for the AID platform in mammalian cells. 
Then, in chapter 4, we will describe the design of a caged auxin candidate meeting the 
specifications described on part 2.2.2. These tools will be combined in chapter 5 for the light-
control of nuclear protein degradation. Eventually, in chapter 6, we will extend this methodology to 
cytoplasmic proteins. 
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Chapter 3 
Development and Optimization of the AID depletion 
system in mammalian cells 
 
3.1 Specifications for the implementation of an AID methodology in 
mammalian cells 
 
The Auxin Inducible Degron (AID) methodology, presented in section 1.4.2 enables the 
proteasomal degradation of a given POI by conditional addition of auxin, as recapitulated on Fig. 
3.1. This strategy necessitates the co-expression of two heterologous proteins: OsTIR1 and POI 
fused to an AID degron (the complete sequence of AtAux/IAA17)2
 
. 
 
 
Fig. 3.1: the AID process allows conditional depletion of POI in mammalian cells. Addition of the small molecule auxin 
mediates the direct interaction between heterologous POI-AID and F-box TIR1, forming a functional ubiquitin ligase 
with endogenous SCF components. This leads to the subsequent polyubiquitination and degradation of the POI-AID. 
                                                 
2 Contrary to the techniques presented in part 1.2, where expression of a single POI fused to a destabilizing domain is 
necessary, and which rely only on the endogenous degradation machinery. 
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3.1.1 AID methodology necessitates dual expression of heterologous proteins 
 
3.1.1.1 Bicistronic vector strategy allows dual protein expression 
We first elaborated a strategy to control the relative levels of the two proteins heterogously 
expressed proteins. In transient transfection systems, the expression efficiency is related to the 
uptake of exogenous plasmid by culture cells, which is a stochastic event. Co-transfection of two 
different plasmids reduces the individual control of the relative expression of proteins. We thus used 
an alternative co-expression strategy (except in chapter 6). 
 
In the original AID methodology (Nishimura, 2009), Kanemaki et al. used a bicistronic IRES 
vector3
 
. In this strategy, explained on Fig. 3.2.a, a single transcript under the dependence of a CMV 
(Cytomegalovirus) promoter allows the expression of two cistrons separated by an Internal 
Ribosomal Entry Site (IRES). This element acts as a ribosome recruitment site (other than the 5'), 
allowing initiation of translation from an internal region of the mRNA, eventually enabling the 
translation of two proteins from a single mRNA (see the IRESite database for complete reference). 
 
Fig. 3.2: a) A bicistronic strategy allows dual expression of proteins separated by an IRES sequence from a single 
mRNA regulated by a CMV promoter. b) Map of pAG1 plasmid allowing OsTIR1-9cMyc/EGFP-AID-NLS expression 
in mammalian cells. 
 
3.1.1.2 A single plasmid strategy for AID implementation 
We chose this bicistronic plasmid strategy for dual protein co-expression in mammalian cells. The 
pNHK60 plasmid (OsTIR1-9cMyc-IRES-EGFP-AID-NLS) described in (Nishimura, 2007) 
(courtesy of Pr. Kanemaki) and enabling the expression of OsTIR1 and EGFP fused to AID and a 
                                                 
3 Another strategy in mammalian cells has later been described (Holland, 2012): mammalian cell lines stably expressing 
OsTIR1 were constructed by retroviral transduction. Heterologous POI fused with AID under the dependence of a 
conditional doxycyclin promoter can be expressed by single plasmid transient transfection. This constitutes a generic 
platform for conditional degradation of various POI targets. An elegant alternative was proposed for the development of 
the AID methodology in Trypasonomas, an eukaryotic unicellular organism where IRES sequences are inefficient. 
Instead, the P2A peptidic sequence can be inserted between the two proteins. This sequence is cut through a co-
translational process, ensuring dual protein expression in a strict 1:1 stoichiometry (Kreidenweiss, 2013). 
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nuclear localization signal was modified by insertion of sequence coding for a HA epitope at the N-
terminus of EGFP-AID-NLS4
 
, giving new plasmid pAG1 (OsTIR1-9cMyc-IRES-HA-EGFP-AID-
NLS), displayed on Fig. 3.2.b. 
3.1.2 Specification of cell line model for evaluation of the AID methodology 
 
3.1.2.1 Mammalian cell line and culture medium selection 
We first chose Chinese Hamster Ovarian (CHO), a classically-used mammalian cell line model for 
recombinant protein expression, characterized with a rapid growth (American Type Culture 
Collection (ATCC) database). A mammalian cell culture medium had then to be selected; first, it 
must be fit for cell survival and growth. Dulbecco-Modified Eagle Medium (D-MEM) is classically 
used. Addition of animal serum is often necessary, but can be an issue in protocols depending on the 
addition of small molecules (some serum proteins, such as albumin, are known to adsorb 
hydrophobic molecules (Fasano, 2005)). This question will be further discussed on chapter 5. Some 
cell lines, such as CHO, also need to be supplemented with non-essential amino-acids (ATCC). 
 
3.1.2.2 Culture medium must be auxin-free5
Native presence of free auxin in culture serum might induce unwanted AID depletion. As the 
phytohormone auxin is highly abundant in plant, it might therefore be present in herbivorous 
species serum such as  fetal bovine serum (FBS); however, no variation of EGFP fluorescence 
signal was observed between CHO cells co-expressing OsTIR1-9Myc and EGFP-AID-NLS 
cultivated in D-MEM with 1%, 5% or 10% FBS (data not shown). 
 
 
3.1.2.3 Culture medium must be compatible with light illumination 
One last requirement is that the UV light used for actuation does not interfere with the medium. 
Phenol red, a pH indicator dye classically used in culture media such as Dulbecco Modified Eagle 
medium (D-MEM), has been described to give toxic by-products upon UV illumination (Stoien, 
1974), and can absorb a non-negligible part of the light used for actuation. On chapters 5 and 6, we 
switched to a phenol red free medium for light induced depletion in microscopy. 
 
                                                 
4  HA tag is a widely used epitope derived from Human Influenza Haemaglutinin. However, immunoblotting 
experiments directed against this epitope did not allow reliable quantification (data not shown). 
 
5 Interestingly, natural auxin IAA was first isolated and purified from human urine in the 1930s (Abel, 2010). 
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3.1.3 Validation of the AID methodology in a mammalian cell line 
 
3.1.3.1 Implementation of auxin-conditional control of POI in CHO cells 
We first tested whether we could implement conditional depletion by addition of auxin in CHO 
culture cells. However, transient transfection of plasmid pAG1 in CHO cells was associated with 
both poor transfection efficiency and low expression level. We thus looked for an alternative to 
optimize AID expression6. As a first strategy, we constructed a stable CHO cell line. We took 
advantage of the Gentamycin resistance gene present in the pAG1 plasmid. CHO cells were 
transfected with pAG1, and a polyclonal cell line was established by G418 selection7
 
. Monoclonal 
cell lines were established by isolation and selection of individual clones. 
This stable cell line enabled to validate the auxin-induced depletion. Addition of 500 µM of natural 
(Indole Acetic Acid, IAA) or synthetic auxin (Naphtalene Acetic Acid, NAA) for 2 hours led to a 
quantitative depletion of EGFP-AID-NLS assessed by EGFP epitope in immunoblotting. No 
significant variations were observed for the heterologous OsTIR1-9Myc and endogenous actin 
protein levels assessed by immunoblotting (Fig. 3.3.a/b). This excluded that the observed EGFP-
AID-NLS depletion might be attributed to a differential transfection efficiency or sample loading in 
Western-Blot experiment. 
 
This observation was further validated by monitoring EGFP fluorescence in fixed CHO cells in 
confocal microscopy. Specific nuclear EGFP fluorescence was observed in CHO cells co-
expressing heterologous EGFP-AID-NLS and OsTIR1-9Myc, but not after incubation with 500 µM 
IAA and NAA for 2 hours (Fig. 3.3.c). We thus validated that quantitative protein depletion could 
be implemented by addition of auxin in mammalian culture cells, reproducing the observations 
reported by (Nishimura, 2009). However, low expression levels were observed (see auto-
fluorescence in Fig. 3.3.c); moreover, the cell-line was poorly-stable and derived rapidly in absence 
of G418. For these reasons, we preferred to change cell line for higher expression level and prevent 
detrimental activity by transient expression in culture cells. 
                                                 
6 Although high heterologous protein expression is desirable to enhance the specificity of the signal measured, several 
papers reported concerns that over-expression of UPS-interacting proteins might lead to the saturation of the UPS, 
impairing both endogenous and artificial protein degradation (Sellmeyer, 2009), (Zhou, 2000). 
 
7 The neo gene (from bacterial transposon Tn5) encodes an aminoglycoside phosphotransferase (APT 3'). Heterologous 
expression in mammalian cells confers resistance to G418, a Gentamycin-related antibiotic. Consequently, cells having 
incorporated a transfected plasmid by homologous recombination can be selected in one to three weeks by addition of 
G418, at a concentration range toxic for WT cells (100-1000 µg.mL-1, depending on plasmid and cell type). 
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Fig 3.4: (a-b) WT CHO cells (left) and CHO cells stably expressing EGFP-AID-NLS and OsTIR1-Myc (SCL = Stable 
Cell Line, right) were incubated with (+) or without (–) 500 µM IAA for 2 hours (a), or with various concentrations of 
IAA for 2h (b). Cell lysates were analyzed by immunoblotting (IB) with the indicated antibodies. (c) Cells incubated as 
in (a) were fixed, stained with DAPI, and visualized in confocal microscopy. 
 
3.1.3.2 Implementation of auxin-conditional control of POI in HEK cells 
A second strategy to optimize the heterologous protein expression was to switch to another cell line 
enabling a good model expression system. Human Embryonic Kidney 293 (HEK293) cell lines are 
fast-growing and offer excellent transfection efficiencies and high expression of heterologous 
protein (ATCC). Moreover, HEK293 cells are a classical model for proteasome-dependent 
degradation, as UPS components  are endogenously present at high levels (Gastaldello, 2008). 
 
We first confirmed that conditional depletion could be induced by addition of auxin in HEK293 
cells co-expressing EGFP-AID-NLS and OsTIR1-myc. Addition of 500 µM IAA led to significant 
depletion of EGFP-AID-NLS in 2 hours assessed by EGFP epitope in immunoblotting (Fig. 3.4.a).  
To determine the timing and extent of auxin-induced depletion, we monitored the EGFP 
fluorescence signal in individual HEK293 cells co-expressing EGFP-AID-NLS and OsTIR1-myc in 
confocal time-lapse microscopy8
                                                 
8 Confocal microscopy enables increased optical resolution and contrast, due to selection of focused light by a pinhole 
positioned at the confocal plane; it both allows precise visualization of 2-D slices and 3-D reconstructions. As precise 
evaluation of fluorescence was desirable for reproducible depletion, we selected this visualization methodology. 
. In presence of 500 µM IAA at 37°C, we observed a depletion of 
the EGFP fluorescence, with a half-life of 36 ± 3 min, whereas control cells incubated with DMSO 
showed no significant depletion (Fig. 3.4.b/c). 
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Fig. 3.4: (a) HEK293 cells co-expressing EGFP-AID-NLS and OsTIR1-Myc were incubated with (+) or without (–) 
500 µM IAA for 1 hour. Cell lysates were analyzed by immunoblotting (IB) with the indicated antibodies. M: Mock 
samples. (b) The nuclear fluorescence of HEK293 cells co-expressing EGFP-AID-NLS and OsTIR1-Myc was 
quantified by confocal microscopy at various times after 500 μM IAA addition (square). Plots show the normalized 
nuclear fluorescence intensity in function of time (mean ± SD, n = 10). Least squares fits (lines) gave the half-lives of 
EGFP-AID-NLS. Control experiments without IAA (circle) are shown. (c) Confocal micrographs of representative cells 
at various times post-IAA addition, or post-DMSO control addition. 
 
3.2 Optimization of the AID methodology for efficient POI depletion in 
HEK293 cells 
 
3.2.1 Subcellular addressing is an important parameter for efficient POI 
depletion in AID methodology 
 
3.2.1.1 Slow POI depletion is observed upon auxin addition in HEK293 cells 
The rather slow degradation timescale reported in section 3.1.3.2 contrasted with the half-life of 10 
minutes for AID-GFP-NLS previously assessed by immunoblotting experiments (Nishimura, 2009) 
in similar conditions. Moreover, it also contrasts with observations by Holland et al. who reported 
shorter half-lives (< 18 min) for five AID-tagged POI in mammalian cells ((Holland, 2012), see 
section 1.4.2.2). However, Holland et al. reported a considerably longer half-life of 40 min for 
Histone H2B-AID, which is close to our observations for AID-GFP-NLS 9
                                                 
9 Contrary to the other nuclear AID-tagged protein (TRF2 and CENP-A), H2B and AID-GFP-NLS are diffuse in the 
nucleus; It might be possible that TRF2 and CENP-A might be expressed at lower levels than H2B, facilitating their 
complete depletion. Alternatively the positively-charged H2B-AID is relatively inaccessible for ubiquitination, as it is 
. This discrepancy 
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between the reported auxin-dependent degradation rates and our observations is an issue for the 
development of an efficient conditional depletion platform, which we will address next. 
 
3.2.1.2 Heterologous OsTIR1 and AID-GFP-NLS are not colocalized in HEK cells 
We first wondered whether the poor degradation efficiency reported above might originate from 
poor nuclear addressing of heterologous OsTIR1-myc. As this process depends on auxin-mediated 
direct interaction, it is important that the two co-expressed proteins have the same subcellular 
localization. As heterologous AID-GFP-NLS is localized in the nucleus (Fig 3.4), OsTIR1-Myc has 
thus to be addressed in sufficient quantity to this compartment to ensure functional interaction. 
 
The heterologous OsTIR1-Myc is a 78 kDa protein, which is largely above the exclusion size for 
passive diffusion through the nuclear pore (Lange, 2007). Nuclear accumulation of OsTIR1-myc 
protein necessitates therefore a nuclear import mechanism, depending on the presence of a Nuclear 
Localization Signal (NLS). No strong endogenous NLS was predicted in the sequence of OsTIR1-
9Myc by bioinformatics tools (cNLS mapper). We postulated therefore that heterologous OsTIR1-
9Myc is present principally in the cytoplasm, and poorly imported in the nucleus. 
Immunocytochemistry experiments in fixed HEK293 cells confirmed this hypothesis (Fig. 3.5.a). 
 
 
 
 
Fig. 3.5: Graphical map of the heterologous proteins expressed in pAG1 and pAG38, and micrographs of fixed 
HEK293 cells that expressed (a) OsTIR1-Myc and EGFP-AID-NLS (first row), and (b) OsTIR1 fused to a Myc-tag and 
a nuclear localization signal (OsTIR1-NLS-Myc) and EGFP-AID NLS (second row), were stained with DAPI and 
immunostained with an anti-Myc primary antibody and an Alexa 647-conjugated secondary antibody. Selective 
detection of the EGFP signal shows the cellular localization of EGFP-AID-NLS, while selective detection of theAlexa 
647 signals shows the cellular localization of OsTIR1-Myc and OsTIR1-Myc-NLS. Scale bar 10 μm. 
 
 
                                                                                                                                                                  
tightly associated with the chromatin. 
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3.2.2 Co-localization of TIR1 and AID-GFP-NLS increases the degradation rate 
 
3.2.2.1 OsTIR1 can be addressed to the nucleus by NLS fusion 
Consequently, a NLS sequence was fused to OsTIR1-Myc in a new plasmid construction (pAG 38, 
OsTIR1 NLS--cMyc-IRES-HA-EGFP-AID-NLS). This NLS is expected to lead to the nuclear 
accumulation of heterologous OsTIR1-Myc-NLS. This was confirmed by immunocytochemistry 
experiments in fixed HEK293 cells10
 
 (Fig. 3.5.b). 
3.2.2.2 Co-localization of TIR1 and AID-GFP-NLS increases the rate of degradation twofold 
We next confirmed that this construction was functional for auxin-conditional depletion in HEK293 
cells co-expressing EGFP-AID-NLS and OsTIR1-9cMyc-NLS. Addition of 500 µM IAA for 2 
hours led to a significant depletion of EGFP-AID-NLS in EGFP immunoblotting (Fig. 3.6.a). 
To demonstrate that localization of OsTIR1 might affect the degradation efficiency, we quantified 
by time-lapse confocal microscopy the auxin-induced depletion of EGFP fluorescence signal in 
individual HEK293 cells co-expressing EGFP-AID-NLS and OsTIR1-Myc-NLS (Fig. 3.6.b/c). In 
presence of 500 µM IAA at 37°C, we observed a significant depletion of the EGFP fluorescence, 
with a half-life of 19 ± 2 min, which is in good accordance with other examples reported in the 
literature (Nishimura, 2009) (Holland, 2012).                                                                           
 
Fig. 3.6: (a) HEK293 cells co-expressing EGFP-AID-NLS and OsTIR1-NLS-Myc were incubated with (+) or without 
(–) 500 µM IAA for 1 hour. Cell lysates were analyzed by immunoblotting (IB) with the indicated antibodies. M: Mock 
samples. (b) The nuclear fluorescence of HEK293 cells co-expressing EGFP-AID-NLS and OsTIR1-NLS-Myc was 
quantified by confocal microscopy at various times after 500 μM IAA addition (square). Plots show the normalized 
nuclear fluorescence intensity in function of time (mean ± SD, n = 10). Least squares fits (lines) gave the half-lives of 
EGFP-AID-NLS. Control experiments without IAA (circle) are shown. (c) Confocal micrographs of representative cells 
at various times post-IAA addition. 
                                                 
10 It was reported (Holland, 2012, Fig 6) in the case of centromeric POI tagged with AID that addition of auxin led to 
the reversible recruitment of cytoplasmic OsTIR1 at the centrosome. 
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3.2.2.3 Observations 
Concomitantly with the acceleration of degradation kinetics, we observed fluorescence distribution 
changes upon auxin addition, highlighted in Fig. 3.7: 
 
Fig. 3.7: Confocal micrographs of representative HEK293 cells co-expressing EGFP-AID-NLS and OsTIR1-Myc were 
incubated with 500 µM IAA at various times.  
 
Although the heterologous EGFP-AID-NLS is a nuclear protein, an increase of the cytoplasmic 
fluorescence is observed upon conditional auxin addition, concomitantly with the global depletion 
(Fig. 3.7). A possible explanation to this phenomenon is that the degradation of the 
polyubiquitinated EGFP-AID-NLS by the proteasome is incomplete, as it requires active unfolding 
of the target protein. EGFP proteins undergo a post-translational maturation forming an active 
chromophore, which might not be efficiently unfolded by the proteasome (Fig. 3.8.c). Consistently, 
a specific signal below 30 kDa is observed in immunoblotting of HEK cells expressing EGFP-AID-
NLS, which increases upon auxin addition (Fig. 3.8.a). This signal might be due to EGFP protein 
resulting from degradation, free to diffuse in cytoplasm due to absence of NLS signal. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.8: (a) HEK293 cells co-expressing EGFP-AID-NLS and OsTIR1-NLS-Myc were incubated with (+) or without 
(–) 500 µM IAA for 1 hour. Cell lysates were analyzed by immunoblotting (IB) with α-GFP antibody. (b) HEK293 cells 
co-expressing EGFP-AID-NLS and OsTIR1-NLS-Myc were incubated with (+) or without (–) 50 µM MG132 for 2 
hours. Cell lysates were analyzed by immunoblotting (IB) with α-GFP antibody. (c) Proposed mechanism for 
incomplete degradation of EGFP fusion proteins. The β-barrel EGFP cannot be unfolded and access the proteolytic core.  
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As this signal is present in absence of auxin, we suspected that background degradation of EGFP-
AID-NLS took place in absence of auxin. Consistently with this, an increase of the EGFP-AID-
NLS signal was observed in HEK293 cells expressing OsTIR1-NLS-myc incubated with 
proteasome inhibitor MG132 for 2h (Fig. 3.8.b). In the same time, we observed a rapid fluorescence 
loss in the nucleoli11
 
. 
3.2.2.4 Discussion 
The almost two-times acceleration of the degradation rate between OsTIR1 and OsTIR1-NLS 
confirmed that colocalization of OsTIR1 and AID-tagged POI is an important parameter for the 
optimization of the AID depletion platform, as summarized in Fig. 3.9. 
 
 
 
 
 
Fig. 3.9: Comparative graphic showing the 
importance of colocalization for EGFP-AID-
NLS and OsTIR1-myc; poor nuclear 
addressing of OsTIR1-myc prevents 
formation of functional ubiquitin ligase 
degrading nuclear EGFP-AID-NLS, in 
contrast with nuclear OsTIR1-NLS-Myc. 
 
 
Histoimmunostaining experiments (Human Protein Atlas, proteinatlas.org) showed that Cullin1 is a 
predominantly nuclear protein, although it can be inhomogenously associated with vesicles in the 
cytoplasm. Cytoplasmic aberrant expression of Cullin1 is associated with the development of 
aggressive carcinoma (Do, 2014). Therefore, it is expectable that the formation of a functional 
SCFTIR1 is more efficient in the nucleus. 
 
One can interrogate how a slow but functional specific degradation process can take place without 
colocalization of the two heterologous proteins. We propose here two hypotheses: 
                                                 
11 The heterologous EGFP-AID-NLS is a nuclear protein accumulating in the nucleoli (Fig. 3.4). Upon auxin addition, 
fluorescence is rapidly depleted from the nucleoli in 10 to 20 minutes before global depletion affects the nucleoplasm 
(Fig. 3.6.c and 3.7). A hypothesis to explain this feature might be that nucleolar EGFP-AID-NLS have a higher 
diffusion coefficient than nucleoplasmic one (which might interact with DNA) (Boyd, 2011); therefore, they are more 
accessible to auxin-dependent polyubiquitination, and degraded first. Alternative hypothesis is that specific degradation 
take place in the nucleoli. However, this is not consistent with the nuclear distribution of UPS protein (Human Protein 
Atlas). Otherwise, it was reported that specific polyubiquitination of p53 in the nucleoli can drive their nucleolar export 
(Boyd, 2011). However, no specific differential depletion was seen with proteasome inhibitor MG132 (which does not 
prevent polyubiquitination) upon auxin addition (see 5.2.3.3). 
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• Heterologous OsTIR1-myc contains a mild NLS sequence. This might be sufficient to 
address a minority fraction of the protein to the nucleus, where it can form functional  
SCFTIR1, however in default to EGFP-AID-NLS, explaining the slow degradation rate 
• A dynamical exchange can exist between nuclear and cytoplasmic addressing, although 
largely unbalanced in favor of nuclear localization. This mechanism might explain the 
slower degradation rate, which necessitates the nuclear export of EGFP-AID-NLS. 
 
We later found another confirmation of this strategy reported in the literature:  nuclear addressing of 
heterologous AtTIR1 by fusion with NLS addressed limitations of the classical AID methodology in 
yeast and accelerated the auxin-dependent degradation of nuclear proteins12
 
 (Kanke, 2011). 
3.2.3 Probing F-box/Skp1 fusions for AID optimization 
 
3.2.3.1 F-box/Skp1 fusions were reported to enhance AID depletion in yeast 
In the same paper (Kanke, 2011), the authors expressed concerns that heterologous AtTIR1 might 
fail to incorporate efficiently within endogenous SCF components. In the AID methodology 
(Nishimura, 2009), endogenous Skp1 (S phase kinase associated protein 1) mediates the interaction 
between heterologous AtTIR1 (or OsTIR1 in mammalian cells) through its N-terminal F-box 
domain and the Cullin1 to form a functional E3 ubiquitin ligase complex13
 
 (see section 1.3.1). 
Therefore, an improved AID (iAID) was developed by fusing ScSkp1 to AtTIR1-NLS. This strategy 
was expected to enhance the probability of forming a functional ubiquitin ligase by decreasing the 
numbers of partners, and thus accelerate the kinetics of ubiquitination. Indeed, auxin addition 
accelerated the depletion of AID-GFP-NLS reporter from 50% to 90% in one hour (Kanke, 2011). 
3.2.3.2 F-box/Skp1 fusion enhance AID depletion in mammalian cells 
We adapted this strategy to our degradation system, by fusing the entire HsSkp1 sequence (160 a.a., 
19kDa) to OsTIR1-9Myc and OsTIR1-9Myc-NLS in new plasmid constructions (resp. pAG 39 and 
pAG 40). This strategy is summarized in Fig. 3.10.a.These constructions allowed EGFP-AID-NLS 
degradation by conditional 500 µM auxin addition within 2 hours. Consistently with section 3.2.2.1, 
nuclear addressing of HsSkp1-OsTIR1 by NLS fusion enhanced depletion efficiency (Fig. 3.10.b). 
                                                 
12 In yeast cells expressing AtTIR1, heterologous Mcm4-AID (a chromatin-bound protein essential for replication) is 
degraded in presence of auxin, but this depletion is slow (3 hours) and incomplete (up to 75%).  
 
13 Skp1 is involved in the regulation many cellular processes such as cell-cycle regulation. In a context where Skp1 
proteins are inabundant, others F-Box proteins such as Skp2, which is differentially expressed through the cell-cycle, 
might compete with heterologous OsTIR1 so that the ubiquitination of substrates is a limiting step. 
[PART B : RESULTS] 
 
82 
 
 
 
Fig. 3.10: (a) Graphical abstract of the heterologous proteins HsSkp1-OsTIR1-(NLS)-myc strategy (b) HEK293 cells 
co-expressing EGFP-AID-NLS and either HsSkp1-OsTIR1-Myc or HsSkp1-OsTIR1-NLS-Myc were incubated with (+) 
or without (–) 500 µM IAA for 1 or 2 hours. Cell lysates were analyzed by immunoblotting (IB) with the indicated 
antibodies. M: Mock samples. (c) Proposed mechanism for the growth defect observed with pAG39 or pAG40. 
Overexpression of Skp1 fusion might saturate endogenous Cullin1 scaffold and prevent interaction of endogenous Skp1 
with essential cell-cycle protein Skp2. 
 
However, transient transfection with both pAG39 and pAG40 visibly inhibited HEK cells growth 
and affected the nuclear shape. Skp1 is an essential cell-cycle regulation factor (cf section 9.1). It is 
therefore expectable that overexpression of a Skp1-fusion protein might saturate the endogenous 
SCF complexes, displaying major perturbations in the cell-cycle. Consequently, we abandoned this 
strategy for further optimization. 
 
3.3 Acceleration of POI depletion kinetics using AID F-box variants 
 
3.3.1 TIR1 homologs allow auxin-conditional degradation in heterologous system 
 
3.3.1.1 TIR1 homologs exhibit differential range of auxin-response depletion kinetics in plants 
The F-box protein TIR1 is the paradigmatic, first identified auxin nuclear receptor in A. Thaliana 
(Dharmassi, 2005), (cf section 1.4.1). This culminated in 2007 by the publication of the structure of 
a TIR1-Auxin-Aux/IAA complex, which showed that auxin mediates the direct interaction between 
TIR1 and an Aux/IAA protein (Tan, 2007). However, AtTIR1 is part of a larger six-gene clade of 
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Auxin-signaling F-Box protein (AFB) with conserved F-Box and LRR domains 14  (Bargmann, 
2014). Complex combinatorial association in AFB and Aux/IAA protein pairs results in variable 
response to auxin in plants. In a yeast heterologous co-expression system, AtAFB2 promoted faster 
degradation than AtTIR1 for most AtAux/IAA tested15
 
 (Villalobos, 2012). In particular, this was the 
case for AtAux/IAA17 (the AID), with three-fold acceleration of degradation rate (Havens, 2012). 
3.3.1.2 Development of mammalian AID methodologies based on TIR1 homologs 
Therefore, we wondered whether we could optimize our depletion system in mammalian cells by 
replacing heterologous OsTIR1 by AtAFB2, to accelerate the kinetics of degradation of AID-tagged 
POI. However, based on the reported development of AtTIR1-based AID methodology (Nishimura, 
2009), it is expectable that heterologous AtAFB2 is functional at 24°C, but not at 37°C. 
Consistently with the approach of Kanemaki, we also proposed to introduce the putative AFB2 
found in Oryza sativa16
 
. We thus replaced OsTIR1-Myc-NLS by AtAFB2-Myc-NLS and OsAFB2-
Myc-NLS in new plasmids constructions (resp. pAG52 and pAG53) (Fig. 3.11.a). 
Fig. 3.11: (a) Graphical map of the heterologous proteins expressed in pAG52 and pAG53. (b) HEK293 cells co-
expressing EGFP-AID-NLS and either AtAFB2-NLS-Myc (left) or OsAFB2-NLS-Myc (right) were incubated with (+) 
or without (–) 500 µM IAA for 1 hour. Cell lysates were analyzed by immunoblotting (IB) with the indicated antibodies. 
 
We next confirmed that these constructions were functional for auxin-conditional depletion in 
HEK293 culture cells. Addition of 500 µM IAA for 1.5 hour led to a significant depletion of EGFP-
AID-NLS in EGFP immunoblotting for both constructions, although to a lesser extent for OsAFB2-
Myc-NLS (Fig. 3.11.b), which was consequently abandoned. 
                                                 
14 All members of this family are auxin receptors, as identified by pull-down experiments.  However, individual 
TIR1/AFB proteins display different biochemical properties, especially regarding their auxin-dependent affinities to 
Aux/IAA proteins (Villalobos, 2012). 
 
15 Yeast heterologous systems have been proposed as semi-synthetic platform to estimate the association kinetics 
displayed by variable pairs of Aux/IAA and AFBs, resulting in different kinetics of auxin-induced degradation assessed 
by YFP reporter tags (Villalobos, 2012), (Havens, 2012). 
 
16 The candidate gene TIR1-like Os04g0395600 displayed the highest homology (67%) with AtAFB2 in BLAST 
sequence alignments. 
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3.3.1.3 Kinetic comparison of F-box AtAFB2 and OsTIR1 for auxin-induced degradation 
We then compared the kinetics of AID-GFP-NLS depletion when using AtAFB2-NLS instead of 
OsTIR1-NLS. Incomplete degradation was observed in time-lapse confocal monitoring of EGFP-
AID-NLS in HEK293 cells expressing AtAFB2-NLS (Fig. 3.12) (compare with Fig. 3.6). This 
feature prevented further investigations. 
 
Fig. 3.12: (a) The nuclear fluorescence of HEK293 cells co-expressing EGFP-AID-NLS and AtAFB2-NLS-Myc was 
quantified by confocal microscopy at various times after 500 μM IAA addition (square). Plots show the normalized 
nuclear fluorescence intensity in function of time (mean ± SD, n = 10). Least squares fits (lines) gave the half-lives of 
EGFP-AID-NLS. Control experiments without IAA (circle) are shown.  
 
3.3.1.4 Conclusion 
This approach validated however that Os and At TIR1 homologs can deplete AtAux/IAA17 in 
heterologous mammalian systems. Moreover, this observation contrasts with reports by (Nishimura, 
2009) that AtTIR1 is not functional in mammalian cells due to non optimal temperature conditions. 
Further optimization work could involve the systematic evaluation of the degradation rates between 
combinations of AFB/Aux-IAA proteins as was done in yeast cells (Havens, 2012) to identify 
efficient pairs for auxin-conditional degradation in mammalian cells. However, in next section, we 
describe another strategy for degradation acceleration based on TIR1 mutants. 
 
3.3.2 Point mutations in TIR1 accelerate auxin-conditional degradation 
 
3.3.2.1 Identification of TIR1 mutants for enhanced Aux/IAA degradation in yeast 
Variants of AtTIR1 displaying enhanced affinity for Aux/IAA proteins were identified in a mutation 
screen in yeast two hybrids (Yu, 2013). Point mutations D165E and M468L enhanced the auxin-
induced interaction with all members of the AtAux/IAA family tested17
                                                 
17 The kinetics of degradation were assessed by exogenous expression of the TIR1 variants with Aux-IAA tagged with 
Yellow-Fluorescent Protein: auxin-induced depletion was determined by flow-cytometry exhibited. Regrettably 
Aux/IAA 17, corresponding to the AID degron was not tested. 
. Consequently, remarkable 
acceleration of the degradation kinetics (five to six times faster that wild-type AtTIR1) was 
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observed for each mutant. These mutations seem to act independently, as the effect on the double-
mutant was synergic. Remarkably, D170E and M473L mutations are located in the Leucine Rich 
Regions (LRR) outside the contact interface with Aux/IAA, or in the hydrophobic auxin-binding 
pocket, as one could have expected18
 
 (Fig. 3.13.b). These mutations might hypothetically induce 
structural changes in the auxin-binding pocket of TIR1 (Yu, 2013). 
 
 
Fig. 3.13 (a) BLAST alignment between AtTIR1, OsTIR1 and AtAFB2 highlighting D165 and M468 conserved 
neighboring regions. (b): AtTIR1 visualization in Pymol highlighting positions D165 and M468 (blue), auxin (red) and 
Aux/IAA7 peptide (green) (PDB reference:2P1Q). 
 
Identification of F-box variants with enhanced partner binding properties might be interesting for 
optimization of protein degradation platform in a chemical biology approach19
 
. We therefore looked 
to introduce these mutations in mammalian cells in order to accelerate auxin-dependent degradation.  
3.3.2.2 Introduction of point mutations in TIR1 variants in mammalian AID methodology 
However, it was reported that heterologous AtTIR1 is not functional at 37°C. Application of the 
AID methodology from yeasts to mammalian cells necessitated replacing F-box protein AtTIR1 by 
its ortholog OsTIR1, compatible with higher temperatures ((Nishimura, 2007), see part 1.4.2.2). As 
the mutations globally affect AtTIR1 structure (Yu, 2013), one can however postulate that these 
variants might be more plastic and functional in mammalian cells. 
 
Alignment between orthologs AtTIR1, OsTIR1 and AtAFB2 sequences showed that the mutations 
positions were conserved and corresponded to high homology regions (Fig. 3.13.a). We postulated 
                                                 
18  An Alanine scan confirmed that these positions were important for auxin-induced recognition of Aux/IAA. Yeast 
two -hybrids experiments showed that the mutations induced a greater affinity for Domain II of Aux-IAA (Yu, 2013). 
 
19 However, although these mutations dramatically accelerated the degradation of Aux/IAA proteins, no application to 
the yeast AID methodology has been yet reported. 
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that introduction of these mutations in OsTIR1 might enhance the degradation kinetics. Single 
mutants OsTIR1D170E and OsTIR1M473L, and double mutants OsTIR1D170E-M473L directed were 
synthesized by directed mutagenesis. Similarly, we previously showed (section 3.3.1.3) that 
AtAFB2 was functional, although less-efficient than OsTIR1. Thus, we also introduced 
AtAFB2D170E, AtAFB2M473L, and AtAFB2D170E-M473L as heterologous F-box variants. 
 
3.3.2.3 OsTIR1 mutants were selected as potential targets for enhanced AID depletion kinetics 
We first assessed that the new constructions were functional. Depletion of AID-GFP-NLS was 
observed in immunoblotting analysis after incubation of 500 µM IAA for one hour in HEK293 cells 
expressing various OsTIR1 mutants, comparable to WT OsTIR1 (Fig. 3.14.a). Parallely, significant 
depletion was observed for the AtAFB2 variants, although less efficient than the WT AtAFB2 (Fig. 
3.14.b). As this platform is already less efficient for AID methodology, we did not pursue further 
this strategy. In both proteins, a lesser extent of depletion was associated to the double-mutant, in 
contrast to the reported cumulative effects of the two mutations in AtTIR1 in yeasts (Yu, 2013). 
 
 
Fig. 3.14: HEK293 cells co-expressing EGFP-AID-NLS and an F-box protein-NLS-Myc were incubated with (+) or 
without (–) 500 µM IAA for 1 hour. Cell lysates were analyzed by immunoblotting (IB) with the indicated antibodies. 
M: Mock samples. (a) F-box = OsTIR1 or its mutants D170E, M473L, or D170E-M473L (b) F-Box = AtAFB2 or its 
mutants D170E, M473L, or D170E-M473L. 
 
3.3.2.4 Introduction of D170E mutation to OsTIR1 enhances the degradation rate 
To confirm that the three OsTIR1 mutants were functional for auxin-dependent depletion, and 
interrogate whether enhanced depletion rates might be observed, the kinetics of degradation of AID-
GFP-NLS in single HEK293 cells expressing OsTIR1 mutants were quantified by the decay of the 
EGFP signal in time-lapse microscopy (Fig. 3.15). In presence of 500 µM IAA, we observed a half-
life of 15 ± 1 min with OsTIR1D170E-NLS, 25 ± 2 min with OsTIR1M473L-NLS, and 30 ± 2 min with 
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OsTIR1D170E-M473L-NLS, in contrast to the half-life of 19 ± 2 min reported on section 3.2.2.2 with 
OsTIR1-NLS. Hence, introduction of the D170E mutation accelerated the kinetics of degradation 
by 20%, ensuring 90% of protein depletion within 45 minutes. Contrastingly, slower depletions are 
observed with mutations M473L and D170E-M473L.  
 
Fig. 3.15: (a) The nuclear fluorescence of HEK293 cells co-expressing EGFP-AID-NLS and OsTIR1-NLS-Myc 
mutants D170E, M473L, or D170E-M473L were quantified by confocal microscopy at various times after 500 μM IAA 
addition (square). Plots show the normalized nuclear fluorescence intensity in function of time (mean ± SD, n = 10). 
Least squares fits (lines) gave the half-lives of EGFP-AID-NLS. (b) Confocal micrographs of representative cells co-
expressing EGFP-AID-NLS and OsTIR1-NLS-Myc mutant D170E at various times post-IAA addition, in minutes. 
 
In this part, we evaluated the possibility of accelerating the auxin-dependent degradation rates by 
replacing the F-box protein OsTIR1 by homologs (section 3.3.1), or by mutants (section 3.3.2). This 
illustrates the fact that chemical biology approaches enable ever-optimizing strategy with constant 
shuttling with literature reports. We eventually selected the OsTIR1D170E-NLS clone as a 
degradation platform for further applications described in the next chapters. 
 
3.4 Conclusion 
 
In this chapter, we illustrated an optimization approach for the implementation of Auxin-Inducible 
Degradation in mammalian cells. Several modifications were proposed to address the slow initial 
depletion kinetics: this included subcellular addressing of heterologous proteins for optimal 
colocalization, and introduction of F-box variants for enhanced auxin-induced heterodimerization. 
Although most of these approaches were not successful, combination of two modifications 
enhanced two-fold degradation kinetics, as a half-life of the reporter-AID protein of 15 ± 1 min was 
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observed with OsTIR1D170E-NLS-myc, in comparison with 36 ± 3 min in the original system. In the 
work developed in this chapter, we developed a chemical biology approach in which exogenous 
modules can be functionally implemented in heterologous model. These modules can be modified 
by introduction of mutations or protein variants, in an ever-optimizing approach. 
 
 
Supplement 
 
3.5 Development of the AID methodology for generic application in 
mammalian cells 
 
3.5.1 Development of a shorter AID tag 
 
3.5.1.1 Motivation 
Thus far, we have been reusing the AID sequence originally implemented for the Auxin Inducible 
Degron methodology by Kanemaki et al. (Nishimura, 2009). In this strategy, the AID sequence is 
the full length AtAux/IAA17, a 229 amino-acid and 25 kDa protein20
 
, a size comparable to EGFP  
(238 amino-acid). Whether fusion of such protein tags with POI preserves the structure and activity 
of the POI is an important issue in analyzing cellular responses to perturbation techniques (Snapp, 
2010). Therefore, development of shorter protein tags might be useful for a generic method. 
3.5.1.2 Identification of essential functionalities in AID and construction of a short degron 
As a member of the IAA transcription factor family, AtAux/IAA17 is composed of four domains, as 
explained on Fig. 3.16.a; domains I is responsible for the co-transcriptional repression activity, 
whereas domains III and IV mediates homo and heterodimerization with ARF proteins (Villalobos, 
2012). Domain II has been identified as responsible for the interaction with TIR1, through a 
hexapeptide sequence VGWPPV which binds TIR1 through the interaction with auxin (Tan, 2007). 
A 17 peptide from domain II is sufficient to bind TIR1 in presence of auxin in immunoprecipitation 
experiments (Villalobos, 2012). Therefore, we wondered whether deletions introduced in 
                                                 
20 Which can be fused at the N-ter or the C-ter of the POI (Nishimura, 2009). 
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AtAux/IAA17, preserving domain II sequence, might give functional short AID (shAID) degron. 
No crystallographic structure of proteins of the Aux/IAA family had been described by this time (a 
structure was recently released (Han, 2014)). Using sequence alignments (Blast) between different 
proteins of the Aux/IAA family and secondary structure prediction software (Baldwin), we 
identified that domains II and III were separated by an unstructured sequence and postulated that 
they were functionally independent. We deleted the terminal domains III and IV of AtAux/IAA17 to 
build a short shAID degron (pAG47, OsTIR1-9cMyc-IRES-EGFP-shAID-NLS) (Fig 3.16.b). 
 
 
 
Fig. 3.16: (a) Structure of full-length AtAux/IAA17 protein with identified domains I to IV, and predicted strand and 
helix regions. (b) Graphical map of the heterologous proteins expressed in pAG47 (bottom) compared to pAG38 (top). 
 
3.5.1.3 The short AID is functional but less efficient than full-length AID 
We first assessed that the new construction was functional for auxin-dependent degradation: 
significant depletion of shAID-GFP-NLS was observed in immunoblotting analysis after incubation 
with 500 µM IAA for one hour in HEK293 cells expressing OsTIR1, although to a lesser extent 
than full length AID in similar conditions (Fig. 3.17.a). 
 
 
Fig. 3.17: (a) HEK293 cells co-expressing EGFP-shAID-NLS and OsTIR1-NLS-Myc were incubated with (+) or 
without (–) 500 µM IAA for 1 hour. Cell lysates were analyzed by immunoblotting (IB) with the indicated antibodies. 
(b) The nuclear fluorescence of HEK293 cells co-expressing EGFP-shAID-NLS and OsTIR1-NLS-Myc were 
quantified by confocal microscopy at various times after 500 μM IAA addition (square). Plots show the normalized 
nuclear fluorescence intensity in function of time (mean ± SD, n = 10). Least squares fits (lines) gave the half-lives of 
EGFP-AID-NLS. Control experiments without IAA (circle) are shown.  
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To confirm that the shAID was functional, the kinetics of degradation of AID-GFP-NLS in single 
HEK cells expressing OsTIR1 were quantified by the decay of the EGFP signal in time-lapse 
microscopy. In presence of 500 µM IAA, we observed a half-life of 35 ± 4 min (Fig. 3.17.b). This 
slower degradation rate was coherent with immunoblotting experiments. 
 
3.5.1.4 Discussion 
These observations confirmed that an auxin-conditional degradation can be obtained with a degron 
half-shorter than the reported AID sequence (Nishimura, 2009). However, this functionality is 
associated to a twofold loss in degradation rate. Although this prevents generic implementation to 
the classical AID methodology, shAID might however provide a degron tool in contexts where POI 
expression or functionality is sensitive to fusion with large protein tags21
 
 (Moravska, 2013).  
3.5.1.5 Validation in literature 
Convergently, a similar strategy to develop a shorter degron was reported in yeast (Havens, 2012). 
The authors assessed the contributions of residues outside the domain II of Aux/IAA protein to AFB 
proteins binding, by monitoring the depletion kinetics of Aux/IAA truncations in yeast heterologous 
systems. As a complex combinatorial properties between AFB proteins and Aux/IAA proteins (19 
members in Arabidopsis), domain deletion can induce differential kinetic effect, although general 
trends can be outlined. Contrary to depletion of domain I, deletions of domains III and IV do not 
lower the depletion rate, and even accelerates it in some case. This study allowed to identify 
essential residues outside the domain II for auxin-induced degradation, and to engineer a minimal 
40 residue degron that can be useful in contexts where full-length AID fusion is an issue. These 
results where later confirmed by (Yu, 2013). Furthermore, (Villalobos, 2012) measured the auxin-
binding affinities of truncated versions of AtAux/IAA7 to AtTIR1: versions containing Domains I 
and II displayed the same affinity as the WT protein, whereas versions with truncation limited to 
Domain II had an affinity one order of magnitude lower. However, to our knowledge, no application 
was reported to this date in mammalian cells. 
 
                                                 
21 Under the same transfection conditions, basal EGFP-shAID-NLS expression was significantly higher than basal 
EGFP-AID-NLS, whereas the F-box adaptor OsTIR1 expression is the same in both conditions. This relative shAID 
overexpression might imply a saturation of the UPS degradation system relying on endogenous ubiquitin Ligase 
components. Slower degradation rate might be observed, as AID polyubiquitination is a limiting step, Confirming this, 
(Moravska, 2013) reported that fusion of full-length AID considerably reduced Rad53 protein levels to undetectable 
levels, whereas higher expression are observed with truncated versions of AID fusion tags. A solution to this issue might 
be to reduce the overexpression of AID by modifying the strength of the IRES sequence to lower the expression of the 
shAID-tagged protein; other strategies are discussed in note B2.   
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3.5.2 Use of esterase-sensitive auxin for enhanced permeability 
 
3.5.2.1 Motivation 
Due to its anionic carboxylate, the natural auxin IAA is poorly cell permeable at pH 7.4. This 
feature, which is important for the diffusion model of this phytohormone in plants22
 
, is a constraint 
for the AID depletion system which relies on conditional intracellular delivery of auxin, which is 
limited by the slow membrane diffusion process. Consequently, high external concentrations (500 
µM) of auxin are added in the medium for fast depletion, although efficient degradation is observed 
at slower rates for lower concentrations (up to 5 µM) (see Fig. 1.4). 
Alternatively, we used a commercial Methyl-ester version of IAA (Me-IAA) (Fig. 3.18.a). In 
Arabidopsis, the phytohormone IAA can be converted to Me-IAA by endogenous enzymes as a 
supplementary level of regulation of auxin patterns (see section 1.4.2.3) (Yang, 2008). Esterification 
of carboxylate by methanol is a classical strategy in chemical biology for the intracellular delivery 
of poorly-permeable molecules. Endogenous esterases in the cytoplasm hydrolyze the esters, 
liberating the bioactive molecule (Tian, 2012).  
 
3.5.2.2 Me-IAA can trigger AID depletion in mammalian cells 
The kinetics of degradation of AID-GFP-NLS in single HEK293 cells expressing OsTIR1 were 
quantified in time-lapse microscopy. Upon addition of 500 µM Me-IAA, a half-life of 17 ± 2 min 
was observed (Fig. 3.18.b), comparable with the depletion kinetics induced by free IAA. This 
validated that Me-IAA could efficiently trigger AID depletion.  
 
We investigated whether Me-IAA could be more efficient than free IAA at lower concentrations. We 
monitored the depletion of AID-GFP-NLS by immunoblotting in HEK293 cells expressing 
OsTIR1-NLS after one hour incubation with IAA or Me-IAA at various concentrations. Indeed, Me-
IAA seems to be associated with a higher depletion than IAA at lower concentrations (Fig. 3.20.c/d). 
                                                 
22 Neutral IAAH possesses a permeability of 4.10-3 cm.s-1, six orders of magnitude higher than the charged carboxylate 
IAA- . This discrepancy can explain the differential diffusion of protonated auxins across plant plasma membrane, from 
the cell wall (pH < 5) into the cytoplasm (pH > 7), where  it is deprotonated. Charged IAA- efflux are highly regulated 
by permeases such as PIN and AUX1, whose highly regulated differential spatial distribution segregate auxin patterns.  
(Teale, 2006) This process allows diffusion of auxin through cells as fast as 15 mm/h (DeRybel, 2009). 
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Fig. 3.18: (a) Structure of IAA and Me-IAA (b) The nuclear fluorescence of HEK293 cells co-expressing EGFP-AID-
NLS and OsTIR1-Myc were quantified by confocal microscopy at various times after 500 μM Me-IAA addition 
(square). Plots show the normalized nuclear fluorescence intensity in function of time (mean ± SD, n = 10). Least 
squares fits (lines) gave the half-lives of EGFP-AID-NLS. Control experiments without IAA (circle) are shown. (c) 
HEK293 cells co-expressing EGFP-AID-NLS and OsTIR1-Myc were incubated with (+) or without (–) 500 µM 
MeIAA for 1 hour. Cell lysates were analyzed by immunoblotting (IB) with the indicated antibodies. (d) Quantification 
with non-incubated sample (0, lane 2) as reference. 
 
We thus approved that intracellular delivery could be enhanced kinetically by methyl-esterification; 
however, we did not interrogate the differential kinetics at low concentrations. Auxin ester 
derivatives might provide an interesting tool in contexts where cells are sensitive to high amount of 
external metabolites, or for deep penetration of auxin in multicellular layers, such as in tissue or a 
small animal. 
 
 
3.5.3 Development of cytoplasmic AID depletion is hindered by the nuclear 
localization of AID 
 
The AID methodology, as described in (Nishimura, 2009) is a priori generic to any POI and 
applicable to various cellular contexts. In particular, degradation of cytoplasmic POI is highly 
desirable, as many essential regulation processes take place in this compartment. Two examples of 
conditional AID depletion of cytoplasmic POI were reported since in mammalian cells ((Holland, 
2012), see table 1.2). In this section, we will discuss whether we can implement cytoplasmic AID 
depletion with an AID-tagged fluorescent reporter. 
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3.5.3.1 Heterologous AID-EGFP fusions are adressed to the nucleus in HEK293 cells 
In a first attempt to implement cytoplasmic auxin-dependent degradation, we removed the NLS 
sequence present at the C-ter of AID protein of all our precedent constructions. We fused the 
complete AID sequence N-terminally to a mCherry red fluorescent reporter protein under the 
dependence of a CMV promoter (pAG36, CMV-mCherry-AID). However, HEK293 cells 
transiently transfected with pAG36 displayed a strong nuclear fluorescence, indicating that 
endogenous nuclear addressing sequences were present in mCherry-AID (Fig. 3.19). 
 
3.5.3.2 Endogenous NLS sequences are present in AID 
The AID degron corresponds to the complete sequence of AtAux/IAA17, which is a nuclear 
transcriptional repressor in its native plant context. A bipartite NLS, localized between domain I and 
II, has been identified in Os and AtAux/IAA17 (Jain, 2006). As nuclear addressing can vary 
between plant and mammalian cells, we analyzed whether the heterologous AID sequence 
contained specific addressing signals in mammalian cells. Strong NLS sequences were predicted 
(cNLS mapper) between domains I and II, and in domain IV. Together, these features can explain 
the identical nuclear addressing of AID and AID-NLS fused to reporter fluorescent proteins. 
 
 
 
Fig. 3.19: (a) AID sequence (AtAux/IAA17), highlighting NLS sequences described in functional context in plants and  
predicted in mammalian cells (b) HEK293 cells expressing heterologous EGFP-AID-NLS or mCherry-AID imaged in 
confocal microscopy. 
 
The strength of the endogenous NLS is a limitation to the genericity of the AID methodology 
applied to non-nuclear POI23
 
. Alternatively, we embraced the reported examples of AID-tagged 
cytoplasmic POI that we will describe on chapter 6. 
                                                 
23 It was reported that intracellular context might affect the depletion efficiency in methodologies based on small-
molecule conditional stabilization ((Sellmyer, 2012), see section 1.2.2.2). 
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Chapter 4 
Design of photo-activatable auxins 
The work reported in part 4.2.3  was realized in collaboration with Dr Isabelle Aujard (permanent 
researcher in our group), wheras the work reported in parts 4.2.4, 4.3.1 and 4.3.2 was realized in 
collaboration with Chenge Li (master student in our group). 
 
4.1 Introduction: structural analysis of auxin perception by TIR1 
enables the rational design of caged auxins 
 
4.1.1 Auxin perception in plants 
 
In 2007, a molecular mechanism for auxin perception by TIR1 was proposed, as a crystallographic 
structure of a ternary AtTIR1:IAA:Aux/IAA7 was published (Tan, 2007) (section 1.4.1.2). TIR1 has 
a mushroom-shape with LRR domains responsible for auxin perception and Aux/IAA7 substrate 
recruitment. At the top surface of TIR1, a pocket contains a promiscuous hydrophobic binding site 
able to accommodate planar structures such as the Indole-ring of natural auxin IAA24
 
 (Fig. 4.1.a). 
Benzene region of indole ring interacts with two-hydrophobic residues in TIR1 (Phe79 and Phe82), 
whereas the carboxylic group of IAA binds to Arg403 and Ser 438 residues25
                                                 
24 An inositol 1,2,3,4,5,6-hexakisphosphate (InsP6) cofactor is also bound at the core of TIR1. 
 (Fig. 4.1.b). Insertion 
of auxin docks the hydrophobic pocket, allowing the insertion of the coiled IAA7 peptide on the 
upper part of the pocket, through a short hydrophobic domain II WPPV motif. The aromatic ring of 
25 Synthetic auxins 1-NAA and 2,4-D also bind TIR1 through their common carboxyl group although their hydrophobic 
ring structures are different (but mimic the indole ring binding to the TIR1 hydrophobic cavity). 
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IAA displays hydrophobic interactions with the close tryptophan and second proline residues in 
Aux/IAA7 on one side, with Phe82 in TIR1 on the other side (Fig. 4.1.c). Aux/IAA thus forms a co-
receptor with TIR1, with auxin acting as“molecular glue”, enhancing hydrophobic interactions (Fig. 
4.1). Neither binding of auxin or of IAA7 peptide affects however the structure of the TIR1-LRR 
domain. Rational design based on the crystal structure led to the development of specific auxin 
antagonists26
 
. 
 
 
 
 
Fig. 4.1: Crystal structure of TIR1:IAA:Aux/IAA7 (Tan, 2007). (a) Overall structure of the TIR1 complex with auxin 
and degron IAA7 peptide (b) detail zoom on the hydrophobic pocket in TIR1 binding IAA. The auxin molecule (IAA) 
is shown as a green stick model. The TIR1 residues surrounding auxin and right underneath the auxin-binding site are 
shown as a yellow stick model. Essential residues Phe82, Arg403 and Ser438 are displayed. (c) A close-up side view of 
the central GWPPV motif in the IAA7 peptide upon binding to TIR1. Interacting residues of the substrate peptide and 
TIR1 are shown as orange and yellow stick models, respectively. Auxin is shown as a green stick model. 
 
 
 
 
 
 
 
 
 
                                                 
26 The first reported works led to the development of specific α –alkyl substituted auxin antagonists which insert the 
binding site of TIR1, perturbing Aux/IAA interaction due to steric hindrance with Pro residues in Aux/IAA (Hayashi, 
2008). Further development based on in silico screening led to the development of auxinole-based-antagonists. Phenyl 
ring of stack with Phe82, enhancing the affinity of IAA-antagonists (Hayashi, 2012). 
 
[PART B : RESULTS] 
 
97 
 
4.1.2 Caged auxins in plants 
 
Caged auxin methodologies were reported for single cell studies in plants27
Endogenous plant serine esterases were suspected to be responsible of this background release in 
the dark. Consequently, the authors developed esterase-insensitive auxins by addition of bulky-
groups phenyl derivatives to NB caging groups, in order to block access to catalytic serine residues 
in esterase active sites. This resulted in a global enhanced stability in dark conditions, without 
affecting the photo-liberation kinetics
 (Kosuka, 2009). The 
carboxylic group common to three different auxins Indole Acetic Acid (IAA), Naphtalene Acetic 
Acid (NAA) and 2,4 Dichlorophenoxyacetic (2,4-D) were esterified with ortho-nitrobenzyl (NB) 
alcohol caging group (classically used in mammalian cells) (Fig. 4.2). In vitro, these caged auxins 
were stable in the dark, and efficiently released upon UV light illumination, as assessed by HPLC. 
However, in vivo studies indicated that the caged auxins were biologically unstable in the dark. 
28
 
. In particular, 2,4 dimethoxyphenyl-2-nitrobenzyl (DMPNB) 
caged auxin were stable in the dark, but short (2s) UV light pulses allowed manipulation of auxin 
levels in single cells (uncaging quantum yield Φ= 0.04). This caged molecule was later used in 
another study to probe the complex interaction of auxin with the actin cytoskeleton (Maisch, 2009). 
Fig. 4.2: Caged auxins developed by (Kosuka, 2009). 
 
Based on these studies, we identified the carboxylic group as a potential target for protection; 
addition of a large caging group must hinder the carboxylic group involved in the interaction with 
TIR1, therefore preventing the auxin-dependent interaction of TIR1/AID in heterologous systems.  
                                                 
27 Auxin control many physiological processes in plants, such as cell division, elongation or differentiation. As local 
gradients of auxin form complex and yet not fully understood patterns, plants biologists were interested in the fast 
release of auxin in high spatiotemporal control offered by caging approach (DeRybel, 2009). Free auxin is often 
quantified using a reporter gene under the control of an auxin-dependent promoter in Arabidopsis (Kosuka, 2009). 
28 However, diminution of solubility by introduction of hydrophobic groups could be an issue. 
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4.2 Development of carboxylate-conjugated DMNB caged auxin  
 
4.2.1 First-generation 
 
4.2.1.1 Motivation 
The 2-nitrobenzyl caging group used for auxin protection in (Kusaka, 2009) is efficiently cleaved at 
280-300 nm, a toxic wavelength range for mammalian cells. Alternatively, we chose the 4,5-
dimethoxy-2-nitrobenzyl (DMNB) as a caging platform which is widespread for biological studies29
 
. 
This group is known to be efficiently cleaved upon illumination within the 350-400 nm range. 
Moreover, caged DMNB-molecules were reported to be stable in the dark in mammalian cells 
(Ouyang, 2010). We thus proposed to synthesize DMNB-caged auxins NAA and IAA. 
4.2.1.2 Synthesis 
The caged auxin DMNB-NAA 1N and DMNB-IAA 1I were obtained with 92% yield (resp. 40%) 
by coupling NAA (resp. IAA) with (4.5-dimethoxy-2-nitrophenyl) methanol in presence of 
dicyclohexylcarbodiimide (DCC) and dimethylaminopyridine (DMAP) (Steglich esterification) in 
dichloromethane at room temperature overnight (Fig. 4.3). 
 
Fig. 4.3: Synthetic scheme of 1N and 1I. 
 
4.2.1.3 Photochemical characteristics 
UV spectra of the caged molecules exhibit a large band at 365 nm, characteristic of the DMNB 
caging group (Fig. 4.4.a). Interestingly, while both free NAA and IAA are fluorescent (with resp. 
max. emission at 324 and 354 nm), this was not the case for their DMNB-caged analogs, 
hypothetically due to intramolecular quenching introduced by the caging group. This property was 
                                                 
29 This caging platform had been previously used and further developed in our laboratory (see section 2.2.1.2). 
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used to characterize the uncaging of 1N (resp. 1I) by following the extent of NAA (resp. IAA) 
release upon UV illumination 30
 
 in fluorometry at its maximum emission wavelength. The 
corresponding results are displayed for 1N in Fig. 4.4.a. The quantum yields of photolysis for 1I 
and 1N were evaluated to resp. 5.9×10-4 and 5.6×10-4. 
 
Fig. 4.4: (a) Absorption spectrum of 1N (violet) and NAA (red); Temperature: 20°C, Solvent water/acetonitrile  1:1 
(v:v). (b) Fluorescence emission spectrum of 1N (red) (excitation 280 nm) after various duration of 365 nm illumination 
compared to NAA (violet) at 10 µM concentration in solvent water/acetonitrile 1:1 (v:v), Temperature: 20°C. (c) 
Quantification of fluorescence emission at 339 nm at various times under 365 nm illumination (excitation 280 nm). 
 
4.2.1.4 In vivo stability 
We next evaluated whether caged auxin 1N and 1I were stable in mammalian cells in the dark, 
which is an essential parameter for physiological studies as background release would liberate 
constitutively the active compound. The stability of the caged auxin candidates in the dark was 
evaluated indirectly by monitoring the depletion extent of EGFP-AID-NLS in CHO cells expressing 
OsTIR1-myc incubated with various concentrations of 1N or 1I. Fig.4.5 displays the results for 
both caged auxins 1I and 1N and their respective free auxin equivalent IAA and NAA. Liberation of 
free auxin by hydrolysis would trigger interaction of OsTIR1-myc and EGFP-AID-NLS, leading to 
the polyubiquitination of EGFP-AID-NLS and its subsequent proteasomal degradation. 
 
 
 
Fig 4.5: Mammalian cells co-expressing EGFP-AID-NLS and OsTIR1-myc were incubated with (a) 1I and its free 
auxin equivalent IAA, or (b) 1N and its free auxin equivalent NAA at various dilutions and incubated in the dark for 1 h. 
Cell lysates were analyzed by immunoblotting (IB) with indicated antibodies. 
                                                 
30The UV illumination power was evaluated by monitoring nitrone photoconversion (protocol section 10). 
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We observed a depletion of the EGFP-AID-NLS protein level (monitored by the EGFP epitope) in 
presence of the caged molecules in the dark, even at low concentrations, compared to the standard 
level incubated with DMSO. We concluded that the candidates 1N and 1I were not stable in vivo. 
 
4.2.2 Discussion 
 
DMNB-caged auxin incubation leads to a background degradation activation, indicating that these 
caged molecules are not stable in vivo. Although esters-based caging groups are often less stable 
than amides or carbamates (Carrie, 2005), these results are contrasting with the relative stability of 
reported DMNB-conjugated examples in mammalian cells. For example, Abscissic acid conjugated 
to simple DMNB group by its carboxylic group was reported to be stable at 10 μM in HEK293 cells 
(Wright, 2015).  
 
One can therefore hypothesize that the self-hydrolysis of the caged ester is due to enzymatic 
recognition of auxin-based moiety rather than the caging group, unlike methyl- or ethyl- derived 
esters recognized by specific esterases in vivo (Tian, 2012). Although IAA esterases are present in 
plants, we did not find equivalents in mammalian cells (BLAST). However, an interesting candidate 
is the pancreatic enzyme chymotrypsin, which hydrolyses terminal aromatic residues in peptides. It 
was reported that chymotrypsin processes aromatic carboxyl esters (Sawyer, 1975) 31
 
.  
4.2.3 Second generation 
 
4.2.3.1 Synthesis 
In order to address the background activation of DMNB-auxins in the dark and enhance the stability 
of the caged auxin in vivo, we developed a bulky version of DMNB (or equivalent 4, 5- methylene-
dioxy-2-nitrophenyl), by incorporating Methyl or Tribromomethyl substituents on the connecting 
carbon atom (see (Klan, 2014) for a recent review). These substitutions have been previously 
described to be efficiently cleaved upon illumination in vivo (resp. (Allan, 1998) and (Aujard, 
2006)). Addition of the bulky groups might hinder the ester from active site of endogenous esterases. 
These bulky DMNB groups were conjugated to IAA by Steglich esterification (vide 4.2.1.2). 
                                                 
31  Although this enzyme is not expressed in HEK293 cells (Human Protein Atlas), others enzymes present 
chymotrypsin-like activity, such as cathepsin in the lysosome or proteasome subunit β-type 5 in cytosol and nucleus. 
Proteasomal chymotrypsin-like activity enabled the development of ester-based inhibitors (Kuhn, 2004).  As 
proteasome particles are highly present in HEK 293 cells, a possible explanation for the background hydrolysis of 
DMNB-IAA might be the low-affinity degradation by inner-core proteasome particles. 
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Resulting caged auxins candidates 2I and 3I are displayed on Fig. 4.6 with their synthetic yield. 
 
 
Fig. 4.6: Synthetic scheme of 2I and 3I. 
 
4.2.3.2 Stability 
As in vivo stability was a determinant specification for the development of caged auxins in section 
4.2.1.4, we first evaluated the stability of the caged candidates in vivo in the dark prior further 
photophysical analysis. The depletion extent of EGFP-AID-NLS was monitored in HEK293 cells 
expressing OsTIR1-myc incubated with 2I and 3I at a concentration of 50 μM (duplicate 
experiments). Cells incubated with 2I displayed significant EGFP depletion, although less than cells 
incubated with 1I or free-auxin IAA at the same concentration. Cells incubated with 3I showed 
depletion at a lesser extent (Fig. 4.7). We hypothesized that the large tribromomethyl group present 
in 3a hindered background hydrolysis by endogenous esterases. We chose to continue this strategy 
by addition of larger bulky groups. 
 
 
 
Fig. 4.7: HEK293 cells co-expressing EGFP-AID-NLS and OsTIR1-myc were incubated with candidate caged auxins 
1I, 2I and 3I at 50 µM and incubated in the dark for 1 h. Negative and positive controls (cells incubated with resp. 
DMSO or IAA at 50 µM) are displayed. Cell lysates were analyzed by immunoblotting (IB) with indicated antibodies. 
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4.2.4 Third generation 
 
4.2.4.1 Synthesis 
We developed bulky versions of the DMNB by incorporating an extra 2, 5-dimethoxyphenyl group 
on the connecting carbon atom. 4,5-dimethoxy-2-nitrobenzaldehyde was reacted with the 
commercial 2,5-dimethoxy-phenyl (DMP) Grignard reagent in THF at –15°C for 30 minutes to 
yield the alcohol with 82% yield. This bulky PNB-OH group was conjugated to IAA and NAA by 
Steglich esterification (vide section 4.2.1.2) (Fig. 4.8). Resulting caged auxins candidates 4I to 4N 
were obtained with respectively 89 % and 85 % yield. 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.8: Synthetic scheme of caged auxin 4N and 4I. 
 
4.2.4.2 Photochemical characterization 
4I and 4N displayed the expected absorption properties (Fig. 4.9). As characterized by HPLC 
titration, both 4I and 4N were stable in the dark in aqueous media. Moreover, both 4I and 4N were 
quantitatively photocleaved at 350 nm with respective uncaging quantum yield Φ = 0.012 and Φ = 
0.007 (Fig. 4.10). These values are in accordance with previous reports on similar light-removable 
protecting groups (Aujard, 2006). 
 
Fig. 4.9: (a) Absorption spectra of 4I (solid line) and IAA (dashed line). Absorption spectra of 4N (solid line) and NAA 
(dashed line). Temperature: 20°C, solvent: acetonitrile/ 20 mM Tris buffer 1:1 (pH 7.5). (b) Stability of 4I (a) and 4N (b) 
in aqueous media in darkness. Solutions (25 μM) were kept in the dark for various times: plots show the percentage of 
caged auxin (determined by HPLC) in function of time. Solvent: 20 mM Tris pH 7.5 / acetonitrile 1:1 (v:v). 
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Fig. 4.10: Auxin release upon photolysis of photoactivatable auxins. (a) Photolysis of 4I. Solutions of 4I ( 400 µL at 21 
µM) were illuminated at 350 nm (light intensity ~ 10–8 Ein.s–1, pathlength of the light beam 1 cm). Plots show the 
concentrations of 4I (circle) and IAA (square) in function of time. (b) Photolysis of 4N. Solutions of 4N ( 400 µL at 25 
µM) were illuminated at 350 nm (light intensity ~ 10–8 Ein.s–1, pathlength of the light beam 1 cm). Plots show the 
concentrations of 4N (circle) and NAA (square) in function of time. 
 
4.2.4.3 In vivo stability 
The depletion of EGFP-AID-NLS was monitored in HEK293 cells expressing OsTIR1-myc. No 
significant EGFP depletion was observed upon incubation of 4I and 4N up to 200 μM concentration. 
 
 
Fig. 4.11: HEK293 cells co-expressing EGFP-AID-NLS and OsTIR1-myc-NLS were incubated with 4I (a) and 4N (b) 
at various dilutions and incubated in the dark for 1 h. Positive control displays cells incubated with 500 µM of 
corresponding auxin. Cell lysates were analyzed by immunoblotting (IB) with indicated antibodies. 
 
However, 4N was poorly soluble in water. This feature might prevent the efficient intracellular 
delivery of 4N. Therefore, 4N was not further characterized in cells. 
 
4.2.5 Conclusion 
Eventually, our approach allowed us to select a caged auxin candidate 4I that meet the 
specifications mentioned in section 2.2.2. First candidate caged molecules 1I and 1N were not 
stable in vivo (section 4.2.1.4). We addressed this issue by a strategy designed to hinder the DMNB 
caging group from endogenous esterases, by addition of substituent groups. As a general trend, 
caged auxins were more stabilized with the addition of bulkier substituents (section 4.2.3.2). 
However, a limit to the addition of large substituent is that it can lower the solubility, as in the case 
of 4N (section 4.2.4.3). Eventually, 4I appears a potential candidate for photo-activation of IAA, as 
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it is stable in the dark in vitro and in vivo, and is efficiently cleaved by UV illumination with 
reasonable action cross-section efficiency. However, we investigated whether use of other caging 
groups might allow the development of caged auxins with enhanced photochemical properties. 
 
4.3-Alternative strategies for the development of caged auxins 
 
4.3.1 Coumarin-based caging groups 
 
As an alternative strategy we proposed to conjugate the carboxylic group of IAA with a [(7-
(diethylamino)-coumarin-4-yl]-methyl (DEACM) caging group, which is known to be efficiently 
cleaved upon illumination within the 350-400 nm range (Fournier, 2013). 
 
Based on the instability of DMNB caged auxin reported on section 4.2.1, we chose at first to 
develop bulky version of DCEAM by incorporating an extra 2,5-dimethoxyphenyl group on the 
connecting carbon atom, to hinder the ester function from endogenous esterases. We called the 
resulting caging group PCM (2,5-dimethoxyphenyl-7-diethylamino-coumarin-4-methyl). 7-
(diethylamino)-2-oxo-2H-chromene-4-carbaldehyde was reacted with the commercial 2,5-
dimethoxyphenyl Grignard reagent in THF at –15°C for 2 hours and then reacted at room 
temperature overnight to yield the alcohol PCM-OH with 66% yield. The caged auxin 5I was 
obtained with 96% yield by coupling IAA with PCM-OH in presence of DCC and DMAP (section 
4.2.1.2) in dichloromethane at room temperature overnight (Fig. 4.12). 
 
 
Fig. 4.12: Synthetic scheme of caged auxin 5I. 
 
5I displayed the expected absorption properties (Fig. 4.13.a) and was stable in the dark (Fig. 
4.13.b). The stability in aqueous media in darkness and uncaging upon light illumination of 5I were 
characterized by HPLC titration. The photolysis reaction displayed first-order kinetics. 5I was 
photocleaved faster than 4I with a quantum yield of ~ 0.03 and a corresponding action cross-section 
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of ~ 100 m2.mol–1. This 10-fold increase in photolysis action cross-section results from the 
convolution of a higher quantum yield of photolysis and a larger cross-section of absorption. 
 
 
Fig. 4.13: (a) Absorption spectra of 5I (solid line), IAA (dashed line) and PCM-OH (dotted line). Temperature: 20°C, 
solvent: acetonitrile/ 20 mM Tris buffer 1:1 (v:v) (pH 7.5). (b) Stability of 5I in aqueous media in darkness. Solutions 
(25 µM) were kept in the dark for various times: plots show the percentage of caged auxin (determined by HPLC) in 
function of time. Solvent: 20 mM Tris pH 7.5 / Acetonitrile 1:1 (v:v). (c) Photolysis of 5I. Solutions of 5I (400 μL at 25 
μM) were illuminated at 390 nm (photon rate 4 nmol.s-1, pathlength of the light beam 1 cm). Plots show the 
concentrations of 5I (circle), IAA (square) and PCM-OH (diamond) in function of time. Temperature: 20°C, solvent: 
acetonitrile/ Tris buffer 1:1 (v:v) (pH 7.5). 
 
 
Although quantitative 5I degradation was observed upon 390 nm illumination, only about 30 % 
IAA was released (Fig. 4.13.c). A likely explanation to this partial release is the competitive 
formation of an unreactive side-product through a rearrangement reaction. As such side-reaction 
could prevent reliable photorelease of IAA in cells; we abandoned this strategy which did not allow 
quantitative photolysis, an important specification for caged auxin development. 
 
4.3.2 NH-protection strategy 
4.3.2.1 Motivation 
Alternatively, we proposed to cage other positions than the carboxylic acid in auxins. As we 
hypothesized that the in vivo instability of caged auxins 1X to 3X (X = I or N) resulted from 
hydrolysis of the ester linkage by endogenous esterases (section 4.2.3.2), we expected that caging 
other positions with non-ester linkage might enhance the in vivo stability. 
 
An important specification is that the introduction of the caging group prevents interaction with 
TIR1 (see section 4.1.1). The NH Indole ground in IAA displays an important interaction with the 
amide group of Leu439 in TIR1 (Tan, 2007). This was further proved by development of auxin-
antagonists (see note B.25), in which N-alkylation of IAA dramatically reduced affinity to TIR1. 
Thus, we next evaluated strategies to cage the NH group of IAA with an N-caging group. 
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4.3.2.2 Model for reactivity 
We chose to evaluate the experimental parameters for conjugation of the NH group using a simple 
model reaction: IAA was activated upon deprotonation with a base and subsequent alkylation with a 
halide derivative (1-bromopropane) (Fig. 4.14). Different bases and solvents were tested. IAA 
reaction with 1-bromopropane in anhydrous dimethylformamide (DMF) with sodium hydride (NaH) 
leads to two by-products (O-alkylated IAA and N,O-dialkylated IAA), but not to the expected N-
alkylated IAA (Na-I)). Reactions performed in THF solvent rather than DMF do not work, likely 
due to solubility issues. To prevent activation of the carboxylic group of IAA by NaH, we used a 
methyl ester derivative (MeIAA). MeIAA in the same conditions led to the expected N-alkylated 
MeIAA (Na-MeI) and two by-products (N, O-dialkylated IAA BP-1 and O-alkylated IAA BP-2) 
resulting from trans-esterification. 
 
 
 
Fig. 4.14: Exploration of the experimental condition for IAA/Me-IAA N-conjugation with a model alkylating reaction.  
 
This preliminary study indicated that the synthetic condition 4 might enable the caging of MeIAA. 
Eventually, caged methyl IAA could either be processed by ester hydrolysis to obtain the N-caged 
IAA, or incubated directly in cells. In section 3.4.2, we showed that Me-IAA mediated AID-
degradation in HEK293 cells with rate similar rate to IAA, indicating that it is efficiently cleaved by 
endogenous esterases. 
 
4.3.3 NH-protection with DMNB 
4.3.3.1 Synthesis 
We first assessed the possibility to use DMNB as a protecting group of the NH group in Me-IAA. 
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To synthesize DMNB-N-caged Me-IAA (6-MeI), 1-(bromomethyl) -4,5-dimethoxy-2-nitrobenzene 
in DMF was reacted with MeIAA deprotonated with NaH to yield the DMNP-MeIAA with only 10% 
yield (Fig. 4.15). The major product was the product of the trans-esterification (56%). 
 
 
 
Fig. 4.15: Synthetic scheme of caged auxin 6MeI. 
 
4.3.3.2 Photochemical evaluation 
Light illumination of 6MeI led to its fast disappearance with first-order kinetics. However, 
accumulation of intermediate molecule and slow release of Me-IAA were observed in HPLC (data 
not shown). A thermally-driven step within the uncaging process is likely rate-limiting. This slow 
release of auxin prevents further use of this caged compound for cellular photoactivation. 
 
 
Fig. 4.15: Photolysis of 6MeI. Solutions of DMNB-MeIAA (400 µL at 25 µM) were illuminated at 350 nm (light 
intensity ~ 2× 10–8 Ein.s–1, pathlength of the light beam 1 cm). Plots show the relative concentrations of 6MeI in 
function of time. 
 
 
4.4 Conclusion 
In this part, we described the synthesis and characterization of caged auxin candidates to identify a 
potential photo-activatable auxin that meets reasonably the specifications listed on section 2.2.2. 
Based on a described structure of auxin interaction with receptor TIR1, we proposed that the 
carboxylic group common to natural auxin IAA or synthetic auxin NAA could be targeted for 
inactivation by conjugation with a caging group. 
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DMNB-ester caged auxins were sensitive to hydrolysis in vivo, leading to background activation in 
the dark. This issue was addressed by introduction of bulky-substituted caging groups, which led to 
the identification of caged auxin 4I as a potent candidate. Alternative strategies lead to the 
development of caged auxin candidates 5I and 6MeI that did not allow efficient photorelease. 
 
  λmax 
(nm) 
k1 
(min–1) 
k2 
(min–1) 
I0 
(Ein.s–1) 
σφ 
(m2.mol–1) 
ε 
 (M–1.cm–1) 
σ  
(m2.mol–1) 
φ 
4I 350 0.22 0.23 1.1×10–8 14 5160 1187 0.012 
4N 350 0.12 0.12 9.7×10–9 8 5080 1168 0.007 
5I 390 0.65 0.70 3.9×10–9 116 17420 4007 0.029 
6MeI 350 0.51 ----- 1.8×10–8 ------ 4420 1017 ------ 
 
Table 4.2. Photolysis parameters of the photoactivatable auxins. The wavelength λmax of maximal absorption, the 
kinetic constant of caged auxin disappearance k1, the kinetic constant of auxin appearance k2, the light intensity of the 
lamp I0, the action cross-section of photolysis σφ, the molar absorption coefficient ε, the molar absorption cross-section 
σ and the quantum yield of photolysis φ are given for the different photoactivatable auxins. 
 
Therefore, 4I was chosen for photo-controlling auxin liberation, and will from now on be dubbed 
PA-IAA for Photo-Activatable IAA. We will assess in Chapter 5 the possibility to trigger protein 
depletion in living cells by PA-IAA photocontrol. 
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Chapter 5 
Photo-induced protein degradation in living cells 
 
In chapter 3, we described the optimization process for an auxin-dependent degradation platform, 
and selected OsTIR1D170E as an optimized heterologous F-box protein. Then, in chapter 4, we 
described the synthesis and selection of a caged auxin candidate PA-IAA. In this part, we will 
discuss the possibility of implementing the degradation of a POI through light-control by combining 
the two tools detailed in the previous chapters, as summarized on Fig 5.1. 
 
 
Fig. 5.1: Overview of a light-controlled AID for conditional depletion of POI in mammalian cells. PA-IAA is inactive in 
the dark, whereas its photolysis by UV illumination mediates the direct interaction between heterologous POI-AID and 
F-box OsTIR1, leading to the subsequent polyubiquitination and degradation of the POI-AID. 
 
5.1 Validation of the protein depletion strategy triggered by PA-IAA 
photocontrol by immunoblotting 
 
5.1.1 Description of the protocol for global UV illumination 
Using the optimized degradation system described on chapter 3, we next tested our ability to 
globally promote protein depletion in HEK293 cells grown on culture dish by photoliberation of 
PA-IAA. Besides giving a validation of the approach, this allowed us to adjust the parameters of 
illumination. HEK293 cells co-expressing OsTIR1D170E-NLS and EGFP-AID-NLS were incubated 
in presence of PA-IAA in complete medium, illuminated at 365 nm with a hand UV lamp (Fig. 5.2).  
[PART B : RESULTS] 
 
110 
 
 
Fig 5.2: Overview of the illumination protocol. HEK293 cells were cultivated in 12-wells dishes, and transfected with 
pAG72 for 24h before manipulation. Cells were then incubated with PA-IAA for 20 min in the dark, illuminated with a 
hand UV lamp for 8 min and left in the dark at 37°C for one to two hours. 
 
The hand UV-lamp delivered a measured photon flux I = 100 µmol.s–1.m–2. Using the uncaging 
cross-section ε.Φ = 6 m2.mol-1 determined for PA-IAA in section 4.2.4.2, the half-time for 
photorelease was evaluated to 500 s, according to equation (5.1): 
𝑡1/2 =
ln (2)
2.3 ε.Φ 𝐼
   (5.1) 
Post-illumination, the cells were left in the dark at 37°C for various times. Cells lysates were 
analyzed by immunoblotting to monitor the EGFP-AID-NLS depletion. 
 
5.1.2 Optimization of the PA-IAA concentration 
 
The photo-activation strategy in vivo necessitates optimizing the concentration of PA-IAA used, 
which has to be: 
 
• high enough for a genuine biological effect. IAA has a reported dissociation constant KD for 
AtTIR1 below 100 nM (Dharmasiri, 2005); therefore, a low amount of IAA might be 
sufficient to trigger the heterodimerization of TIR1 and Aux/IAA; however, sufficient 
amount of activatable PA-IAA has to accumulate intracellularly before illumination. It is 
expectable that protection with a caging group might enhance the diffusibility of the poorly-
permeable IAA, based on our observations with methyl-ester IAA reported on section 3.4.2. 
 
• below a limit concentration where hydrolysis or auto-activity become non-negligible, to 
avoid a background effect in the dark. 
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We tested various concentrations of PA-IAA in HEK293 cells co-expressing EGFP-AID-NLS and 
OsTIR1D170E-NLS, in the dark or illuminated by a UV-lamp for 8 min, which corresponds to the 
half-life for photorelease. The corresponding results are displayed on Fig 5.3:  
                 
Fig. 5.3: HEK293 cells co-expressing EGFP-AID-NLS and OsTIR1D170E-NLS were incubated with PA-IAA in a range 
from 50 to 200 µM for 20 min in the dark at 37°C, then illuminated (+) or not (-) at 365 nm with a photon flux of 100 
μmol.s-1.m-2 for 8 min and finally left in the dark for 1 hour at 37°C. Cell lysates were analyzed by immunoblotting (IB) 
with the indicated antibodies. HEK293 cells co-expressing EGFP-AID-NLS and OsTIR1D170E-NLS were used for 
controls. Negative control (lane 1, untreated cells) displays the initial EGFP-AID-NLS immunoblotting level. Positive 
control (lane 2, cells treated for 2 h with 500 µM IAA) displays the free-auxin induced depletion in identical time. 
 
We deduce from variations of the EGFP-AID-NLS level (assessed by EGFP immunoblotting) that: 
• As previously reported on section 4.2.4.3, EGFP-AID-NLS is stable for PA-IAA 
concentrations up to 200 µM.  
• Significant protein depletion was observed for each concentration following illumination. 
Although it might be possible that even lower concentrations could be as effective, we thus chose 
50 μM as a working concentration of PA-IAA for the following experiments. 
 
5.1.3 Optimization of the UV-illumination time 
 
We next assessed the UV illumination time necessary to significantly photoliberate the caged 
product. We tested various illumination times from 0 to 8 min in HEK293 cells co-expressing 
EGFP-AID-NLS and OsTIR1D170E-NLS incubated with the previously determined 50 µM PA-IAA 
concentration. The corresponding results are displayed on Fig 5.4. The EGFP-AID-NLS depletion 
increases with illumination time. Efficient depletion is observed for 8 min illumination, 
corresponding to the half-life of photoliberation. Although we assume that no cytotoxic effects32
                                                 
32 This corresponds to delivering a photon irradiation of 48 µmol.m–2 (or 0.25 J.m–2), which is below the reported 
phototoxicity for UV-A in mammalian culture cells (Sun, 2010). 
 are 
associated with this range of illumination, longer UV exposure would not however be desirable. 
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Fig. 5.4: HEK293 cells co-expressing EGFP-AID-NLS and OsTIR1D170E-NLS were incubated with 50 µM PA-IAA for 
20 minutes in darkness, then illuminated at 365 nm with a photon flux of 100 μmol.s–1.m–2 for 0, 2, 4 or 8 min, and 
finally incubated in the dark for 2 h (lanes 4-7). Cell lysates were analyzed by immunoblotting (IB) with the indicated 
antibodies. HEK293 cells co-expressing EGFP-AID-NLS and OsTIR1D170E-NLS were used for controls. Negative 
controls display the initial EGFP-AID-NLS immunoblotting level (lane 1, untreated cells), and the UV-induced 
depletion at maximal illumination (lane 2, cells exposed to 365 nm with a photon flux of 100 μmol.s–1.m–2 for 8 min). 
Positive control (lane 3, cells treated for 2 h with 500 µM IAA) displays free-auxin induced depletion in identical time. 
 
We then validated that the parameters previously determined allowed light-dependent conditional-
degradation in three independent experiments in HEK293 cells co-expressing EGFP-AID-NLS and 
OsTIR1D170E-NLS. The corresponding results are displayed on Fig. 5.5: 
 
Fig. 5.5: (a) HEK293 cells co-expressing EGFP-AID-NLS and  OsTIR1D170E-NLS were incubated with (+) or without 
(–) 50 µM PA-IAA for 20 minutes in darkness, then illuminated (+) or not (–) at 365 nm with a photon flux of 100 
μmol.s–1.m–2 for 8 min, and finally incubated in the dark for 1 h (lanes 2, 4 and 5). Cells lysates were analyzed by 
immunoblotting (IB) with the indicated antibodies.  Negative control experiments display the initial EGFP-AID-NLS 
IB level (lane 1, untreated cells), and the UV-induced depletion at maximal illumination (lane 2, cells exposed to 365 
nm with a photon flux of 100 μmol.s–1.m–2 for 8 min). (b) Western blot quantification. Plots represent the mean ± SD of 
3 independent experiments. Data represent the EGFP-AID-NLS level normalized by the Os-TIR1D170E-NLS level. The 
statistical significance was evaluated by a one-way analysis of variance (*** p value < 0.001, **** p value < 0.0001). 
 
This series of three independent experiments confirmed that PA-IAA in these conditions met the 
specifications of a caged-auxin candidate: 
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• no significant depletion of AID-EGFP-NLS was observed in cells illuminated in absence of 
PA-IAA, nor in cells incubated with 50 µM PA-IAA in the dark. 
• significant protein depletion of AID-EGFP-NLS was observed in cells incubated with 50 
µM PA-IAA and illuminated at 365 nm. 
These experiments confirmed that specific photocontrol of the cellular stability of POI fused to AID 
was possible by photolysis of PA-IAA, using the parameters determined on section 5.1.1. However, 
immunoblotting displays averaged results in a global system, and is therefore inefficient to 
interrogate the degradation dynamics in individual cells. We next tested whether we could induce 
local photo-induced degradation by monitoring fluorescence depletion in confocal microscopy. 
 
5.2 Monitoring of protein depletion triggered by PA-IAA photocontrol 
in confocal microscopy 
 
We next tried to photolyse PA-IAA in HEK293 cells at 365 nm, using a microscope metal-halide 
lamp equipped with a DAPI filter as light source. HEK293 cells were grown on individual 
microscopy dishes and were illuminated on a surface of 0.1 mm2 with a 63 × objective (NA 1.4). 
 
5.2.1 Evaluation of the local illumination parameters 
 
A method to quantify the local surfacic illumination power was necessary to estimate the 
illumination conditions necessary for significant uncaging of PA-IAA. This implies the setup of a 
protocol monitoring optical changes varying linearly with UV light illumination intensity. 
Classically, the photoliberation of a caged fluorophore can be used for calibration33
 
. 
5.2.1.1 Kikume Green/Red can be used as a local illumination reporter 
We however chose another strategy by using a fully genetically encoded Kikume Green/Red (Kik 
G/R) reporter protein, developed for regional tracking in cells, as explicated on Fig. 5.6. KikG/R is 
a photo-switchable protein able to irreversibly convert from green to red fluorescence when 
illuminated by UV or violet light (Tsutsui, 2005). However, the excitation lights used to elicit red or 
                                                 
33 Such as PA-Fluoresceine, with a DMNB caging group. Caged fluoresceine is uncolored, whereas free fluoresceine 
exhibit a strong green fluorescence. Assuming that the photophysical properties of PA-IAA and PA-Fluoresceine are 
comparable, following the photoliberation of PA-Fluoresceine might be a good reporter of the UV illumination power. 
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green fluorescence do not induce the photoconversion. The green to red ratio can be calculated and 
reports directly to the power of UV illumination. 
 
 
 Fig. 5.6: Principle of single cell-tracking by KikG/R photoconversion from Green to Red upon UV illumination. 
 
5.2.1.2 Validation of local illumination by KikG/R 
KikG/R was expressed in HEK293 cells using a commercial plasmid under a CMV promoter. 
Positive transfected cells grown in dark conditions exhibit a strong cytoplasmic fluorescence in the 
green range, but not in the red range. We photoconverted KikG/R in HEK293 cells on a surface of 
0.1 mm2, using a microscope metal-halide lamp equipped with a DAPI filter as light source. 
Quantitative photoconversion of fluorescence from green to red was observable upon 10 s UV 
illumination (Fig. 5.7). As KikG/R and PA-IAA cross-sections are comparable (resp. 8 and 6 
m2.mol-1) (Tsutsui, 2005), this confirmed that significant photoliberation of PA-IAA is expected 
within seconds using this illumination protocol. Consistently, the illumination photon flux I0 was 
evaluated to 100 mmol.s-1.m-2 using a powermeter. 
 
 
 
Fig. 5.7: KikG/R expressed in HEK293 cells accumulate as a green fluorescent cytoplasmic protein. Green to red 
photoconversion is observed upon 10s UV illumination with a metal halide lamp  and a 63 × objective (NA 1.4, photon 
flux at specimen plan ~ 100 mmol.s–1.m–2). 
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5.2.2 Implementation of protein degradation by a photoliberation protocol 
 
5.2.2.1 Description of the protocol for global UV illumination 
We next characterized the kinetics of degradation of EGFP-AID-NLS co-expressed with 
OsTIR1D170E-NLS in HEK293 cells upon photorelease of IAA. EGFP fluorescence was used as a 
reporter of EGFP-AID-NLS protein level and quantified by time-lapse confocal microscopy. PA-
IAA absorbance is negligible beyond 425 nm (see section 4.2.4.2); therefore, EGFP could be 
excited at 488 nm without activating PA-IAA photolysis. With an uncaging cross-section εΦ = 6 
m2.mol-1, the half-life of PA-IAA under an illumination power I0 =100 mmol.s-1.m-2 was evaluated 
to 0.5 s (equation (5.1)). Therefore, quantitative photoliberation is expected with a 12 s illumination 
time. No major cytotoxic effects are associated with these illumination parameters (see note B32). 
 
5.2.2.2 Optimization of the illumination protocol for PA-IAA release 
However, first attempts to trigger PA-IAA in HEK293 cells co-expressing OsTIR1D170E-NLS and 
EGFP-AID-NLS did not lead to significant EGFP fluorescence depletion. We suspected that the 
presence of serum in the incubation medium might affect the effective PA-IAA concentration. 
Indeed, addition of serum is known to deplete hydrophobic molecules from medium due to 
adsorption to serum proteins such as albumin (Fasano, 1975). We therefore replaced the complete 
D-MEM medium (containing fetal calf serum), by OptiMEM (a serum-free, phenol-red free 
synthetic medium supplemented with growth factors). However, in HEK293 cells co-expressing 
OsTIR1D170E-NLS and EGFP-AID-NLS incubated with 50 μM PA-IAA, we monitored limited 
depletion (25% in one hour) after a single UV pulse (12 s) (Fig. 5.8.a). 
 
We next addressed the timing of UV illumination, to assess whether, for identical light illumination, 
multiple frequent pulses were more efficient than one single pulse. In HEK293 cells co-expressing 
OsTIR1D170E-NLS and EGFP-AID-NLS, we successively monitored the depletion induced: 
• first, by a single UV illumination (12s) for one hour. 
• second, by several pulses of 1s illumination every 5 min (12×1s) for one hour. 
 
We measured differential relative depletion kinetics within one hour (Fig. 5.8.b): 25 ± 2 % for 
single UV pulse, compared to 73 ± 23 % for several pulses. Thus, a protocol based on multiple 
short illumination pulses spaced apart by darkness periods every 5 min was chosen. Further UV 
illumination might be toxic for cells. Relying on the light calibration on section 5.2.1.2, 1s 
illumination pulse should convert 75% of intracellular PA-IAA into active IAA every 5 min. 
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Fig. 5.8: (a) Normalized nuclear fluorescence intensity in function of time (mean ± SD, n = 10 cells). HEK293 cells co-
expressing EGFP-AID-NLS and OsTIR1D170E-NLS were incubated from t = -30 min with 50 μM PA-IAA min in dark. 
Imaging started at t= -10 min. At t = 0 min, cells were illuminated for 12 s at 365 nm (photon flux at the specimen plane  
~ 100 mmol.s–1.m–2) (+PA-IAA +UV). Also displayed are control experiments where cells were not illuminated (+PA-
IAA -UV). (b) Confocal micrographs of HEK293 cells co-expressing EGFP-AID-NLS and OsTIR1D170E-NLS were 
incubated with 50 μM PA-IAA from t = -20 min in the dark and imaged from t = -10 min. At t = 0 min, cells were 
illuminated for 12 s at 365 nm. From t = 60 min, cells were illuminated for 1 s at 365 nm every 5 min for 1 hour. Photon 
flux at the specimen plane  ~ 100 mmol.s–1.m–2. 
 
5.2.2.3 EGFP fluorescence robustly reports for EGFP-AID-NLS level upon UV illumination 
However, quantification of the photobleaching induced by UV illumination was necessary to ensure 
that the observed depletion in the EGFP fluorescence signal was not due to photobleaching. EGFP 
fluorescence was monitored in individual HEK293 cells co-expressing EGFP-AID-NLS and 
OsTIR1D170E-NLS following the UV illumination and imaging protocol used for photoactivation. 
The results are displayed on Fig. 5.9.a. Loss of fluorescence was below 10% within one hour. 
 
 
Fig. 5.9: (a) HEK293 cells co-expressing EGFP-AID-NLS and OsTIR1D170E-NLS were imaged in following conditions: 
(i) cells were incubated with 50 μM PA-IAA for 20 min in the dark (t=-20 min) and imaged from t= 0 min. (+PA-IAA -
light); (ii) from t = 0 min, cells were illuminated for 1 s at 365 nm (photon flux at the specimen plane ~ 100 mmol.s–
1.m–2) every 5 min for 1 hour. (-PA-IAA +light). (b) Kinetic summary of the experimental conditions. (c) Normalized 
nuclear fluorescence intensity in function of time (mean ± SD, n = 10 cells). 
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Another specification for PA-IAA was to be stable in the dark. Although global PA-IAA stability 
was evaluated previously in immunoblotting (section 4.2.4.3), we monitored EGFP fluorescence in 
control cells incubated with 50 μM PA-IAA (Fig. 5.10.a.) Loss of fluorescence was below 10% 
within one hour. 
 
5.2.3.4 Significant, rapid protein depletion following PA-IAA photoliberation 
Therefore, the photoliberation of IAA by UV-light pulses was tested. In HEK293 cells co-
expressing OsTIR1D170E-NLS and EGFP-AID-NLS pre-incubated with 50 µM PA-IAA, we 
observed significant depletion within 1 hour by flashing at 365 nm for 1s every 5 min (Fig. 5.10). 
We determined a protein half-life of 20 ± 3 min, in accordance with the degradation kinetics 
observed with free IAA. 
 
 
 
 
Fig. 5.10 (a) HEK293 cells co-expressing EGFP-AID-NLS and OsTIR1D170E-NLS were imaged in following conditions: 
• cells were incubated with 50 μM PA-IAA for 20 min in the dark (t=-30 min) and imaged from t= -10 min. From 
t = 0 min, cells were illuminated for 1 s at 365 nm (photon flux at the specimen plane ~ 100 mmol.s–1.m–2) 
every 5 min for 1 hour (+PA-IAA +light). 
• cells were pre-treated for 1 hour with 50 μM MG132 (t= -60 min), and then incubated with 50 μM PA-IAA for 
20 min in the dark (t=-30 min) and imaged from t= -10 min. From t = 0, cells were illuminated for 1 s at 365 nm 
(photon flux at the specimen plane ~ 100 mmol.s–1.m–2) every 5 min for 1 hour (+PA-IAA +light +MG132). 
(b) Kinetic summary of the experimental conditions. (c) Normalized nuclear fluorescence intensity in function of time 
(mean ± SD, n = 10-30 cells). 
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5.2.3.5 The light-induced protein depletion is a proteasomal degradation 
The observed depletion cannot be explained by the convolution of both PA-IAA background 
hydrolysis and photo-bleaching, as indicated by control experiments in 5.2.2.3 and 5.2.3.1. 
However, we also confirmed that the observed fluorescence depletion was not due to the release of 
reactive species produced by PA-IAA photoactivation. In control cells pre-treated with the 
proteasome inhibitor MG132, no degradation was observed upon photoactivation of PA-IAA34
 
 (Fig. 
5.10), showing that the observed EGFP loss upon IAA photorelease was indeed due to proteasome 
degradation and not to inactivation by reactive oxygen species. 
5.2.4 Discussion 
 
To sum up, we setup a methodology to trigger protein degradation by UV-light short pulses.  
Parameters were adjusted, such as PA-IAA concentration, and UV light pulse intensity, but also 
frequency. Interestingly, we observed that a protocol based on multiple short illumination pulses 
spaced apart by darkness periods was more efficient for maintaining efficient degradation than one 
single initial pulse. We will now discuss on the origin of this discrepancy. 
 
5.2.4.1 Possibility of auxin-catabolism in HEK293 cells 
A first hypothesis to address the relative inefficiency of single UV pulse to trigger depletion is that 
the active IAA is metabolized by HEK293 endogenous enzymes. As IAA is closely related to the 
Tryptophan amino-acid, we first postulated that IAA might be degraded by one of the two major 
pathways35
 
 for tryptophan catabolism existing in human cells (Fig. 5.11): 
• Indoleamine 2, 3-dioxygenase (IDO1) catalyses the oxydative opening of the indole ring, 
which is the first step of the kynurenine pathway. However, it is not expressed in HEK293 
cells (Human Protein Atlas). 
• Tryptophan hydroxylase (THP) catalyses the hydroxylation of C5 in tryptophan, the first 
step of the serotonin formation pathway. THP2 is expressed at low levels in HEK cells 
(Human protein atlas), although it is highly abundant in kidney36
                                                 
34 An actual increase of GFP fluorescence of 10% was observed, indicating that heterologous EGFP-AID-YFP is 
degraded by the UPS in HEK293 at corresponding rates. 
. 
35 Another reported degradation pathway in human cells is the generation of cytotoxic species by oxidation of IAA 
catalyzed by horseradish peroxidase has been reported as a potential cancer therapy (Jeong, 2010).  
 
36 HEK cells were originally assumed to originate from an adenovirus transformed fibroblastic or epithelial embryonic 
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Consequently, it is improbable that neither of these mechanisms is sufficient to explain the rapid 
depletion of active IAA observed after PA-IAA photorelease. 
 
 
Fig 5.11: Overview of two hypothetical catabolic pathways for IAA degradation in mammalian cells, based on the 
described tryptophan pathway : (a) Tryptophan hydroxylase, first enzyme involved in serotonin synthesis pathway ; (b) 
Indoleamine 2,3 dioxygenase catalyzing oxidative opening of the Indole-ring. 
 
5.2.4.2 Possibility of export of photo-liberated IAA in HEK293 cells 
Another hypothesis is that the active IAA is externalized out of the cells by porines or permeases. 
Geisler et al. observed a net efflux of radiolabeled auxins in HeLa cells, in a few minutes timescale. 
Heterologous expression of plant auxin-transporter enhances this efflux effect (Geisler, 2005). 
 
A first hypothesis for auxin efflux in mammalian cells is the existence of human homologs of plant 
auxin-transport proteins. Multi-drug resistance (MDR) gene MDR/TAP1 presents the highest 
homology in sequence alignment with plant MDR transporter AtPGP1 (BLAST). MDR/TAP1 is 
expressed at a medium level in HEK293 cells (5 times higher than in HeLa cells), but not in other 
human cell lines, such as MCF-7 (Human Protein Atlas). Indeed, auxin efflux processes in HeLa 
cells were reduced by using plant and mammal MDR inhibitors, but not totally, indicating that an 
MDR-independent background efflux exists in mammalian cells (Teale, 2006), (Geisler, 2005). 
   
Another possibility involves amino-acid transporters 37
                                                                                                                                                                  
kidney tissues. Recent studies rather related HEK cells to immature neurons or adrenal cells (Shaw, 2002). 
, which play important roles in kidney 
physiology and have been extensively reviewed in mammalian cells (Palacin, 1998). One can 
suspect SLC16A10/TAT1 (Tyrosine and Tryptophan Amino-acid transporter) (Mariotta, 2012) as the 
possible actor of auxin efflux.  TAT1, a Na+ and H+-independent uniport, allows net efflux and 
influx of aromatic amino acids with low-affinity (KD from 3 to 6 mM), but also recognizes N-
methylated derivatives of amino-acids and monocarboxylates (Broer, 2006). SLC16A10 is 
expressed at a medium level in HEK293 cells, contrary to other cells lines such as HeLa where it is 
absent (Human Protein Atlas). This feature would allow net efflux of the high-concentration of free 
auxin liberated by PA-IAA illumination. 
37  In contrast to other transporters, such as the broad heteromeric transporter of neutral amino-acid transporter 
4F2hc/LAT2 found at the basolateral membrane in kidney. This is not however the major hydrophobic amino-acid 
efflux pathway in kidney, but rather an exchanger with intracellular Cys (Liu, 2006). 
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Eventually, one can propose a model to explain the inefficiency of single pulses, as the liberated 
IAA can be rapidly inactivated by a cellular process, either catabolism, or more likely export by 
porines. This mechanism is summarized in Fig. 5.12. 
 
 
Fig. 5.12: Overview of the hypothetical mechanism reporting the IAA apparent de-activation post UV-liberation: (a) 
addition of PA-IAA in the dark for 20 min leads to the equilibration within extra and intracellular media. (b) UV-light 
pulses (1 s) liberate free IAA within the illumination area. Active auxin can induce the TIR1-dependent AID 
degradation; however, either catabolic degradation or porine export leads to the depletion of free IAA within minutes. 
PA-IAA accumulates again due to equilibrium exchange with the reservoir. 
 
5.2.5 Conclusion 
 
In this part, we showed that local photo-control of protein degradation could be obtained with the 
conditional release of a caged effector molecule. Although this protocol necessitates several pulses, 
it can be easily implemented and convenient for manipulators. The actuation timescale is 
comparable to free auxin addition (half-life of target protein < 20 min). One major advantage of 
caged molecules is to allow high spatial resolution for active molecule photorelease38
                                                 
38 For example this feature is of particular interest for the precise release of neurotransmitters such as L-glutamate in 
neurons (Specht, 2006), (Matsuzaki, 2010). 
. The specific 
control of degradation in individual cells by local photorelease, down to the single cell level, is thus 
highly desirable, and will be discussed in the next section. 
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5.3 Protein depletion with single-cell resolution triggered by PA-IAA 
resolution 
 
5.3.1 Evaluation of the local illumination parameters 
 
Next, we assessed the possibility to trigger spatially-controlled POI degradation using local 
photorelease of IAA using a commercial confocal microscopy laser setup. Local photolysis of PA-
IAA was achieved using a laser diode at 405 nm, a wavelength at which PA-IAA still absorbs 
enough for efficient uncaging (section 4.2.4.2), using a bleaching procedure of the confocal 
observation Software (Zen Zeiss). A rectangular region of interest (ROI) of 200 μm2 was defined 
and illuminated (protocol in section 10.2). The photon flux was adjusted by photoconverting 
heterologous KikG/R expressed in single HEK293 cells on a ROI, as displayed on Fig. 5.13.  
 
 
 
Fig. 5.13: (a) Single-cell highly specific photoconversion of KikG/R heterologously expressed in HEK293 cells can be 
achieved upon 405 nm illumination. (b) Evolution of the green and red fluorescence upon 405 nm illumination. 
Quantitative conversion is observed upon 5 sequences of illumination. 
 
Five consecutive illumination events were sufficient to achieve complete photoconversion, with a 
highly specific single-cell resolution. This comforted us in the fact that spatial control of photo-
illumination pattern can be achieved with 405 nm laser illumination. As a single series of 
illumination enabled 50% photoconversion, and to avoid high illumination powers, a protocol based 
on single 405 nm illumination every 10 min was selected. 
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5.3.2 Significant selective protein depletion induced by patterned illumination 
 
5.3.2.1 Specific protein depletion in single-cell 
We next characterized whether we could induce specific degradation of EGFP-AID-NLS cells upon 
specific photorelease of IAA. HEK293 cells co-expressing EGFP-AID-NLS and OsTIR1D170E-NLS 
were pre-incubated in the dark for 20 minutes with 50 μM PA-IAA in OptiMEM buffer. Regions of 
interest (ROI) of 200 μm2 were delimited within individualized cells. IAA bursts localized to ROI 
were generated by flashing repeatedly every 10 min with the 405 nm laser. Consequently, specific 
EGFP fluorescence depletion was observed in ROI, as exemplified on Fig. 5.14: cells #1 and #2, 
which were included in the illuminated ROI displayed at 75% loss within one hour. 
 
 
Fig. 5.14:  (a) Summary of confocal micrographs of cells before illumination (t = 0 min), after local illumination at 405 
nm (t = 60 min) and after global illumination at 365 nm (t = 90 min). The red square shows the region of interest (ROI) 
illuminated at 405 nm. Scale bars 10 μm. (b) Normalized nuclear fluorescence of cells 1-4 in function of time. The 
arrows successively indicate beginning of local illumination and of global illumination. 
 
To show that photobleaching was not involved in EGFP fluorescence depletion specifically 
observed in the illuminated area, systematic picture acquisition before and after illumination was 
performed, as shown in Fig. 5.15. In the series of experiment shown, the relative fluorescence 
difference before and after a single illumination event was evaluated to 0.27 ± 0.9 % for UV-
illuminated cells (n=12), and 0.12 ± 0.8 % for non illuminated-cells (n=12), showing that local 
depletion cannot be attributed to photobleaching. 
 
5.3.2.2 Spatial selectivity in protein depletion 
Local photorelease of IAA enabled to induce proteolysis with high spatial resolution, as shown on 
Fig. 5.14. Cells #3 and #4, distant of 60 μm to the ROI display less than 20% fluorescence loss in 
one-hour post-illumination. Finally, global illumination at 365 nm, using a microscope metal-halide 
lamp led to global EGFP depletion in the illuminated field, at timescales comparable to those 
reported on section 5.2.2. 
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Fig. 5.15: Global time-lapse of locally-induced protein degradation summarized in Fig. 5.14.a. For each time point, pre-
and post-illumination images are shown to evidence that the loss of fluorescence is not due to photobleaching. 
 
However, statistical analysis showed that EGFP-AID-NLS depletion following illumination was not 
strictly limited to the ROI, but also affected surrounding cells. To monitor the spatial selectivity of 
PA-IAA uncaging, we related the fluorescence EGFP loss in one hour in individual cells to their 
distance to the illuminated ROI (Fig. 5. 16). Specific depletion was restricted to cells immediately 
surrounding the ROI at a distance shorter than 20 μm, whereas no significant difference was 
observed further, compared to non-incubated cells. 
 
In conclusion, specific EGFP fluorescence depletion was observed in the uncaging ROI and 
immediately surrounding cells at a distance shorter than 20 μm. This indicates that local 
photorelease of IAA could enable the control of protein degradation at the single cell level. 
 
 
 
Fig 5.16: Percentage of fluorescence loss in individual cells 60 min after local 
illumination in function of their distance to the illuminated spot (red circles; n =66 
cells from 12 experiments). In control experiments, cells were illuminated and 
imaged in the same conditions but in absence of PA-IAA (blue squares; n = 26 
cells from 6 exp.). 
 
[PART B : RESULTS] 
 
124 
 
5.3.3 Modelization of IAA diffusion following single-cell PA-IAA photoliberation 
In a simple model of auxin diffusion, one can consider a punctual source of free IAA which diffuses 
following a 3D diffusion (7.2) distribution along the distance r in the time t: 
𝑐(𝑟, 𝑡) =  1
(4𝜋𝐷𝑡)
3
2�
. 𝑒−
𝑟2
4𝐷𝑡    (7.2) 
We took 700 μm2.s-1 for D, the diffusion coefficient of IAA (Hetherington, 2008). Fig. 5.17 reports 
the predicted IAA distribution at various distances from the source (computed with Matlab). 
Following illumination (t=0 s), short (< 1 s) bursts of auxin are observable at 5 and 10 μm, rapidly 
decreasing with distance. Almost no effective concentration of IAA is seen in regions beyond 10 μm. 
 
Fig 5.17: (a) Predicted temporal evolution of active IAA distribution at various distances after PA-IAA photoliberation: 
5 µm (violet), 10 µm (red), 20 µm (blue) (b) Predicted distribution profiles of active IAA diffusion at various times: 
0.01 s (blue), 0.02 s (black), 0.05 s (red) following PA-IAA photoliberation. 
 
This simplified model can be compared to our observations. PA-IAA illumination creates an active 
auxin pattern that rapidly dissipates in space and time, although the mechanism is not determined39
 
. 
Free auxin is poorly permeable due its anionic carboxylate and high concentrations of auxin are 
necessary to trigger AID degradation in mammalian cells (Nishimura, 2009), see also Fig 3.1.3. 
Membrane permeation might be a kinetic determinant step. 
5.4 Conclusion  
 
This set of experiments showed the possibility to implement light-activated protein depletion of 
AID-tagged protein upon photorelease of IAA in individual cells, down to the single-cell level with 
multiple short light pulses; although this protocol is more constraining than activation by single 
pulse, it does not necessitate continuous light-illumination contrary to other reported methods for 
light-induced degradation, which will be further discussed on part 7.1. 
                                                 
39 Further refinements would include the suspected efflux of intracellular auxin discussed on 5.2.3. However, diffusion 
would also induce rapid dissipation of auxin, so that subsequent depletion might be limited to surrounding regions. 
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Chapter 6 
Photo-induced protein degradation of a cytoplasmic 
protein in living cells 
 
So far in previous chapters, a nuclear AID-EGFP reporter has been used as a model for auxin-
induced degradation. Application to actual POI is an important specification for the development of 
a generic protein depletion methodology. The generic AID methodology can be a priori applied to 
any POI, regardless of their cellular context (Nishimura, 2009). This potentiality has been illustrated 
in mammalian culture cells with six different POI targets, including two cytoplasmic proteins, 
which were conditionally degraded by auxin addition (Holland, 2012). Thus, development of the 
AID methodology in a cytoplasmic context is desirable. We will address this question in this chapter. 
 
6.1 CyclinB1 is a cytoplasmic target for conditional AID degradation  
 
In section 3.4.3, we reported that endogenous sequences present in AID may prevent in some cases 
the cytoplasmic localization of fusion proteins. To implement light-inducible protein degradation in 
a cytoplasmic context, we focused on cytoplasmic AID-fusion proteins previously reported. 
 
6.1.1 Heterologous Cyclin B1-AID is addressed to cytoplasm in mammalian cells 
HsCyclin B1 fused to AID was reported as an example of cytoplasmic POI 40
                                                 
40 Plk4 (Polo Kinase 4) was also described as cytoplasmic POI target. AID-YFP-Plk4 was degraded upon auxin addition 
with a half-life of 9 min. These two cytoplasmic proteins however differ by their sub-localization: Plk4, which regulates 
the centriole duplication, is punctually associated with centrosome.  
. Fluorescence 
microscopy confirmed that the fusion protein Cyclin B1-AID-YFP colocalized in the cytoplasm 
with endogenous Cyclin B1 (Holland, 2012). This implied that the nuclear addressing driven by 
endogenous sequences in AID is balanced by cytoplasmic addressing signals in Cyclin B1. 
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6.1.2 Heterologous Cyclin B1-AID is conditionally degraded by auxin addition  
Cytoplasmic Cyclin B1-AID-YFP transiently transfected in HEK293 cells stably expressing 
OsTIR1-myc, was rapidly degraded by auxin addition (half-life of 17 min) (Holland, 2012). Last, 
fusion with AID-YFP did not prevent interaction with Cyclin B1 endogenous substrate CDK1, as 
assessed by pull down experiments. These features identified Cyclin B1-AID-YFP as a candidate 
for both cytoplasmic degradation and functional light induced perturbation implementation. 
 
6.2 Light-controlled degradation of Cyclin B1-AID in HEK293 cells 
 
6.2.1 Cyclin B1-AID-YFP degradation can be controlled by light-activation 
 
6.2.1.1 Motivation 
Consequently, we used the Cyclin B1-AID-YFP plasmid (Courtesy of Dr Cleveland) to test our 
ability to control the degradation of a functional cytoplasmic POI with light, in the strategy reported 
in Fig.6.1. In their original paper, Holland et al. constructed mammalian cell lines stably expressing 
OsTIR1, in which Cyclin B-AID-YFP was transiently transfected (Holland, 2012). We chose an 
alternative strategy by constructing a plasmid expressing OsTIR1-myc under the dependence of a 
CMV promoter. Co-expression of the two plasmids in HEK293 cells at a 1:1 ratio allowed the co-
expression of Cyclin B-AID-YFP and OsTIR1-myc, which are both cytoplasmic41
 
. 
 
Fig. 6.1: Overview of photoactivation process for Cyclin B1-AID-YFP degradation in HEK cells. UV-light illumination 
of a photoactivatable auxin liberates free auxin, which induces the dimerization of heterologous Cyclin B1-AID-YFP 
and artificial ubiquitin ligase SCFOsTIR1, leading to the polyubiquitination of Cyclin B1-AID-YFP and its eventual 
proteasomal degradation. 
 
6.2.1.2 Local PA-IAA photo-activation triggers CyclinB1-AID-YFP degradation 
We thus assessed whether the protocol elaborated on 5.2 could be used for CyclinB1-AID-YFP to 
                                                 
41 CyclinB-AID-YFP: Fig. 6.2; OsTIR1myc: fig. 6A in (Holland, 2012) and section 3.2.2 in this dissertation. 
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locally induce light-activated degradation using a microscope metal-halide lamp setup equipped 
with a DAPI filter as light source. We monitored the depletion by time-lapse confocal microscopy. 
However, to simplify the protocol of acquisition compared to section 5.2.3, a period of 60 min of 
incubation with PA-IAA in the dark preceded the light-activation of depletion. Therefore, 
background activation control and depletion monitoring post-photorelease were coupled. HEK293 
cells co-expressing Cyclin B1-AID-YFP and OsTIR1myc were incubated with 20 μM PA-IAA in 
OptiMEM in the dark. No depletion of Cyclin B1-AID-YFP was observed after one hour in the dark, 
as shown on the time-lapse in Fig. 6.2.a. Subsequently, we illuminated the observation field by 
flash illumination at 365 nm for 1s every 5 min spaced apart by darkness periods. A significant 
depletion was observed within one hour, with a characterized half-life of 18 ± 4 min.  
 
 
Fig. 6.2: (a) HEK293 cells co-expressing Cyclin B1-AID-YFP and OsTIR1D170E-NLS were imaged in conditions:  
• cells were incubated with 20 μM PA-IAA from t= -80 min in the dark. Imaging started at t = -60 min. From t = 
0 min, cells were illuminated for 1 s at 365 nm  every 5 min for 1 hour. (+PA-IAA +light). 
• cells were pre-treated for 1 hour with 50 μM MG132 (t= -120 min) cells were incubated with 20 μM PA-IAA 
from t= -80 min in the dark. Imaging started at t = -60 min. From t = 0 min, cells were imaged for 1 s at 365 nm 
(photon flux at the specimen plane ~ 100 mmol.s–1.m–2) every 5 min for 1 hour. (+PA-IAA +light +MG132). 
(b) Kinetic summary of the experimental conditions. (c) Normalized fluorescence intensity in function of time of 
experiments a) (mean ± SD, n = 10-15 cells). 
 
This timescale is in good accordance with the value (17 min) reported in the literature for IAA-
induced Cyclin B1-AID-YFP degradation (Holland, 2012). It is also consistent with timescales 
determined in chap. 1 and 3 for the optimized nuclear degradation, induced resp. by addition of free 
IAA or photoliberation of PA-IAA (resp. 15 ± 1 min and 20 ± 3 min). This confirmed that PA-IAA, 
stable in dark, can be liberated by short UV pulses, inducing rapid Cyclin B1-AID-YFP depletion. 
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6.2.1.3 PA-IAA dependent Cyclin B1-AID-YFP degradation is a proteasomal process 
We confirmed that the PA-IAA + light-dependent POI degradation was indeed mediated by the 
proteasome. We repeated the previous experiment in the presence of proteasome inhibitor MG132 
(pre-incubated 1 h before PA-IAA addition). No significant fluorescence depletion42
 
 was observed 
in presence of PA-IAA in one hour, neither in the dark nor with UV illumination (Fig. 6.2), 
confirming that the observed depletion is not due to photobleaching. This set of experiments 
showed that we could induce proteasome-dependent depletion of cytoplasmic AID-tagged POI upon 
photorelease of IAA, on a time-scale comparable to our reported observations for nuclear proteins 
(part 5.2.3). 
6.2.2 PA-IAA dependent Cyclin B1-AID-YFP degradation is spatially controlled 
 
Then, as for nuclear GFP-AID-NLS protein in previous chapter (section 5.3.2), we demonstrated 
that we could induce specific protein degradation at the single cell level by local photorelease of 
IAA using the parameters described on section 5.3.1. HEK293 cells co-expressing Cyclin B1-AID-
YFP and OsTIR1 were pre-incubated in the dark for 20 minutes with 20 μM PA-IAA in OptiMEM 
buffer. Regions of interest (ROI) of 200 μm2 were chosen. ROI-localized IAA bursts were generated 
by flashing repeatedly every 10 min with the 405 nm laser. 
 
Consequently, specific YFP fluorescence depletion was observed in ROI, as shown on Fig. 6.3: cell 
#1 included in the illuminated ROI displayed a 60% YFP fluorescence loss in the hour timescale, 
unlike cells #2, #3 and #4 (distance from the ROI > 20 μm). Global illumination starting at t=60 
min led to significant degradation in these cells. 
 
Fig. 6.3 (a) Summary of confocal micrographs of cells before illumination (t = 0 min), after local illumination at 405 
nm (t = 60 min) and after global illumination at 365 nm (t = 90 min). The red square shows the region of interest (ROI) 
illuminated at 405 nm. Scale bars 10 μm. (b) Normalized cytoplasmic fluorescence of cells # 1-4 in function of time. 
The arrows successively indicate beginning of local illumination and of global illumination. 
                                                 
42 An actual increase of YFP-fluorescence of 10% per hour was observed, indicating that heterologous Cyclin B1-AID-
YFP is degraded by the UPS in HEK293 at corresponding rates. 
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6.2.3 PA-IAA photo-activation can trigger degradation of nuclear-activated 
Cyclin B1-AID-YFP 
 
During the experiments described on section 6.2.1.2, on a single event, we were able to activate the 
degradation of a nuclear-translocated Cyclin Bl-AID-YFP. This process, linked to the activation of 
CyclinB-Cdk in mitosis, will be presented in section 9.1.  
 
In cell #1 in Fig. 6.4, cytoplasmic Cyclin B1-AID-YFP was imported to the nucleus between t= -10 
min and t= 0 min (before light activation), concomitant with the Nuclear Envelope Breakdown 
(NEB) (Fig. 6.4.b/c). At t= 0 min, PA-IAA was photo-activated, leading to the subsequent 
degradation of global (cytoplasmic + nuclear) Cyclin B1-AID-YFP in cell #1, at rates comparable to 
neighboring cells displaying cytoplasmic Cyclin B1-AID-YFP localization (Fig. 6.4.d). 
 
Fig. 6.4: (a) HEK293 cells co-expressing Cyclin B1-AID-YFP and OsTIR1D170E-NLS were incubated with 20 μM PA-
IAA from t= -80 min in the dark. Imaging started at t = -60 min (-UV). From t = 0 min, cells were imaged for 1 s at 365 
nm every 5 min for 1 hour (+UV). (b) Zoom on cell #1 between times t=-10 and 40 min, showing nuclear import from 
t=-10 min and light-activated degradation from t=0 min. (c) Quantification of nuclear import in b): Normalized 
nuclear/cytoplasmic fluorescence intensity ratio between times t= -10 and t= 40min in cell #1. d) Normalized total 
fluorescence intensity in function of light-induced degradation experiment reported between t = 0 and 60 min in a). 
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Moreover, an intriguing phenomenon was observed from t= 90 min (30 min after photoactivation 
start), a time by which 55% of initial Cyclin Bl-AID-YFP had been depleted. The mitotic spindle, 
easily identifiable in transmission microscopy (Fig. 6.5.a), was off-centered; moreover, radial 
rotation of the spindle was observed, at constant angular speed, as displayed (Fig. 6.5.b/c).  
 
A series of micrographs illustrates this process, highlighting positions of the spindle at various times 
starting at t=120 min. Complete revolution around the cell in direct sense is observed within 5 
minutes, a process observed consecutively several times. Auto-rotation of the spindle was observed, 
so that it sometimes oriented perpendicular to the surface (as between t = 120 to 160 s in Fig. 6.5.a). 
 
 
Fig. 6.5: (a) Transmission micrographs of cell #1 from Fig. 6.4 at various times (in seconds). The dotted circle shows 
the spindle (b) Model for spindle position quantification. (c) Quantification of the angular position of the spindle 
relative to the definition in (b). 
 
Implications of these observations on the possibility to control the degradation of active Cyclins at 
different phases of the cell-cycle will be further discussed on section 9.1.3. 
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6.3 Conclusion: PA-IAA photo-activated degradation of AID-tagged 
POI is a generic perturbation method 
 
This series of experiments confirmed further that the light-induced degradation methodology 
elaborated on nuclear reporter in chapter 5 was extendable to cytoplasmic targets, with possible 
high spatial resolution ; more generally, it illustrates that the Auxin-Inducible Degradation method 
is a priori generic, associated to important potentialities for POI targeting in various cellular 
contexts. AID has also been implemented with reticulum, mitochondrial or plasma membrane 
proteins. An essential condition is that AID degron is exposed to the cytoplasm (Nishimura, 2009). 
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PART C 
DISCUSSION 
PERSPECTIVES 
 
L’objet matérialise l’intention préexistante qui lui a donné naissance et sa forme s’explique par la 
performance qui en était attendue avant même qu’elle s’accomplisse. Rien de tel pour le fleuve ou 
le rocher, que nous savons ou pensons avoir été façonnées par le libre jeu de  forces physiques 
auxquelles nous ne saurions attribuer aucun projet. Ceci tout au moins si nous acceptons le 
postulat de base de la méthode scientifique : à savoir que la Nature est objective et non projective. 
C’est donc par référence à notre propre activité projective, c’est parce que nous sommes nous-
mêmes fabricants d’artefacts, que nous jugeons du « naturel » ou de l’ « artificiel » d’un objet 
quelconque1
Jacques Monod, 
. 
 
Le Hasard et le Nécessité 
 
 
 
                                                 
1 The artifact materializes the pre-existent intention that gave birth to it, and its forms can be explained by the 
performances that were expected even before their realization. There is nothing equivalent for the river or the rock, 
which we know, or think to know, to result from the free interplay of physical forces to which we cannot attribute any 
project. This at least if we accept the basic postulate of the scientific method, that is that Nature is objective, but not 
projective. Thus, it is in reference to our own projective activity, because we make artifacts ourselves, that we assess the 
natural or artificial nature of a given object (Jacques Monod, Chance and Necessity). 
 
Le hasard et la nécessité, Essai sur la philosophie naturelle de la biologie moderne, POINTS ESSAIS, p 19. First edition: 
Editions du Seuil, 1970. 
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Chapter 7 
Discussion 
 
In Chapter 1, we reviewed the existing methodologies to control the stability of a given POI by UPS 
degradation. Based on the endogenous mechanisms controlling the stability of proteins in vivo, POI 
can be constitutively destabilized. Conditionality can be introduced as a refinement of this 
constitute perturbation approach, as the transition between a stable and an unstable state of the 
degron-POI can be driven by a controllable perturbation. We identified light as a potential 
perturbation method and reviewed the existing methodologies for photo-actuation in Chapter 2. In 
this part, we will compare our work with alternative approaches for photo-induced POI depletion. 
 
7.1 Photo-activatable degradation systems enable light-control of 
Protein degradation 
 
7.1.1 Light control of POI degradation by PA-IAA 
 
In this work, we presented an approach for the control of POI stability by light. We developed a 
caged auxin (PA-IAA, see section 4.2.3), which acts as a photo-activatable inducer of the auxin 
inducible degradation AID platform, a generic method enabling the conditional degradation of POI 
upon auxin addition. IAA mediates the heterodimerization between AID-tagged POI and an 
artificial SCFOsTIR1 E3 Ubiquitin Ligase (see section 3.3), eventually leading to POI 
polyubiquitination and degradation by the proteasome. 
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We observed that active IAA can be locally released by the photolysis of PA-IAA with short UV 
light pulses. With this strategy, we were able to promote the efficient protein degradation in 
mammalian cells within an hour timescale, with a half-life of 19 min (section 5.2). This method, 
first developed with nuclear proteins, can be extended to cytoplasmic POI (section 6.2) 
 
7.1.2 Alternative strategies for POI degradation by blue-light sensitive 
degradation modules 
 
7.1.2.1 Design of blue-light sensitive degradation modules 
In 2013, the team of C. Taxis applied the photosensitive domains described in section 2.1 to the 
development of a blue-light conditional degradation module dubbed photosensitive degron (psd) in 
yeast cells. The C-terminal Jα-helix  LOV2 domain of AtPhototropin1 was fused to a degron derived 
from the murine Ornithine Decarboxylase (ODC), a 23 amino-acids unstructured peptide with a 
Cys-Ala motif recognized as a degron in eukaryotes2
 
 (Fig. 7.1). This motif is designedly inactivated 
in the dark due to the helical fold interaction with the core LOV2 domain, whereas it is activated by 
Jα helix unfolding. 
Using a similar approach, the team of T. Wandless developed a Blue Light Inducible Degradation 
(B-LID) technique in vertebrates (Bonger, 2014). A small peptide degron (RRRG), inducing fast-
proteasomal degradation in mammalian cells, was fused to the C-terminal alpha helix of the 
AsLOV2 full domain or truncations. 
 
 
Fig. 7.1: Photosensitive LOV-domain based strategies for light-controlled of proteasomal degradation of POI developed 
in (Renicke, 2013) and (Bonger, 2014). A degron fused to a LOV domain is sequestered in the dark; Blue-light 
illumination mediates an unfolding mechanism leading to the degron presentation and proteasomal degradation. 
 
7.1.2.2 Modulation of the properties of blue-light sensitive degradation modules 
General trends are identifiable in the development process of C-terminal B-LID and psd domains. 
In both cases, the engineered light-actuator must meet the two following specifications:   
                                                 
2 Actually, this process is proteasome-dependent but ubiquitin-independent (see section 1.1.4). 
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a) stabilization in the dark due to cryptic sequestration of the degron by the interaction of 
the Jα terminal helix with the LOV core domain. 
b) destabilization in blue-light due to degron exposure by dissociation of the Jα helix, 
leading to proteasomal degradation. 
 
In both cases, several initial constructions did not meet these specifications. Two limit phenotypes 
were observed: first, the candidate exhibited excessive constitutive degradation in dark, meaning an 
insufficient sequestration or excessive strength of the degron. Alternatively, the candidate was stable 
in the dark and upon light exposure, where no significant degradation was observed. Various 
modifications can be introduced to modulate the activity of the fusion protein: 
• Variation of insertion locus
• 
 relative to the Jα helix or variation of the linker length 
Variation of the degron length and strength
• 
, to prevent constitutive degradation or 
enhance lit-state degron recognition                   
Introduction of mutations
 1) stabilize closed-conformation in the dark to prevent unwanted constitutive   
  degradation by thermal exposition of the cryptic degron .                  
 that either : 
 2) stabilize the open-conformation in the lit-state, increasing the time of  
  degron exposure, or increase the dissociation of the Jα helix. 
 
Candidate module exhibiting a satisfactory balance between strong stabilization in the dark and 
degron exposure upon blue-light illumination were selected as B-LID or psd domain, respectively in 
mammalian cells and yeasts.  
 
7.1.2.3 psd module enables blue light-mediated efficient degradation in yeast cells 
In yeast cells, constant blue-light exposure dramatically affects the life-time of a Red Fluorescent 
Protein (RFP)-tagged psd from 157 min to 21 min, allowing an almost quantitative depletion within 
two hours (Renicke, 2013). A second series of psd degron in yeasts was later reported with extended 
range of sensitivity towards blue light induced degradation for the fine tuning of protein stability3
                                                 
3 Combination of site-directed or random mutagenesis and variations on the degron sequence generated psd variants 
whose characteristics were assessed in vivo and in silico. In most cases, low-stability in darkness correlated with short 
half-life under blue-light exposure, so that compromise has to be made between stability and degradation efficiency.  
However, psd candidates optimizing the dark/light ratio and short half-life upon light-illumination were selected. 
 
(Usherenko, 2014 
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Fig. 7.2: Photosensitive LOV-domain based strategies for light-controlled of proteasomal degradation of POI developed 
in (Renicke, 2013). (A) Fluorescence micrographs of yeast cells expressing a reporter RFP protein fused either to 
AtLOV2 (control) or psd in the dark or under blue light illumination. (B) Immunoblotting of yeast cells expressing 
RFP-AtLOV2 or RFP-psd incubated with reported times in the dark or under blue light illumination. (C) Quantification 
of Blue-Light induced depletion of RFP-psd by immunoblotting. Control RFP is displayed (Renicke, 2013). 
 
7.1.2.4 B-LID module enables blue light-mediated efficient degradation in vertebrates  
Similarly, illumination with blue-light induced a significant depletion of a reporter protein fused to 
the B-LID domain in NIH3T3 culture cells with an estimated half-life of 30 minutes (Bonger, 2014). 
This blue-light induced protein depletion methodology was extended to the small transparent, 
Zebrafish embryo by injecting mRNA coding for a B-LID domain fused to a reporter fluorescent 
protein. Significant depletion in fluorescence was observed under blue light illumination. This work 
constitutes a proof-of-principle of the potential of the B-LID domain for the optical destabilization 
of POI in mammalian culture cells and vertebrate small organisms. 
 
Fig. 7.3: Photosensitive LOV-domain based strategies for light-controlled of proteasomal degradation of POI developed 
in (Bonger, 2014). (a) NIH3T3 culture cells expressing YFP-B-LID treated with either vehicle or proteasome inhibitor 
MG132 were kept in the dark or irradiated under blue-light for 2 hours (b) NIH3T3 culture cells expressing YFP-B-LID 
were illuminated for various time. Mean fluorescence Intensity (MFI) was monitored with flow cytometry  (c) NIH3T3 
culture cells (top) or Zebrafish embryos (bottom) expressing mCherry-B-LID incubated in the dark or under constant 
blue-light illumination (resp. for 2 and 6 hours) (Bonger, 2014). 
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7.1.3 Comparison of the described photo-activatable degradation systems 
 
7.1.3.1 Conditional degradation methods enable rapid and efficient depletion   
The half-life and depletion extent of various POI in mammalian cells upon either small-molecule 
addition or light-illumination are reported on Table 7.1. Consistently, these values range between 15 
and 30 min. Although even faster degradation kinetics have been reported for heterologous POI 
(Holland, 2012), these results might indicate that the perturbation induction is not a rate-limiting 
step in conditional degradation. 
POI target GFP-AID-NLS   CyclinB-AID-YFP      B-LID-POI 
Perturbation method   auxin   UV light     auxin   UV light     Blue light 
POI half-life (min) 15 20   17 19   30 
Residual POI after 1h <10%  <20%   <5% <20%   20% 
Ref. Section 3.3.2 Section 5.2.2   Holland, 2012 Section 6.2.1   Bonger, 2014 
 
Table 7.1: Comparison of three conditional degradation methods in mammalian cells, in which the stability of a POI 
can be controlled either by small molecule or light illumination. The half-life of POI after perturbation and residual POI 
monitored one hour after perturbation are reported. 
 
In section 5.2.2 we reported that significant depletion is observed upon illumination. 4
 
 We 
determined a half-life of 19 min. 20% of residual fluorescence was observed after one hour, 
consistent with other reports (Bonger, 2014). As we did not measure further the depletion induced 
by illumination after one hour, it not possible to determine whether this decay will continue, or if an 
asymptotic regime is attained. Bonger et al. reported that the fluorescence signal is stabilized at 20% 
from one to four hours post-illumination in the B-LID degradation methodology (Bonger, 2014). 
Renicke et al. developed a kinetic model to explain the discrepancies observed between half-lives 
of heterologous proteins expressed with different strengths (Renicke, 2013). This model is 
presented on Fig. 7.4.b, and complemented with the equivalent for our methodology (Fig. 7.4.a). At 
steady-state, depending on transcription rates, protein neo-synthesis might compensate the 
degradation, possibly explaining the remnant POI signal upon photolysis. This can be modulated by 
using constitutive promoters with variable strengths, or inducible promoters (Renicke, 2013). 
                                                 
4 The increase of cytoplasmic fluorescence observed during experiment by the release a free EGFP, according to the 
model developed in section 3.2.2.3 was taken in account during in the quantification process. 
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Fig. 7.4: Kinetic model for POI level modeling. Remnant level of POI at steady-state under perturbation can be 
explained by the balance between neo-synthesis accumulating POI and light-dependent or independent degradation 
mechanisms. 
 
7.1.3.2 Light conditional degradation requires either constant blue light or UV pulses                
Comparison of the illumination strategies are recapitulated on table 7.2.  
Method AID/PA-IAA AID/PA-IAA      B-LID   Psd (yeasts) 
  Global Local         
Light wavelenght 365 nm 365 nm   465 nm   465 nm 
Illumination mode 8 min pulse 1s frequent pulses   continuous   continuous 
Light irradiance 100 μmol.m-2.s-1 100 mmol.m-2.s-1   20 μmol.m-2.s-1   30 μmol.m-2.s-1 
Cumulated 
50 mmol.m-2 1 mol. m-2   60 mmol. m-2   110 mmol. m-2 irradiance in 1h 
Reference Section 5.1 Section 5.2   Bonger, 2014   Renicke, 2013 
Table 7.2: Comparison of the illumination parameters for light induced degradation methods in eukaryotes. 
Both B-LID and the PSD systems require long-term constant blue light illumination to maintain the 
LOV-domain in an active state for complete degradation. In contrast, our photo-activation system 
requires short pulses of UV light5
                                                 
5 Contrary to other protocols for uncaging in vivo, the physiological function (proteasomal degradation) cannot be 
controlled by a single UV pulse, hypothetically due to active IAA efflux (see section 5.2.2). 
 every 5 or 10 min for significant degradation. This protocol can 
be easily implemented by manipulator, and is compatible with EGFP monitoring. Blue light is 
reputed less-toxic that long length UV light, although it was reported that it can induce phototoxic 
effects in mitochondria (Godley, 2005). However, neither of both wavelengths used at the reported 
rates are associated with phototoxicity according to literature (see note B.32). 
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7.1.3.3 Light conditional degradation enables spatial control of depletion    
The psd module allows macroscopic monitoring of blue light illumination: in yeasts cells 
expressing RFP-psd reporter protein, a direct inverted dependency links the RFP fluorescence to 
blue light illumination, allowing the creation of macroscopic fluorescence patterns by applying a 
simple illumination mask (Renicke, 2013). In both psd and B-LID methodologies, the spatial 
control of protein degradation was proved macroscopically; however, local photolysis up to the 
single-cell level is theoretically possible. In our work (section 5.3), we showed that local photolysis 
of PA-IAA enabled to control protein degradation down to the single cell level, opening 
perspectives for spatial control of POI stability in complex biological structures. 
 
7.1.3.4 Light conditional degradation is intrinsically limited by diffusion    
The subcellular control of biological mechanisms with light is a highly desirable feature. However, 
spatial resolution is competed by diffusion processes which are rapid at the cellular scale. We 
estimate the timescale of auxin diffusion in the cytoplasm of HEK293 cells by applying the simple 
diffusion power law 7.1:  
𝐷𝜏 = 𝑅
2
6
  (7.1) 
 
where D is a diffusion coefficient for intracellular auxin, evaluated to 700 μm2.s-1, and R is a typical 
length scale (13 μm for the typical diameter of HEK293 cells6). Using these parameters, we find a 
timescale τ = 40 ms for significant diffusion through the cytoplasm, four orders of magnitude lower 
than the half-life of conditional degradation methods in mammalians cells (15 min). Even in the 
fastest yeast-degradation systems, several minutes are necessary to ubiquitinate and degrade a 
substrate protein7. The spatial inhomogeneity induced by the photo-controlled liberation of free 
auxin is relaxed during the time necessary for ubiquitination and degradation. Similarly, for a 
photosensitive protein with an estimated diffusion coefficient of 30 μm2.s-1, we find a timescale τ = 
0.9 s. This estimation implies that subcellular spatiotemporal control of protein degradation is not 
applicable to free-diffusing POI using photo-activatable methodologies8
                                                 
6 These numbers were found in Bionumbers, a very complete data base run by Pr. R. Philips, for biological parameters 
estimation (
. 
http://bionumbers.hms.harvard.edu/). 
 
7 The half-life of POI fused to destabilizing degron can be as low as two minutes for application of the N-end rule and 
typically range from 5 to 20 minutes. 
8
 In 2011, Toettcher proposed to generate spatial patterns of activation for proteins that can be activated and inactivated 
by illumination at different wavelength, by coupling local activation and global inactivation (Toettcher, 2011). 
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7.1.4 Conclusion 
 
Both PA-IAA and LOV domain-based tools (B-LID in vertebrates, psd in yeast cells) enable light 
conditional degradation of POI, with comparable kinetics and depletion extent. However, these 
classes of techniques rely on different endogenous proteasomal degradation pathways (resp. specific 
substrate recognition by SCF E3 ubiquitin ligase and quality control degron recognition), and on 
different light actuation mechanisms (caged small effector vs LOV-based light sensitive protein 
modules). It is therefore difficult to fully compare their implementation. 
 
In this study, we implemented light actuation by manipulating a small phytohormone, auxin, in an 
heterologous dimerization system. The development of methodological tools adapted from plant 
hormones illustrates the potentialities offered by adaptation of molecular features to orthogonal 
species using a chemical biology approach. Several examples have been described recently. In the 
next part, we will focus on Gibberellic acid (GA)- and Abscissic acid (ABA)-based 
heterodimerization systems and their caged-equivalent for light control, in comparison to our work. 
 
 
7.2 Development of caged phytohormone-based systems: a chemical 
biology approach 
 
7.2.1 Development of photo-controlled Chemically-Induced Dimerization based 
on phytohormone 
 
Concomitant to the publication of our work this year (Delacour, 2015), two papers reported light 
control of Chemically-Induced Dimerization (CID) systems based on plant hormones (Gibberellic 
acid and Abscissic acid) in mammalian cells. Interestingly, these studies present several similarities 
with our reported work; therefore, critical comparison of the three strategies for introducing light 
control in a heterologous system is an interesting perspective. 
 
The phytohormone Gibberellic acid (GA) binds to plant protein GID1 and mediates a 
conformational change inducing dimerization with GAI. Similarly, Abscissic acid (ABA) controls 
the dimerization of proteins PYL and ABI. These plant systems were derivatized into orthogonal 
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CID in mammalian systems, allowing control of POI heterodimerization by addition of a small 
molecule (resp. (Lin, 2013) and (Liang, 2011)). 
 
In both reported systems, chemical biology approaches allowed optimization of the CID. This 
included enhanced permeation of GA by carboxylate conjugation to esterase-sensitive groups, and 
reduction of GID1 sequence for the GA-based CID (Miyamoto, 2013). Similarly, PYL protein was 
engineered to inactivate the phosphatase activity, preventing toxicity in heterologous systems 
(Liang, 2011). 
 
 
Fig. 7.5: Principle of Photo-controlled CID exemplified with the development of caged GA. Protection of an essential 
carboxylate by a caging group prevents its interaction with receptor GID1. UV light illumination liberates GA, which 
binds to GID1, inducing a conformational change allowing the heterodimerization of GID1 to GAI. 
 
7.2.2 Photo-activatable phytohormones enable photo-control of dimerization 
 
Caged-GA and caged-ABA for the development of light conditional dimerization were reported this 
year (resp. (Schelkle, 2015) and (Wright, 2015)) (Fig. 7.5). Rational caging strategy was in both 
cases based on crystal structure of the heterodimer receptor:phytohormone and plant physiology 
databases; these studies convergently identified a key carboxylic group. In both cases, this position 
was conjugated to various 2-nitrophenyl-based caging groups. 
 
Both caged-GA and caged-ABA were efficiently liberated by UV light in vitro, as assessed by 
HPLC. In culture cells, they both mediated light-dependent heterodimerization of their respective 
receptors fused to reporter FPs, although much faster in the case of caged-ABA activation9
                                                 
9 The illumination parameters for caged-ABA were: 120s illumination with peak excitation at 365 nm (power density: 
23 mW.cm-2), whereas these parameters were however not described for caged-GA in (Schelkle, 2015). 
. 10 µM 
caged-ABA were used for photo-control, comparable to our reported parameters (20 to 50 µM), 
whereas lower concentrations (1 µM) were necessary for caged-GA, with no background activation 
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of either caged-dimerizer in the dark. However, neither study reported quantum yield values. 
 
 
 
Fig. 7.6: (a) Structure of caged GA. (b-c) Epifluorescence micrographs of COS-7 cells expressing EGFP-GID1 and 
mCherry-GAI addressed to the mitochondria (TOM10-mCherry-GAI). 10s UV light liberation of GA induces the 
redistribution of the nuclear EGFP-GAI by GA-induced heterodimerization with mitochondrial GAI (Schelkle, 2015). 
 
 
Furthermore, caged-ABA photo-liberation controlled heterodimerization of a split transcriptional 
activator, inducing gene expression in HEK293 and CHO cells (Wright, 2015). Spatial selectivity of 
light induced dimerization can be restricted to single (albeit individualized) cells using a 405 nm 
laser in the case of caged-GA (Schelkle, 2015), but not caged-ABA which is not efficiently cleaved 
in these conditions. Therefore, the DMNB caging group in caged-ABA was replaced by a coumarin-
based caging group ([7-(diethylamino)-coumarin-4-yl] methyl group (DEACM)). This allowed 
efficient photo-control in vivo at 405 nm; however, spatial selectivity was not addressed in (Wright, 
2015)10
 
. 
Finally, conjugation of GA to a 2-(o-nitro-phenyl)-propyl derived caging group11
 
 enabled the two-
photon photocontrol of GA-induced heterodimerization in vivo in COS7 cells. As two-photons 
allow deep-tissue penetration and high spatial resolution, this opens the way to new perspectives for 
CID control in small animals and tissues. 
7.2.3 Comparison: photocontrolled CID and PA-IAA methodologies allow light 
induced depletion 
                                                 
10 The authors seem to indicate that ABA diffuses outside cells post-liberation, although not detailing it. 
 
11 2-(o-nitro-phenyl)-propyl caging group with a π-extended diphenylacetylene core structure bearing a functionalized 
dialkylamino moiety in para-position. 
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Caged ABA and GA offer methodologies for photocontrolled CID, with applications to 
sequestration of POI, which can be seen as a rapid conditional method for functional POI 
depletion12
 
 (DeRose, 2012), an alternative to light-activated degradation addressed in this work. 
Interestingly, convergent approaches were set to introduce photo-control and address the limitations 
met during the development of the methodology. These phytohormone-based CID methodologies, 
allow rapid, reversible, non-toxic heterodimerization controlled by a cheap small molecule and 
therefore offer interesting alternatives to reported photocontrolled CID systems based either on 
caged rapamycin (Umeda, 2010) or on caged bi-functional synthetic dimerizers (Ballister, 2014).  
In conclusion, these two systems offer an interesting comparison with the work presented in this 
dissertation; in each case, a functional plant module heterologously expressed in mammalian culture 
cells could be photo-controlled by introduction of a photocaging group in a key carboxylic residue 
of the molecular inducer. They also illustrate the potentialities of phytohormones for chemical 
biology approaches, to be compared with fully-encoded CID tools presented on part 2.1.2. 
 
 
 
 
 
 
 
 
 
 
                                                 
12 For example, significant addressing of a nuclear transcription factor to the plasma membrane by CID leads to global 
genetic inactivation (Haruki, 2008). 
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Chapter 8: Perspectives 
 
Strategies for photocontrol of protein stability 
 
Having reviewed the existing methodologies for modulation of protein stability on chapter 1, and 
for light actuation on chapter 2, we will now adopt the same approach to speculate on new strategies 
that could be used to implement protein degradation by light13
 
.  
8.1 Strategies for the light control of proteins degradation by fusion of 
photo-sensitive protein domains 
 
8.1.1 FP Dronpa might enable development of reversible photo-activatable 
degradation tools 
 
8.1.1.1 Motivation: FP Dronpa monomeric state is reversibly controllable by light 
On section 2.1.2.4, we described the strategy developed by the group of Lin to control the 
association state of FP Dronpa variants with light (Zhou, 2012). Mutants 145N and 145K associate 
into a dimer in the dark. This dimer dissociates upon a 500 nm illumination, but is reformed either 
by thermal return or 400 nm illumination. This elegant approach allows a reversible photoactivation 
process, although protein engineering, with Dronpa fusion at each end can be challenging, and 
sometimes impossible ; therefore, it would be highly desirable to design generic Dronpa-controlled 
effectors designed as tools for the control of downstream target POI stability (LaBella, 2013), rather 
than engineering POI themselves with Dronpa. 
 
                                                 
13 In 2013, while listing the existing strategies for conditional protein depletion, LaBella proposed various speculative 
possibilities to implement light control of protein degradation (LaBella, 2013). Some of these are discussed here. 
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8.1.1.2 Light modulation of protease activity by Dronpa 
Interestingly, light control of the activity of Hepatitis C protease fused to Dronpa was reported 
(Zhou, 2012) 14
• « native » protein is inactive due to Dronpa dimerization masking the TEV active site 
. This method might be extended to Tobacco-Etch Virus (TEV) protease, for 
reversible control of the activation of the TIPI degradation platform (blue light), or inactivation 
(violet light or thermal return) (see section 1.2.1.2). As presented in Fig 8.2, Dronpa-TEV-Dronpa 
fusion might be engineered with the following requirements: 
• 500 nm light dissociates the Dronpa dimer, exposing the active site 
• The Dronpa dimer is reformed by thermal return or 400 nm light, inhibiting TEV protease. 
 
These specifications should be met by variation on the linker sizes, or the use of Dronpa variants. 
Alternatively, a TIPI variant method based on a hepatitis C cleavage site could be developed using 
the readily-described photo-controlled protease. 
 
 
 
Fig. 8.1: Strategy for light controlled protease activation controlling the stability of a POI. The active-site of a TEV 
protease can be hindered by fused Dronpa variants (right). Blue light illumination dissociates the Dronpa dimer, 
liberating the active TEV protease. Alternatively, TEV protease can be modulated by photocaging of a key cysteine 
residue (left) (8.3.1.2). Light activated TEV can condition the exposition of a degron sequence fused to a POI by 
selective cleavage of a TEV sequence in a TIPI strategy (see section 1.2.1.2). 
 
 
                                                 
14 Chimeric Dronpa-protease-Dronpa activation following blue light illumination within one hour was monitored by a 
Fluorescent Protein fused to a membrane-addressing tag separated by hepatitis C target sequence. 
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8.1.2 Development of artificial SCF Ubiquitin Ligase for optical dimerization 
 
8.1.2.1 Motivation: Light induced dimerization can control ubiquitination of SCF substrates 
As a general trend described in section 1.3.1, physical proximity of a substrate with catalytic E2 
Ubiquitin Transferase mediated by SCF complexes can be sufficient to induce their 
polyubiquitination. Modular F-box adapter allow specificity of substrate selection in vivo. This 
principle was adapted into the design of F-box artificial adapters targeting a specific POI, or the 
synthesis of bifunctional PROTACs addressing POI to endogenous F-Box. 
Several examples of optical dimerizers were presented on section 2.1.2 as methodological tools for 
the control of heterodimerization of POI. A general strategy for the light control of protein 
degradation (Fig. 8.3) would be to engineer an artificial F-box protein with an optical dimerizer 
protein (e.g. F-box-Cry2, see 2.1.2.2) (Fig. 8.3). Differential affinity for a binding partner fused to a 
POI (e.g. CIB1-POI) would be triggered by light illumination and would result in the 
polyubiquitination and subsequent proteasomal degradation mediated by the close UCE E2. 
 
Fig. 8.3: Strategy for light-controlled ubiquitination of a POI. Artificial SCF adapter can be engineered by fusion of an 
F-box sequence to a light conditional dimerizing partner (see section 1.3.1) This heterologous protein can interact with 
endogenous components to form an artificial SCF complex, which conditionally binds to an interacting partner fused to 
a POI upon selective light illumination. We present here possible examples based on the description in section 2.1.2. 
[PART C : DISCUSSION AND PERSPECTIVES] 
 
150 
 
One important issue would be to prevent the auto-ubiquitination of the artificial F-box protein. This 
process has been described for endogenous F-box proteins (see note A.27) and might be due to 
accessibility of F-box proteins Lys residues to ubiquitination by spatially-close E2 enzyme. 
 
8.1.2.2 Comparison of various optical dimerization systems 
Development of optical dimerization relies on the choice of efficient light activatable platform. 
Recently, Pathak et al. compared the potentialities of three optical dimerizer systems (which have 
been further described on part 2.1.2) using heterologous yeast transcriptional assay15
• Cryptochrome CRY2 and its binding partner CIB1  
 (Pathak, 2014): 
• TULIPs LOV2-domain-based with a peptide tag at the C-ter of the Jα-helix, binding upon 
light excitation to a engineered (ePDZ) domain 
• Phytochrome-based phyB and its binding partner PIF. 
 
The authors outlined that the phyB/PIF3 system combined low background activation and reversible 
control with far-red reversible control and the highest light activation over the four systems. 
Moreover, red light allows high tissue penetration and low toxicity in contrast to blue light. 
Drawbacks of this system however are the large size of the PIF domain, the required 
supplementation with 10 µM phycocyanobilin (PCB) fluorophore and the extreme light sensitivity 
which might be a constraint for users to prevent unwanted activation during manipulation.  
In contrast, the two blue-light regulated systems CRY2/CIB and TULIPs offer lower-fold activation 
upon light illumination, and can present higher background-activation in the dark. Some TULIPs 
were also reported to be toxic in yeasts cells. These small systems offer high photo-switching 
dynamic range; however, they often require considerable adjustment dependent on each context to 
avoid background activation or slow kinetics upon light illumination. 
 
8.1.2.3 Development of Dronpa-based SCF Ubiquitin Ligase for optical dimerization 
Alternatively, the light-dependent dimerization of Dronpa monomer could be developed in already 
reported ubiquitination systems based on conditional dimerization. For example, an artificial F-box 
bipartite protein might be engineered by fusioning an F-box domain and a 145K Dronpa variant, 
separated by a linker. Upon blue light illumination, this artificial F-box could interact with and 
degrade a POI fused to a 145N Dronpa, with a light-reversible control (8.1.1.2). 
                                                 
15 Yeast two-hybrid using Gal4-BD-POI1 and Gal4AD-POI2 fusions controling the expression of a gene reporter (ß-
galactosidase in this case) are widely used system for monitoring dimerization process. They have been presented on 
part 3.3.1.1 for the evaluation of auxin-dependent dimerization of AFB/Aux-IAA proteins. 
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Fig. 8.2: Strategy for light-controlled degradation. Artificial SCF adapter can be engineered by fusion of an F-box 
sequence to Dronpa 145K (section 2.1.2.4) This heterologous protein can interact with endogenous components to form 
an artificial SCF complex, which conditionally binds to a Dronpa145N fused to a POI upon selective light illumination. 
 
 
8.2 Genetically encoded strategies for the light control of auxin 
inducible degradation 
 
In this work, we implemented light-control over the AID protein degradation methodology 
presented in section 1.4.2. Auxin triggers the direct interaction between F-Box protein TIR1 and an 
AID degron, forming a tertiary complex TIR1::auxin::AID. The small molecule auxin was 
conjugated with a caging protecting group (chapter 2). Free-auxin can be liberated by light 
illumination, leading to the interaction of AID-tagged POI with SCFTIR1, leading to the eventual 
proteasomal degradation of AID-POI. Alternatively, we will discuss in this part the possibility to 
control the activity of the two other partners TIR1 and AID by light. 
 
8.2.1 Genetically encoded caged protein for the light control of AID degradation 
 
8.2.1.1 Motivation 
On section 2.2.1.3, we described the methodologies for genetic incorporation of unnatural amino-
acid, which led to the development of caged-proteins, whose activity can be controlled by light 
illumination, which photolyses the native residue and restores the initial activity of the protein. In 
this section, we will describe potential strategies for light controlled degradation of a POI. 
Implementing a caged-protein strategy to control auxin-conditional degradation implies to identify a 
key residue in either TIR1 or AID whose conjugation to a caging group affects the auxin-dependent 
heterodimerization. This strategy is summarized on Fig. 8.4. Compared to the PA-IAA liberation 
strategy described in this work which necessitated frequent short light pulse, a single light pulse 
would be sufficient to irreversibly activate TIR1 or AID, although the implementation of this 
approach might be complex. 
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8.2.1.2 Strategies for TIR1 light modulation by caged residues  
As a first strategy, TIR1 activity could be controlled by light by conjugating an identified essential 
residue with a caging group. The structural mechanism of auxin-dependent heterodimerization of 
TIR1 and Aux/IAA was presented in section 4.1.1. Auxin enhances the affinity of Aux/IAA by 
docking a hydrophobic LRR-pocket in TIR1. Outlined essential residues were Phe82 and Arg 403. 
However, no genetically-encoded caged-versions of these residues exist. Other close residues in the 
auxin-binding pocket include Ser 462 and Cys 405, for which strategies for incorporation of caged 
derivative have been described in section 2.2.1.3. However, one should be aware that addition of a 
caging aromatic group might mimic the action of auxin by docking the hydrophobic pocket of TIR1, 
resulting in background heterodimerization with Aux/IAA17.  
 
 
 
Fig. 8.4: Strategies for light controlled of the auxin-dependent dimerization of TIR1 and AID-POI proteins. Introduction 
of caged amino-acids replacing of residues critical for interaction, either in TIR1 or in AID sequence can hinder the 
interaction site; UV light illumination liberates the active site for interaction; leading to the polyubiquitination and 
eventual proteasomal degradation of AID-POI. 
 
Alternatively, the K35A mutation was reported to abolish the TIR1-auxin interaction, although it is 
not located on the auxin-binding pocket nor on the interaction surface with Aux/IAA (Kepinski, 
2005). The K35 position in TIR1 could be inactivated by incorporation of a genetically encoded 
caged-Lys a.a.; the full-activity might be recovered upon UV illumination, liberating active Lys16
 
. 
                                                 
16 Lys 485 controling insertion of Inositol 6-P is another potential residue for a caging strategy. Adjacent S462E 
mutation is sufficient to abolish auxin enhanced binding, but does not inhibit basal binding to TIR1 (Tan, 2007). 
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8.2.1.3 Control of the auxin-dependent interaction by AID caging 
Another possibility would be to introduce photo-control by caging of residues in the AID protein17
 
. 
This involves the identification of essential residues whose conjugation to a photosensitive caging 
group globally inactivates AID function. Two distinct features can be identified in AID degradation: 
AID/TIR1 heterodimerization is directly mediated by auxin, through hexapeptide hydrophobic 
motif VGWPPV in domain II (see section 4.1.1). However, no genetically-encoded caged-versions 
of these residues have been yet described. Implementation of this strategy would require the new 
developments in the unnatural mutagenesis technology. 
a) Auxin-dependent heterodimerization 
 
An alternative strategy would be to identify preferred sites for Lys ubiquitination (section 1.1.2) and 
to inactivate them by conjugation with a caging group. A similar approach allowed, for example, the 
photocontrol of nuclear import of POI by photocaging essential Lys residues in NLS (Gautier, 2010). 
b) AID polyubiquitination 
 
K35Q (Villalobos, 2012) and K37Q (Droher 2006) mutations diminished the auxin-binding by resp. 
50% and 70%, but do not quantitatively inactivate the protein function. A systematic analysis was 
recently led in Aux/IAA1 (Gilkerson, 2015): Lys to Arg mutations were introduced to interrogate 
the role played by each of the 16 Lys residues. None of these modifications significantly prevented 
auxin-dependent18
 
 degradation, or nuclear addressing and auxin-dependent association with TIR1. 
Surprisingly, mutations of all Lys residues to Arg did not prevent the rapid degradation of Aux/IAA, 
although at slightly lower rates. This results indicate that ubiquitination of Aux/IAA17 upon auxin 
addition might take place at non Lys sites, such as N-end amine, Ser/Thr hydroxyl or Cys thiols. In 
the current model description, Lys residues are the preferential acceptors of ubiquitination: but 
neighboring residues can be efficient redundant sites for Ub conjugation in their absence. 
However, even if complete inactivation of the degron sequence can be achieved by essential Lys 
residue photocaging, another issue is that Lys residue present in POI fused to AID could be 
                                                 
17 Although the domain DII has been identified as essential for interaction with TIR1, other sequences are required for 
rapid degradation. (Villalobos, 2012) The AID sequence can be reduced to 40 a. a. in yeast without affecting the 
degradation kinetics, contrasting with our reports using similar methodology in mammalian cells (cf section 1.4.2). 
 
18 The Aux/IAA1 variants were still rapidly degraded upon auxin degradation. The authors first hypothesized that the 3 
conserved Lys residues in Aux/IAA variants were preferentially polyubiquitinated, but no specific degradation 
inhibition was observed upon K to R mutation. 
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ubiquitinated due to the plasticity of SCF E3 Ubiquitin-Ligase (see section 1.3.1.1). It would thus 
be necessary to ensure that no Lys residues in POI are structurally close to E2, which would limit 
the development of generic degradation tools. 
 
8.2.2 LOV domains-based systems for allosteric presentation of a degron 
 
 
8.2.2.1 Motivation: development of LOV2-based degradation modules 
 
In section 2.1.2.1, we presented the AtLOV2-based domain modules and their applications. In these 
modules, the conformational change induced by blue light illumination lead to the dissociation and 
unfolding of the Jα helix. This light-driven process paves the way for a chemical biology approach 
for the control of proteasomal degradation. In section 7.1.2, we presented the strategies developed 
by the groups of Taxis and Wandless for light-controlled degradation, resp. in yeasts and vertebrates. 
In these approaches, a chimeric protein can be engineered by fusion and directed evolution of a 
light-sensitive LOV-derived module and a degron sequence fused to the Jα helix. Instability can be 
conferred by differential presentation of a degron driven by blue light illumination.  
 
8.2.2.2 Development of LOV2-based conditional AID degradation 
This strategy might be extended to AID-based systems. As presented in section 1.4.1.2, a 
hexapeptide sequence in Domain II of AID sequence interacts with TIR1::auxin. Although the 
sequence of domain II alone is sufficient for dimerization in crystal structure, its affinity for 
TIR1::auxin is ten-fold lower than the full-length AID. A 40 residue short version of AID, 
containing Domain II and adjacent residues was however as efficient as full-length AID (see section 
3.5.3).A first strategy presented would be to fuse a minimal AID degron to the Jα helix in C-ter of a 
AsLOV2 domain (Fig. 8.5).  
 
 
Fig. 8.5: Strategy for blue-light-control of the degradation of a POI. A functional short AID tag is fused at the C-ter to 
the Jα-helix of a LOV-domain. In the dark, the interacting hexapeptide is hindered by the LOV-core domain. Blue-light 
activation undocks the AID which dimerizes with a heterologous SCFTIR1 in presence of auxin, leading to its 
polyubiquitination and proteasomal degradation. 
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In this approach, the hydrophobic hexapeptide in domain II would be hindered by interaction with 
the LOV2 core domain, whereas blue-light illumination would result in the presentation of the 
degron, interacting with TIR1 in presence of auxin, leading to the polyubiquitination and eventual 
proteasomal degradation of a POI fused to LOV-short AID domain. 
 
8.3 Alternative strategies for the light-control of protein degradation 
 
8.3.1 Caged cysteines for the control of enzymatic-dependent proteolysis 
 
 
8.3.1.1 Motivation 
The ability to implement caged-cysteine modified POI provides interesting perspectives for the 
photo-control of cellular pathways, as key cysteine residues are involved in several important 
enzymatic pathways19
 
 including UAE E1 and UCE E2 enzymes (see section 1.1.2.2). 
8.3.1.2 Caged cysteine for photocontrol of TIPI degradation 
A photo-activatable Tobacco Etch Virus (TEV) protease engineered by directed evolution of the 
PylRS/tRNACUA to incorporate photocaged cysteine was recently reported (Nguyen, 2014). In 
HEK293 cells, 365 nm illumination can induce the fast activation of the caged TEV protease (80% 
within 15 min), as monitored by the FRET signal of fusion reporter proteins composed of two 
Fluorescent Proteins separated by a TEV cleavage site. This photoinducible TEV protease could be 
inserted into the TIPI system described in section 1.2.1.2 for light-control of POI cleavage and 
degron exposure (Fig. 8.2). A single light pulse might be sufficient to irreversibly activate the TEV 
protease, in contrast to the reversible Dronpa-based methodology proposed on section 8.1.1.2. 
 
8.3.2 Caged small molecules modulating protein stability 
 
8.3.2.1 Caged Rapamycin 
An efficient strategy for the subcellular control of dimerization by a caged-rapamycin20
                                                 
19 Genetically encoded strategies applied to phosphorylation, Intein control, or Caspases controlling apoptosis using 
caged Cys were reported (Baker, 2014). 
 has been 
reported (Umeda, 2010). UV illumination releases a macromolecule tethered to rapamycin C40 
 
20 Another reported strategy involves direct caging with a bulky group at the C40 hydroxyl position of Rapamycin 
(Karginov, 2011) However, the caged-rapamycin itself is active, requiring introduction of a modified FKBP dimerizer. 
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hydroxyl group by a light-sensitive linker. Enhanced subsequent permeability of rapamycin allows 
its entry into NIH3T3 cells where it can trigger the heterodimerization of heterologous FRB and 
FKBP-POI. This strategy was used to control the subcellular localization of the small GTPase Rac. 
A photoactivatable rapamycin could conditionally control the interaction of a POI-FRB and an 
artificial FKBP-F-box protein functionally inserted into an SCF complex (Fig. 8.6). 
 
 
Fig. 8.6: Strategy for light-conditional control of addressing of a POI by a Chemically Inducible Dimerization (CID) 
system. An artificial SCF adapter can be engineered by fusion of an F-box sequence to FKBP. This heterologous protein 
can interact with endogenous components to form an artificial SCF complex, which can conditionally bind an 
interacting partner fused to a POI upon rapamycin addition. Free-Rapamycin disponibility can be controlled by light 
using a described caged –version of rapamycin. 
 
Alternatively, introduction of a caged rapamycin methodology would allow photocontrol of the 
strategies reported on chapter 1 for rapamycin-conditional POI degradation. These included: 
• direct addressing to proteasome, mediated by FRB-Rpn10 (section 1.1.1.2) 
• conditional stabilization of a constitutively degraded POI fused to an unstable FRB variant  
(section 1.2.2.2) 
• conditional control of Split Ubiquitin processing to release a constitutively degraded POI 
(section 1.2.1.2). 
 
8.3.2.2 Caged Trimethoprim 
As described on section 1.2.2.2.a, Trimethoprim (TMP), a small-inhibitor of E. coli protein 
Dihydrofolate Reductase protein (ecDHFR) has been reported as stabilizing the tsDHFR degron 
upon temperature-shift. Recently, a caged TMP was described for light-conditional interaction 
between TMP and ecDHFR21
 
 (Ballister, 2014). This tool might allow combination of light and 
temperature-control for the conditional stabilization of  tsDHFR-based degrons. 
                                                 
21 TMP diaminopyrimidine ring was caged using a nitroveratryl-carbamate coupling strategy. This caging inhibited the 
binding with ecDHFR. Photorelease by 387 nm illumination led to the rapid (15s) but reversible (by addition of free 
TMP) recruitment of ecDHFR-FP to centromeres in HeLa cells. 
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8.4 Conclusion 
 
In this section, we proposed alternative strategies for light-control of protein degradation, based on 
the combination of conditional destabilization methods strategies described in chapter 1, and the 
tools developed for light-actuation described on chapter 2. 
 
Methodological development of light-inducible degradation techniques with different characteristics 
might constitute a useful “toolkit” for biologists. These techniques could be implemented in a 
chemical biology approach, depending on the experimental specifications. For example, light 
actuation can be triggered at different wavelengths. Phytochrome-based modules or two-photon 
uncaging strategies allow red and far red activation, an interesting alternative to widely used UV 
and blue light actuation methods. Fully encoded methodologies, such as caged-amino acids or 
photosensitive proteins modules can be particularly efficient strategies in systems such as yeasts 
which can be easily genetically modified.  
 
 
Consequently, the choice of a photoactuation method depends on experimental specifications and 
on several parameters, including the organism, the developmental stage, the target POI or the 
illumination tolerated. In the next chapter, we will propose two biological contexts in which the 
implementation of light-induced degradation methodologies might be an interesting approach. 
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Chapter 9: Perspectives 
 
Light-activatable degradation could be a relevant 
perturbation method in various contexts 
 
We next discuss applications of light-activatable degradation methodologies, which can be potential 
approaches to monitor the activity of a given POI. We identified two biological systems in which 
UPS degradation plays an essential regulation role by controlling the stability of various substrates. 
We thus discuss here the possibility of implementing on-demand artificial ubiquitin ligase for the 
spatio-temporal control of protein target stability in these contexts. 
 
9.1 Cyclins are potential POI for further understanding the cell-cycle 
progression through spatio-temporal perturbative methods 
 
9.1.1 Cyclin B stability is regulated during the cell-cycle 
 
In chapter 6, we have been considering Cyclin B1 as a reporter fusion protein for cytoplasmic 
degradation, without evaluating the physiological perturbation triggered by the light-activated 
degradation of exogenous Cyclin B1-AID-YFP. However, in a single event (see section 6.2.3), 
degradation of a nuclear-translocated Cyclin B1-AID-YFP by PA-IAA photoactivation led to an 
intriguing oriented rotation of the mitotic spindle.  
 
In this part, we will discuss more precisely on the biological role of Cyclin B and the possibility to 
monitor direct cellular changes in responses to a light-induced degradation, which is one of our 
initial motivation. 
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9.1.1.1 Cyclin B activity regulates early mitotic events 
The eukaryotic cell-cycle is a highly time-regulated process (Alberts, 2007, chap. 17). Cyclin-
dependent protein kinases (CDKs) control cell-cycle events by phosphorylation of key substrates, 
requiring activatory subunits called cyclins.  These regulators are expressed in a cell-cycle 
dependent manner and mediate downstream activation. 
 
In human cells, cyclin B/cdk activation has been historically described as the major event controling 
the mitotic state entry. Coherent with its name, the Cyclin B level oscillates during the cell-cycle: 
most of Cyclin B is synthesized over the G2 phase, and peaks during early mitosis. During S and 
G2 phase, Cdk1:Cyclin B is located in the cytoplasm22
 
, and inactive due to phosphorylation of the 
Cdk1 subunit, which is mediated by a complex balance of phosphatases (Burgess, 2010). This 
regulation prevents premature entry into mitosis. In early mitotic events, the active complex is 
translocated into the nucleus, where it regulates essential steps of cell cycle progression during early 
mitosis: chromosome condensation, assembly of the mitotic spindle and Nuclear Envelope 
Breakdown  (NEB) (Tuck, 2013) (Fig. 9.1). 
 
Fig. 9.1: Model for Cyclin B role in early mitotic steps. In (prophase) Cyclin B forms an active complex with 
phosphorylated Cdk1, controling various downstream targets; in (metaphase) Spindle Activation Checkpoint (SAC) 
inhibition as chromosomes are properly aligned at the metaphatic plane activates E3 ubiquitin ligase APC/C, targeting 
Cyclin B for proteasomal degradation. In (anaphase) Cdk1 is inactive in absence of Cyclin B, concomitant with 
chromosome separation and cytokinesis. 
 
                                                 
22 Cyclin B-Cdk1 is targeted for ubiquitination in the nucleus by SCFNIPA to prevent early activation until late G2, where 
NIPA activity is silenced by phosphorylation, enabling nuclear accumulation of Cyclin B (Bassermann, 2005). 
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9.1.1.2 Cyclin B degradation is concomitant to mitotic progression 
Eventually, Cyclin B is degraded at anaphasis by an E3 ubiquitin ligase Anaphase Promoting 
Complex (APC/C) with a fine temporal control. APC/C is inactive until Spindle Assembly 
Checkpoint (SAC); resulting in Cyclin B polyubiquitination and its rapid proteasomal degradation23 
(see Chen, 2014 for a recent complete model). Consequently24
 
, in telophase, mirror phenomenons 
are observed compared to pro- and metaphase: chromosome decondensation, spindle disassembly 
and nuclear envelope reconstitution, concomitant with reduced CDK activity. 
9.1.1.3 Cyclin degradation is a general strategy for cell-cycle regulation             
CDK oscillations are generated by complex regulatory networks at the transcriptional, translational 
and post-transcriptional level, such as proteolysis and phosphorylation control. However, contrary 
to the latter, UPS dependent degradation is an irreversible process, ensuring unidirectionality. 
Therefore, it allows the precise spatial and temporal proteolysis of the main components of the cell 
cycle machinery. Overexpression of a non-degradable mutant of Cyclin B in HeLa cells induces 
mitotic arrest and rapid cell death in G1 phase (Eichhorn, 2014), indicating that the time-controlled 
degradation of Cyclin B is an essential process for cell survival. 
 
Fig. 9.2: Activities of Cyclin A, B and E along the cell-cycle. The total Cyclin B (inactive and active protein) is 
represented in red dotted lines 
Others cyclins have different temporal activation patterns (Fig. 9.2): Cyclin E/Cdk2 activation starts 
in late G1 phase, initiates the DNA replication in S-phase and is degraded by the SCF as the cells 
progress through S and G2 phases. Similarly, Cyclin A/Cdk2 is involved in the G2/M transition. 
While both mitotic Cyclin A and Cyclin B are ubiquitinated by the APC/C, their temporal 
                                                 
23 However in prometaphase, APC/CCdc20 enhances Cyclin B activity by degrading specific inhibitor p21. 
24 A direct link exists as mitotic Cyclin:Cdk inhibit Separase controlling sister chromatide separation. Separase is above 
all inhibited by its interaction with the chaperone Securin, which is degraded upon APC/ C activation, leading to 
Cohesin degradation and chromatide segregation. Cyclin B degradation also activate Cdh1, an APC/C substrate adapter 
inactivated by phosphorylation in early mitosis. 
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degradation profile is different: cyclin A is degraded in prometaphase, whereas cyclin B degradation 
starts in metaphase/anaphase transition 25
 
. Therefore, temporal control of this degradation is 
important to prevent mitotic defects.         
                        
9.1.2 Cyclin B is targeted for degradation by APC/C     
               
The E3 ubiquitin ligase APC/C is structurally related to the SCF complex, although with a more 
complex description due to the higher number of components. Two co-activators: Cdc20 and Cdh1, 
conferring substrate specificity (comparable to F-box protein in SCF) associate with the APC/C 
core at differential stages during cell cycle during cell-cycle progression. Activated at the end of 
metaphase, the APC/C thus coordinates the late mitosis progression (APC/CCdc20), and exit 
(APC/CCdh1) to establish a stable G1 phase (Sarikas, 2011).        
                        
Prior to anaphase, APC/C is inhibited by the Spindle Assembly Checkpoint (SAC), an essential 
mitotic mechanism regulating the correct attachment of kinetochores to the spindle fibers and the 
alignment of chromosomes on the metaphase plate. Mitotic checkpoint proteins such as Bub3 and 
Mad2 sequester Cdc20 in a Mitotic Checkpoint Complex (MCC), inactivating APC/CCdc20. 
                  
A complex interplay exists between APC/C and SCF based E3 ubiquitin ligases. Illustrating this, 
APC/CCdh1 targets cell-cycle progression promoter F-box Skp2 (see part 3.2.3) for degradation; 
consequently, inactivation of APC/CCdh1 in late G1 allows the accumulation of SCFSkp2, promoting 
cell-cycle progression through degradation of specific regulators. As a general trend APC/C and 
SCF complexes have antagonist activities during the cell-cycle and might constitute a regulatory 
loop. This dual repression system between ubiquitin ligases can account for the time control of cell-
cycle transitions. It also illustrates the complex regulation of UPS components which are 
themselves targeted for degradation.          
 
 
 
                                                 
25 Intringuingly, Cyclin A is degraded in early mitosis, a stage at which its specific ubiquitin ligase APC/C should be 
inhibited by active spindle checkpoint; this process might involve an APC/C independent process (van Leuken, 2008). 
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9.1.3 Cyclin B is a potential POI for further understanding of the cell cycle 
progression through spatio-temporal perturbative methods    
                    
9.1.3.1 Motivation: perturbation of the spindle positioning by light-induced degradation         
In Chapter 6, we described the implementation of an artificial SCFTIR1, mimicking APC/CCdc20 for 
the light-conditional degradation of Cyclin B1; however, contrary to the latter, this on-demand 
degradation system can be activated at any cell cycle state. 
On a single event (section 6.2.3), we observed that the light-induced depletion of nuclear-
translocated Cyclin B1 led to a global perturbation of the mitotic spindle positioning. Oriented 
rotation of the spindle around the cell was observed. We will now discuss this observation by 
comparison with reports from the literature.                
 
9.1.3.2 Cyclin knockdown perturbates mitotic progression and spindle positioning          
Cyclin B knockdown by siRNA (Yuan, 2004) and conditional stabilization by Shield1 ((Chu, 2009), 
see section 1.2.2.2) was reported. Significant depletion of Cyclin B led to G2/M arrest in 
mammalian culture cells. However, depletion was achieved on a day timescale and the temporal 
evolution of individual cells upon Cyclin B depletion was not addressed. 
Complete depletion of Gwl (Greatwall), a critical Ser/Thr kinase phosphorylating Cyclin B-Cdc2, 
by siRNA for 48h arrests human cells in G2 (Burgess, 2010). However, partial depletion by a lower 
siRNA dose induced multiple defects in spindle assembly and mitosis. Consistently, severe 
cytokinesis defects were observed in a large number of cells, in a siRNA dose-dependent manner. In 
some cases, dynamical rotation of the spindle within the cell was visible. Alternatively, defects in 
chromosome congression or segregation were observed. Interestingly, no metaphase rotation was 
observed upon introduction of a non-degradable form of Cyclin B1. 
Even more dramatic effects are associated with Cyclin A knockdown in HeLa cells (Beamish, 2009). 
Off-centering and dynamic rotation of the incomplete metaphase plate were often observed, along 
with chromosome impairment in anaphasis 26
                                                 
26 The metaphase plate orientates to allow subsequent division along the longest axis of the cell; a limited rotation of 
the metaphase plane might be consequently observed for the ajustement of this positioning (O'Connell, 2000). 
. This rotation was hypothetically linked to the 
inactivation of Cyclin A/Cdk. Consistently, similar rotation was observed with siRNA knockdown 
of Cdc25B, an activator of cyclin A/cdk2.  
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9.1.3.3 Perturbation of the spindle positioning can be associated with spindle rotation  
Using cells grown on adhesive micro patterns, Fink et al. showed that specific adhesion geometry 
might control mitotic spindle orientation (Fink, 2011). Slight rotation of mitotic spindles (10° –15°) 
was observed between late prometaphase and metaphase in control cells. Laser ablation of 
retraction fibers, or external forces applied on mitotic cells can trigger significant spindle rotation. 
Nocodazole, a microtubule-depolymerizing drug inhibits the spindle rotation in anaphase, indicating 
that astral microtubules are required for this process. 
Selective small-molecule inhibitor of CDK1 RO-3306 has been identified, which reversibly arrest 
human cells at the G2/M (Vassilev, 2006), preventing mitotic entry or inducing mitotic exit. Upon 
low doses of molecule RO-3306 (a Cdk1-specific inhibitor), a minority of spindle rotation and 
lagging chromosome are observed upon incubation (McCloy, 2014). However, CDK1 interacts with 
several Cyclin partners other than cyclin B along the cell-cycle, so that RO-3306 might globally 
affect the spindle positioning.         
                     
9.1.3.4 Perspective: ecchronic degradation of Cyclin as a cell-cycle perturbation method  
Cell division control is essential for cell-fate or organism development; proper division geometry or 
equirepartition of chromosomes are regulated by endogenous mechanisms such as the SAC. UPS 
degradation is an important effector of spatio-temporal control. Targeting of cell cycle effectors 
such as Cyclin B by E3 ubiquitin ligases APC/CCdc20 at specific states can trigger their functional 
depletion, resulting in differential physiological outputs. The ubiquitin ligases themselves are 
temporally regulated, with a complex regulatory network between SCF and APC/C-based 
Ubiquitin-Ligase. APC/C is activated after SAC inactivation in late metaphase, leading to Cyclin B 
degradation (Sarikas, 2011). 
In Chapter 6, we described an artificial SCFTIR1, mimicking APC/CCdc20 for the light-conditional 
degradation of Cyclin B1; however, contrary to the latter, this on-demand degradation system can 
be activated at any cell-cycle state, with a timescale much smaller than siRNA depletion. This 
perturbative approach might be relevant to interrogate the activity of Cyclin B, as well as regulation 
of cellular processes by APC/C, by degrading Cyclin B at times such as prophasis when APC/C is 
normally inactive. This process can be extended to other cyclins which also present a differential 
activity or sensitivity to degradation along the cell cycle. It might also be relevant for better 
understanding the complex interplay between various cyclins27
                                                 
27 Slow cyclin A destruction is associated with delayed cyclin B destruction, which might be explained by SAC 
. 
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Fig. 9.3: Expected activity profile upon light-triggered premature degradation of Cyclin B before SAC by an artificial 
APC/C-like ubiquitin-Ligase. 
 
In 2013, Renicke et al. proposed to implement cell cycle control by light-induced degradation 
(Renicke, 2013). Dominant-active versions of regulators of Cdc28 were fused to a psd module, 
including Cyclin B/Cdc28 inhibitor Sic1 lacking its degradation sequence. Therefore, regulation of 
the stability of effectors is set by light-modulation instead of the endogenous cell cycle mechanisms. 
This allows ecchronic modulation of the degradation of cell cycle effectors by illumination, 
resulting in significant visible phenotype alteration. This confirms that light-activatable degradation 
can be a functional tool for the generation of conditional mutants and the analysis of cell cycle 
mechanisms. 
 
9.2 Light-induced degradation can be relevant to study the generation 
of spatio-temporal pattern of morphogens in living systems 
 
9.2.1 Morphogen distribution generate developmental patterns 
 
9.2.1.1 Motivation 
The generation of spatio-temporal patterns in living systems by diffusible morphogen molecules is a 
fascinating example of interplay between theoretical prediction and experimental observations28
                                                                                                                                                                  
inactivation, or perturbation of the APC/C activation (Di Fiore, 2010). 
. 
28 The hypothesis that gradients of morphogenic chemical substances can explain the patterns observed in multicelular 
organisms roots in previous embryological observations (Wartlick, 2009); in particular, the Spemann organizer 
discovery in the 1920s suggested that local groups of cells were able to release signals control the differentiation of 
surrounding cells. This mechanism was formalized by Alan Turing in 1952, who proved reaction diffusion models were 
able to generate spatial patterns of morphogen concentration. This formalism led to the « French Flag model » by 
Wolpert in 1969: morphogen secretion by source cells (and degradation by a sink) creates a gradient of concentration, 
which itself generates a spatial pattern of gene expression in response to differential thresholds. This model was later 
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Morphogen gradients can generate precise positional information, which determines downstream 
developmental decisions. In the classical « French flag » model, differential distribution of a 
transcription factor along the embryonic axis induces differential genetic pattern due to 
transcriptional activation. 
 
Quantitative approaches are necessary to study the molecular mechanisms controlling the formation 
of these gradients. In this part, we will focus on the protein Bicoid in Drosophila, the paradigmatic 
example of a morphogen gradient. Other morphogen gradients examples (mostly in Drosophila and 
Danio embryos) are listed in (Kicheva, 2012), along with their diffusion coefficient and their 
characteristic lengthscales. 
 
9.2.1.2 The Bicoid morphogen controls the Antero-posterior polarity in D. melanogaster 
Bicoid is a homeodomain transcription factor responsible for the acquisition of the antero-posterior 
(AP) polarity in Drosophila melanogaster (Hecht, 2009). Maternal bicoid mRNA is localized at the 
anterior pole of the oocyte 29
 
; egg deposition initiates the synthesis of Bicoid and its diffusion 
through the embryo; this results in the formation, in 2 hours, of a Bicoid gradient along the AP axis 
(in cycles 10-14) (Fig. 9.4). 
 Bicoid controls the highly robust expression of 
downstream effectors, such as Hunchback (Hb) 30
 
; this 
simple model can explain the reproducible acquisition of 
the segmentation in the body plan of the embryo. 
Fig. 9.4: Overview of Bicoid gradient in Drosophila embryo. 
Diffusion of Bicoid along the Antero-Posterior (AP) axis creates a 
gradient which modulate Hunchback expression 
 
 
 
                                                                                                                                                                  
validated experimentally with the identification of the paradigm morphogen Bicoid as a regulator of the Antero 
Posterior (AP) identity (Frohnhofer, 1986). 
29 However, restricting the source of Bicoid production to a single point is an idealized approximation. More elaborate 
models can include the distribution of the bcd mRNA profile (Liu, 2011 II). 
 
30 An accuracy of 10% of Bcd gradient reproducibility is observed between embryos while 10% precision is observed in 
the readout of Bcd by Hb (Gregor, 2007). The precise mechanism of Bcd-activated transcription is not yet fully known. 
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9.2.2 Evaluation of a morphogen activity in development 
 
9.2.2.1 Morphogen activity can be assessed by perturbative methods 
Perturbative methods can be applied to the study of morphogen gradients formation. Genetic 
inactivation or overexpression methods offer powerful tools to understand the specific roles of 
given genes (e.g. the morphogen Dpp receptor gene (Nellen, 1996)). Recently, Staller et al. 
published an all-cell expression atlas of 13 patterning genes following maternal Gal 4shRNA 
depletion of Bicoid (Staller, 2015). However, poor spatio-temporal actuation resolution can be 
obtained, which prevents fine analysis of these highly dynamical processes.31
 
 
Morphogen gradients can be experimentally measured directly by fusion with fluorescent protein 
reporters 32
 
 (see (Kicheva, 2012) for a review). This enables the estimation of gradient kinetic 
parameters by Fluorescence Correlation Spectroscopy (FCS), or by perturbation of the steady-state 
fluorescence. The latter can be achieved by photobleaching experiments (Kicheva, 2007), or 
photoactivation. These experiments offer excellent spatio-temporal selectivity for the determination 
of diffusion mechanisms, but only affect the fluorescence distribution, not the activities of the POI. 
9.2.2.2 Modelization of a Morphogen activity in a developing organism 
In 2005, Gregor et al. thus used a GFP-Bicoid reporter and modelled the gradient formation by 
integrating a simple diffusion-degradation equation33
where C is the concentration of Bicoid, D the diffusion coefficient of Bicoid in embryo, and k the 
degradation rate. Assuming k is a constant parameter, integration of equation 9.1 at steady-state 
gives a simple exponential decay profile along the AP axis.  
𝐶(𝑡) =  𝐶0𝑒
−  𝑥𝜆           λ = (D k⁄ )
1
2      (9.2) 
: 
𝜕𝐶(𝑥, 𝑡)
𝜕𝑡
= 𝐷Δ.𝐶(𝑥, 𝑡) − 𝑘.𝐶(𝑥, 𝑡)    (9.1) 
The amplitude 𝐶0  and the characteristic length λ both depend on the degradation constant k. This 
                                                 
31  An interesting alternative was the application of temperature sensitive-degrons to study the role of dynamin-
dependent endocytosis in gradient formation (Entchev, 2000). Unlike mammalian, insect cells support temperature-shift, 
although they can highly alter the developmental response. 
 
32 However, these last options require complex calibration and normalization procedures to ensure linearity of the 
measurement. Other options include immunostaining or indirect observations through target gene expression domains. 
 
33 Morphogen gradients can be described in two ways: discrete models explicit the molecular mechanisms at a cellular 
resolution, whereas continuum models offer low resolution and continuous morphogen concentration changes, 
capturing the essential biological processes. 
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model was applied to direct monitoring of Bicoid-EGFP fluorescence in fly embryos (Gregor, 2005). 
Although this diffusive model can explain the Bicoid gradient formation, it is insufficient to explain 
biological features, such as the length scaling between different embryos. Other mechanisms are 
likely to be involved, such as dynamical exchanges between nuclei, or cytoplasmic fluid flows (Liu, 
2011). Although the value of the diffusion coefficient D has been much discussed, the degradation 
rate k has often been considered constant in time and space34
 
. However, the precise degradation 
mechanism phenomenologically modeled by k was often not explicated. 
9.2.3 Control of the activity of a morphogen by UPS degradation 
 
9.2.3.1 Bicoid is targeted for UPS degradation by the SCF 
In 2011, it was proved that Bicoid can be degraded in a UPS-dependent manner. The F-Box protein 
Fates-shifted (Fsd) was identified as the specific SCF adapter for the ubiquitination of Bicoid. 
Polyubiquitinated Bicoid is degraded by the proteasome. It is thus relevant to wonder whether UPS-
dependent degradation is involved in the shaping of the Bicoid gradient. 
 
Indeed, perturbation of Bicoid degradation in fsd knock-out embryos results in alteration of the 
Bicoid gradient profile, resulting in a higher value of characteristic length λ. This observation 
implied that controlled degradation could be important for the Bicoid gradient formation and 
shaping (Liu, 2011). Moreover, it was also observed that the lifetime of the embryos varies during 
the early stages on Bicoid gradient formation (around 15 min during the first two hours35
 
, more than 
40 min after) (Liu, 2011, II), implying that the degradation rate k is not constant in time and space. 
9.2.3.2 Light-activatable degradation of Bicoid can be a relevant perturbation method for 
evaluation of morphogen activity 
We propose thus to replace the constant degradation parameter k by k(x,t) variable in space and time 
in the simple diffusion-reaction equation 9.3 (Gregor, 2005)36
                                                 
34 A model for the formation of a stable Bicoid gradient in absence of degradation was proposed (Coppey, 2007), which 
involves nuclear trapping. 
. 
 
35 This high degradation process contrasts with others gradient formation models, and might shed new lights on 
controversies on the diffusion coefficient value D (Coppey, 2007) (Abou-Arish, 2010). 
 
36 Non-linear degradation mechanisms have been described in Drosophila for Hedgehog (Hh) which enhances its own 
degradation by a feedback mechanism with its receptor Patched (Ptc). This affects the gradient nature (see (Wartlick, 
2009) for an extensive model). 
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𝜕𝐶(𝑥, 𝑡)
𝜕𝑡
= 𝐷Δ.𝐶(𝑥, 𝑡) − 𝑘(𝑥, 𝑡).𝐶(𝑥, 𝑡)    (9.3) 
To assess the importance of non-linear degradation in the Bicoid gradient formation, we propose to 
implement an artificial Fsd-like ubiquitin Ligase to control the degradation of heterologous Bicoid 
fused to a controllable degron. This strategy could be implemented with either the photo-activatable 
AID methodology developed in this work, or one of blue-light sensitive degradation modules (psd 
in yeasts cells (Renicke, 2013); or B-LID in mammalian cells or Danio embryos, see section 7.1.2). 
Validation of these methodologies in Drosophila would be a first requirement to implement a light-
controlled protein degradation strategy. 
 
This would constitute an interesting approach to investigate the stability and the robustness of the 
gradient: controllable depletion would allow identifying developmental stages and locations in 
which UPS dependent degradation is determinant for the shaping of the Bicoid gradient, in different 
contexts: 
– fsd embryos where the gradient phenotype is altered 
– Embryos over-expressing ectopic Bicoid-degron 
 
In these two contexts, the Bicoid gradient phenotype would be 
altered (a longer characteristic length is expected). 
Conditional rescue of the phenotype, either during the 
gradient formation, or with a steady-state gradient, might 
provide valuable informations on the Bicoid gradient 
formation. 
 
 
Fig. 9.5: Overview of a light-induced strategy for the perturbation of 
Bicoid activity in Drosophila embryo. Photo-activatable Bicoid can be 
implemented by fusion with light-sensitive degradation modules (such as 
B-LID, psd or AID/PA-IAA) along the Antero-Posterior (AP) axis creates 
a gradient which modulate Hunchback expression. 
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Chapter 10 
Materials and Methods  
 
10.1 Chemistry part 
 
10.1.1 General 
 
Commercially available reagents were used as obtained. 1H and 13C NMR spectra were 
recorded at room temperature on Bruker AM 300 spectrometers; chemical shifts are reported 
in ppm with protonated solvent as internal reference 1H, CHCl3 in CDCl3 7.26 ppm, 
CHD2COCD3 in CD3COCD3 2.05 ppm, CHD2OD in CD3OD 3.35 ppm; 13C, 13CDCl3 in 
CDCl3 77.0 ppm, 13CD3COCD3 in CD3COCD3 29.9 ppm, 13CD3OD in CD3OD 48.8 ppm; 
coupling constants J are given in Hz. Mass spectra (chemical ionization and electronic impact 
with NH3 or CH4, or high resolution) were performed by the Service de Spectrométrie de 
Masse de Chimie ParisTech (Paris, France) or the Service de Spectrométrie de Masse 
IMAGIF/ICSN de Gif-sur-Yvette (France). Column chromatography was performed on silica 
gel 60 (0.040- 0.063 nm) Merck. Analytical thin-layer chromatography (TLC) was conducted 
on Merck silica gel 60 F254 precoated plates. The UV−vis absorption spectra were recorded 
at 20°C on an Agilent Cary 300 spectrophotometer equipped with 1 × 1 Peltier cell holders. 
Molar absorption coefficients were extracted while checking the validity of the Beer−Lambert 
law. High pressure liquid chromatography (HPLC) was carried out on Agilent 1260 infinity 
equipped with a column (poroshell 120, C18, 27mm). 
 
 
10.1.2 Photolysis quantification 
Solutions of caged auxins (400 μL at 25 μM) in Acetonitrile / TRIS buffer pH 7.5 were 
illuminated at 350 nm or 390 nm with a mercury lamp equipped with a monochromator 
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(pathlength of the light beam 1 cm) using a LPS 220 spectrofluorometer (PTI, Monmouth 
Junction, NJ), equipped with a TLC50 cuvette holder (Quantum Northwest, Liberty Lake, 
WA) thermoregulated at 20°C. Solution concentration was adjusted so that optical density at 
max. Absorption was between 0.1 and 0.15. Measures were carried out on 0.4 mL samples in 
quartz cuvettes 1.0 × 0.2 cm2 (l =1cm). Solutions were illuminated for various times and the 
concentrations were quantified by HPLC or fluorometry. For each caged-auxin, the action 
cross-section of photolysis σΦ was extracted from the temporal evolution of the concentration 
C of photoactivatable auxin by fitting with the following equation (Aujard, 2006) : 
𝐶(𝑡)
𝐶0
=  𝑒−𝜎𝛷
𝐼0.𝑙.𝑡
𝑉  
where C0 is the initial concentration of the photoactivatable auxin, σ is the molar absorption 
cross-section at maximal absorption wavelength, Φ is the quantum yield of photolysis, V is 
the solution volume, l is the pathlength of the light beam and I0 the light intensity or photon 
rate (in mol.s–1). I0 was determined following previously reported protocol (Aujard, 2006).  
 
10.1.3 First generation of carboxylate-DMNB caged auxins (section 4.2.1) 
 
 
(4,5-dimethoxy-2-nitrophenyl)ethyl 2-(1H-indol-3-
yl)acetate 1I 
 
Indole Acetic Acid (IAA) (100 mg, 0.571 mmol), (4,5-dimethoxy-2-nitrophenyl)methanol 
(DMNBA, 122 mg 0.571 mmol) and dimethylaminopyridine (DMAP, 69.7 mg, 0.571 mmol) 
were added and dissolved in 10 mL anhydrous dichloromethane. Dicyclohexycarbodiimide 
(DCC, 118 mg, 0.571 mmol) was added at 0 °C to the stirred solution under nitrogen. After 
10 min, ice was removed and the reaction was left overnight at room temperature. Reaction 
was checked on TLC (cyclohexane/dichloromethane 70/30). The reaction mixture was filtered 
over a Buchner  with dichloromethane, then washed twice with 10 mL HCl 1.2 M and twice 
with 10 mL saturated NaHCO3. The remaining organic phase was then dried over MgSO4, 
filtered with a filter paper and evaporated. The product was purified on a flash 
chromatography (cyclohexane/ethyl acetate 70/30). 35 mg of 1I was obtained as a yellow 
powder (0.095 mmol, yield 40 %). 1H NMR (300 MHz, CDCl3, δ in ppm): 3.14 (s, 3H), 3.82 
(s, 3H), 3.86 (s, 2H), 5.52 (s, 2H), 6.47 (s, 1H), 7.29 (d, 1H), 7.61 (d, 2 H), 8.10(s, 1H). 13C 
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NMR (75 MHz, CDCl3, δ in ppm) :  26.7, 31.7, 55.5, 56.2, 63.1, 76.6, 77.1, 77.6, 107.8, 
108.8, 111.3,118.7, 119.7, 122.2, 123.6, 127.6, 136.1, 147.8, 153.6, 171.2, 206.6. MS (CI, 
NH3): m/z 388.15 [M+NH4]+, calcd mass for [C19H22N3O6]+: 388.15. 
 
 
(4,5-dimethoxy-2-nitrophenyl)ethyl 2-(1H-naphtalen-
yl)acetate 1N 
 
Naphtalene Acetic Acid (NAA, 106.3 mg, 0.571 mmol), (4,5-dimethoxy-2-
nitrophenyl)methanol (DMNBA, 122 mg, 0.571 mmol) and dimethylaminopyridine (DMAP, 
69.7 mg, 0.571 mmol) were added and dissolved in 5 mL anhydrous dichloromethane. 
Dicyclohexycarbodiimide (DCC, 118 mg, 0.571 mmol) was added at 0 °C to the stirred 
solution under nitrogen. After 10 min., ice was removed and the reaction was left overnight at 
room temperature. Reaction was checked on TLC (cyclohexane/dichloromethane 70/30). The 
reaction mixture was filtered over a Buchner with dichloromethane, then washed twice with 
10 mL HCl 1.2 M and twice with 10 mL saturated NaHCO3. The remaining organic phase 
was then dried over MgSO4, filtered with a filter paper and evaporated. The product was 
recrystallised twice in cyclohexane by adding ethyl acetate at 85°C. 98 mg of 1N was 
obtained as a white powder (0.25 mmol, yield 85%). 1H NMR (300 MHz, CDCl3, δ in ppm): 
3.12 (s, 3H), 3.81 (s, 3H), 4.14 (s, 2H), 5.46 (s, 2H), 6.28 (s, 1H), 7.17 (s, 1H), 8.01 (d, 1H, J 
= 9 Hz). 13C NMR (75 MHz, CDCl3, δ in ppm) = 24.7, 25.6, 34.0, 39.5, 55.6, 56.6, 63.5, 76.6, 
76.9, 77.5, 108.0,108.7, 123.7, 125.7, 126.2, 126.6, 128.2, 128.4, 128.7, MS (CI, NH3): m/z 
382.13 [M+H]+, calcd mass for [C21H20NO6]+: 382.13. 
 
10.1.4 Second generation of carboxylate-DMNB caged auxins (section 4.2.3) 
 
 
1-(4,5-Methylenedioxy-2-nitrophenyl)ethan-2-ol  
 
was prepared according to literature procedures (Teague, 1996) : To a solution of 6-
nitropiperonal (1.95 g, 10 mmol) in dry methylene chloride (60 ml) was added dropwise at 
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0°C trimethylaluminium (2M in hexane, 11 ml, 2.2 eq). The reaction mixture was stirred at 
room temperature for 4h, then cooled to 0°C and quenched with an aqueous hydrochloric acid 
solution (1.2M, 100 ml). Extraction with dichloromethane, drying and evaporation gave a 
yellow solid which was purified by silica column chromatography (cyclohexane/ethyl acetate: 
7/3, v/v; 0.46 g, 85 %). 1H NMR (300MHz, CDCl3, δ in ppm): 7.38 (s, 1H), 7.20 (s, 1H), 6.05 
(s, 1H, J =1.2 Hz), 6.04 (s, 1H, J =1.2Hz), 5.38 (q, 1H, J = 6.3 Hz,), 2.26 (s, 1H), 1.46 (d, 3H, 
J = 6.3 Hz,). 
 
 
1-(5-Nitrobenzo[1,3]dioxol-6-yl)ethyl 2-(1H-indol-3-
yl)acetate 2I  
 
Dicyclohexycarbodiimide (47 mg, 0.23 mmol, 1 eq.) was added at 0°C under nitrogen to a 
stirred solution of 2-(1H-indol-3-yl)acetic acid (40 mg, 0.23 mmol), 1-(4,5-Methylenedioxy-
2-nitrophenol)ethan-2-ol (50 mg, 0.23 mmol, 1 eq.) and 4-dimethylaminopyridine (33 mg, 
0.23 mmol,1 eq.) in anhydrous dichloromethane (10 mL). The mixture was stirred for 10 min 
at 0°C and for 12h at 20°C. The organic phase was washed with 1.2 M hydrochloric acid (2 x 
10 mL) and with saturated aqueous solution of sodium hydrogen carbonate (2 x 10 mL). It 
was subsequently dried over magnesium sulfate and evaporated. The resulting residue was 
purified by silica column chromatography (cyclohexane/ethyl acetate: 7/3, v/v) then 
suspended in methanol. The precipitate was filtered, washed with cold methanol and dried 
under reduced pressure to give 2I as a yellow powder (70 mg, 83%). 1H NMR (300MHz, 
Acetone-d6, δ in ppm): 10.05 (s,1H), 7.53 (d, 1H, J=8.1 Hz), 7.43 (s, 1H), 7.38 (d, 1H, J =8.1 
Hz), 7.27 (d, 1H, J =2.1 Hz), 7.13-6.98 (m, 2H), 6.92 (s, 1H), 6.25 (q, 1H, J =6.3 Hz), 6.18 (d, 
1H, J =1 Hz), 6.15 (d, 1H, J =1 Hz), 3.82 (d, 1H, J =0.6 Hz), 3.81 (d, 1H, J =0.6 Hz), 1.42 (d, 
3H, J =6.3 Hz); MS (ESI): m/z 367.4 (calcd av. mass C19H15N2O6: 367.3). 
 
 
2,2,2-Tribromo-1-(4,5-dimethoxy-2-nitrophenyl)ethanol  
 
was prepared according to literature procedures (Aujard, 2006): Tribromoacetic acid 
previously recrystallised in chloroform (1.05 g, 3.55 mmol, 1.5 equiv) was added to a solution 
of 4,5-dimethoxy-2-nitrobenzaldehyde (500 mg, 2.36 mmol) in freshly distilled dimethyl 
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sulfoxide (12.5 mL). The mixture was stirred for 1 h at room temperature under nitrogen. 
Then it was poured into ice-cold water (125 mL). The solution was extracted with ether. The 
organic phase was washed with sodium hydrogenocarbonate solution (5% m/m), and dried 
over magnesium sulfate. After solvent evaporation, the product was obtained as a yellow solid 
(962 mg, 88%). 1H NMR (400 MHz, CDCl3, δ in ppm):  7.63 (s, 1 H), 7.53 (s, 1 H), 6.61 (s, 1 
H), 4.01 (s, 3 H), 3.96 (s, 3 H), 3.65 (s, 1 H). 
 
 
2,2,2-Tribromo-1-(4,5-dimethoxy-2-nitrophenyl)ethyl 
2-(1H-indol-3-yl)acetate 3I 
 
 
Same as for 2I with Dicyclohexycarbodiimide (16 mg, 0.08 mmol, 1 eq.), 2-(1H-indol-3-
yl)acetic acid (13 mg, 0.08 mmol), 2,2,2-Tribromo-1-(4,5-dimethoxy-2-nitrophenyl)ethanol 
(35 mg, 0.08 mmol, 1 eq.), 4-dimethylaminopyridine (10 mg, 0.08 mmol,1 eq.). 3I was 
obtained as a yellow powder (35 mg, 75%). 1H NMR (300MHz, acetone-d6, δ in ppm): 10.26 
(s,1H), 7.79 (s, 1H), 7.73 (d, 1H, J =7.8 Hz), 7.63 (s, 1H), 7.42 (d, 1H, J =7.8 Hz), 7.37 (d, 
1H, J =2.4 Hz), 7.15-7.02 (m, 2H), 7.09 (s, 1H), 3.92 (s, 6H), 3.36 (s, 2H). 
 
10.1.5 Third generation of carboxylate-DMNB caged auxins (section 4.2.4) 
 
 
[(4,5-dimethoxy-2-nitrophenyl)(2,5-dimethoxyphenyl)     
 methanol] PNB-OH 
 
 
To a stirred solution of 4,5-dimethoxy-2-nitrobenzaldehyde (500 mg, 2.4 mmol) in dry THF 
(12 mL) was slowly added (2,5-dimethoxyphenyl) magnesium bromide (9.5 ml, 4.8 mmol, 
2.0 eq.) at –15°C. The solution was stirred for 15 min at –15°C. HCl (0.2 N, 25 mL) was 
added to quench the reaction and then the aqueous layer was separated and extracted with 
EtOAc (3 × 100 mL). The combined organic extracts were washed with an aqueous saturated 
NH4Cl solution and brine, dried over anhydrous magnesium sulfate, filtered, and concentrated 
in vacuo to afford the crude residue, which was purified by flash chromatography on silica gel 
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with cyclohexane/EtOAc (7/3, v/v). Compound PNB-OH is obtained as an orange powder 
(682 mg, 82% yield). 1H NMR (300 MHz, CDCl3, δ in ppm) : δ 7.61 (s, 1H), 7.20 (s, 1H), 
6.83 (d, J = 8.9 Hz, 1H), 6.77 (dd, J = 8.9, 2.9 Hz, 1H), 6.72 (s, 1H), 6.61 (d, J = 2.9, 1H), 
3.96 (s, 3H), 3.90 (s, 3H), 3.79 (s, 3H), 3.71 (s, 3H); 13C NMR (75 MHz, CDCl3, δ in ppm): 
153.6, 153.3, 151.0, 147.8, 140.6, 132.9, 131.9, 113.6, 112.6, 111.5, 110.5, 107.7, 66.79, 56.4 
(2C), 56.0, 55.7; MS (CI, NH3): m/z 366.99 [M+NH4]+, calcd mass for [C17H23N2O7]+: 
367.15; HRMS (ES): m/z 332.1122 [M+H–H2O]+, calcd mass for [C17H18NO6]+: 332.1134. 
 
 
 
 
(4,5-dimethoxy-2-nitrophenyl)(2,5-dimethoxyphenyl) 
methyl 2-(1H-indol-3-yl)acetate] 4I  
 
 
A solution of compound PNB-OH (100 mg, 0.29 mmol), indole 3-acetic acid (IAA, 60 mg, 
0.34 mmol, 1.2 eq.), N,N’-dicyclohexylcarbodiimide (DCC, 71 mg, 0.34 mmol, 1.2 eq.) and 
4-dimethyl aminopyridine (42 mg, 0.34 mmol, 1.2 eq.) in CH2Cl2 (5 mL) was stirred at room 
temperature overnight. After the addition of an aqueous saturated NH4Cl solution (10 ml), the 
aqueous layer was separated and extracted with CH2Cl2 (3 × 30 mL). The organic layer was 
washed with brine, dried over anhydrous Na2SO4, filtered, and concentrated in vacuo. The 
residue was purified by flash chromatography on silica gel with cyclohexane/EtOAc (7/3, 
v/v). Precipitation in MeOH yielded to 4I (130 mg, 89% yield) as gray yellow powder. 1H 
NMR (300 MHz, Acetone-d6, δ in ppm) : 10.23 (s, 1H), 7.79 (s, 1H), 7.66 - 7.60 (m, 2H), 
7.42 (d, J = 8.1 Hz, 1H), 7.35 (m, 1H), 7.13 (t, J = 8.1 Hz, 1H), 7.02 (t, J = 8.0 Hz, 1H), 6.95 
(d, J = 8.9 Hz, 1H), 6.88 – 6.81 (m, 2H), 6.44 (d, J = 3.0 Hz, 1H), 3.92 (s, 3H), 3.90 (s, 1H), 
3.89 (s, 1H), 3.75 (s, 3H), 3.53 (s, 3H), 3.41 (s, 3H); 13C NMR (75 MHz, Acetone-d6, δ in 
ppm) : 171.0, 154.7, 154.5, 152.6, 149.6, 141.6, 137.9, 130.1, 129.8, 128.7, 125.2, 122.7, 
120.1, 120.0, 114.7, 114.7, 113.2, 112.6, 111.3, 109.2, 108.7, 69.1, 56.8, 56.8, 56.4, 55.98, 
32.43; MS (CI, NH3): m/z 524.02 [M+NH4]+, calcd mass for [C27H30N3O8]+: 524.20; HRMS 
(ES): m/z 529.1585 [M+Na]+, calcd mass for [C27H26N2O8Na]+: 529.1587. 
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(4,5-dimethoxy-2-nitrophenyl) (2,5-dimethoxyphenyl) 
methyl 2-(naphthalen-2-yl) acetate 4N 
 
 
A solution of compound PNB-OH (100 mg, 0.29 mmol), 1-Naphthaleneacetic acid (NAA, 64 
mg, 0.34 mmol, 1.2 eq.), N,N’-dicyclo hexylcarbodiimide (DCC, 71 mg, 0.34 mmol, 1.2 eq.)  
and 4-dimethylaminopyridine (DMAP, 42 mg, 0.34 mmol, 1.2 eq.) in CH2Cl2 (5 mL) was 
stirred at room temperature overnight. After the addition of aqueous saturated NH4Cl solution 
(10 ml), the aqueous layer was separated and extracted with CH2Cl2 (3 × 30 mL). The organic 
layer was washed with brine, dried over anhydrous Na2SO4, filtered, and concentrated in 
vacuo. The residue was purified by flash chromatography on silica gel with cyclohexane 
/EtOAc (7/3, v/v). Precipitation in MeOH yielded to 4N (127 mg, 85% yield) as yellow solid. 
1H NMR (300 MHz, Acetone-d6, δ in ppm) : 8.11 (m, 1H), 7.94 (m, 1H), 7.88 (d, J = 8.1 Hz, 
1H), 7.79 (s, 1H), 7.61 (s, 1H), 7.57 - 7.44 (m, 4H), 6.93 (d, J = 8.9 Hz, 1H), 6.86 – 6.82 (m, 
2H), 6.45 (d, J = 3.0 Hz, 1H), 4.27 (s, 2H), 3.93 (s, 3H), 3.70 (s, 3H), 3.58 (s, 3H), 3.57 (s, 
3H); 13C NMR (75 MHz, Acetone-d6, δ in ppm) : 170.6, 154.7, 154.4, 152.5, 149.7, 141.7, 
135.2, 133.4, 132.0, 129.7(2C), 129.5, 129.4, 129.0, 127.4, 126.9, 126.7, 125.2, 114.8, 114.6, 
113.1, 111.4, 109.2, 69.3, 56.8(2C), 56.7, 56.0, 39.7; MS (CI, NH3): m/z 535.04 [M+NH4]+, 
calcd mass for [C29H31N2O8]+: 535.21; HRMS (ES): m/z 540.1610 [M+Na]+, calcd mass for 
[C29H27NO8Na]+: 540.1634. 
 
10.1.6 Coumarin-based caged auxins (sections 4.3.1) 
 
 
[7-(diethylamino)-4-((2,5-dimethoxyphenyl)(hydroxy)methyl)-
2H-chromen-2-one] 
 
PCM-OH 
 
 
To a stirred solution of 7-(diethylamino)-2-oxo-2H-chromene-4- carbaldehyde (130 mg, 0.5 
mmol) in dry THF (1.5 mL) was slowly added (2,5- dimethoxyphenyl) magnesium bromide 
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(2.0 ml, 1.0 mmol, 2.0 eq.) at –15℃. The solution was stirred for 2 hours at –15℃, then at 
room temperature overnight. HCl (1 N, 1 mL) was added  to quench the reaction and then 
aqueous layer was separated and extracted with EtOAc (3×25 mL). The combined organic 
extracts were washed with an aqueous saturated NH4Cl solution and brine, dried over 
anhydrous magnesium sulfate, filtered, and concentrated in vacuo to afford the crude residue, 
which was purified by flash chromatography on silical gel with dichloromethane /acetone 
(96/4, v/v). PCM-OH was obtained as a yellow brown solid (133 mg, 66% yield). 1H NMR 
(300 MHz, CDCl3, δ in ppm) 7.34 (d, J = 9.3 Hz, 1H), 6.89 (d, J = 8.9 Hz, 1H), 6.82 (dd, J = 
8.9, 3.0 Hz, 1H), 6.74 (d, J = 3.0 Hz, 1H), 6.51 (s, 2H), 6.37 (s, 1H), 6.32 (d, J = 3.0 Hz, 1H), 
3.90 (s, 3H), 3.69 (s, 3H), 3.37(q, J = 7.2 Hz, 4H), 1.17 (t, J = 7.2 Hz, 6H). 13C NMR (75 
MHz, CDCl3, δ in ppm) 162.7, 156.3, 156.2, 153.8, 150.5, 150.1, 129.5, 125.8, 114.1(2C), 
111.9, 108.4, 106.6, 106.36, 97.5, 66.5, 56.1, 55.6, 44.6 (2C), 12.4(2C). MS (CI, NH3): m/z 
384.27 [M+H]+, calcd mass for [C22H26NO5]+: 384.18; HRMS (ES): m/z 384.1815 [M+H]+, 
calcd mass for [C22H26NO5]+: 384.1111. 
 
 
 
[(7-(diethylamino)-2-oxo-2H-chromen-4-yl)(2,5-
dimethoxy phenyl)methyl 2-(1H- indol-3-yl)acetate] 
 
5I 
  
 
A solution of PCM-OH (95mg, 0.25 mmol), indole 3-acetic acid (44 mg, 0.30 mmol, 1.2 eq.), 
N,N’-dicyclohexylcarbodiimide (DCC, 62 mg, 0.11 mmol, 0.30 eq.) and 4-dimethyl 
aminopyridine (37 mg, 0.30 mmol, 1.2 eq.) in CH2Cl2 (4.5 mL) was stirred at room 
temperature for 5h. After the addition of an aqueous saturated NH4Cl solution (10 ml), the 
aqueous layer was separated and extracted with CH2Cl2 (3×30 mL). The organic layer was 
washed with brine, dried over anhydrous Na2SO4, filtered, and concentrated in vacuo. The 
residue was purified by flash chromatography on silica gel with dichloromethane /acetone 
(96/4, v/v). 5I was obtained (130 mg, 96% yield) as a red brown solid. 1H NMR (300 MHz, 
CDCl3, δ in ppm) 8.24 (s, 1H), 7.55 (d, J = 7.8 Hz, 1H), 7.45 (s, 1H), 7.35 (m, 2H), 7.14 (m, 
3H), 6.82 (m, 2H), 6.74 (s, 1H), 6.48 (s, 1H), 6.43 (s, 1H), 6.06 (s, 1H), 3.88 (s, 2H), 3.77 (s, 
3H), 3.59 (s, 3H), 3.35 (q, J = 7.0 Hz, 4H), 1.16 (t, J = 7.0 Hz, 6H). 13C NMR (75 MHz, 
Acetone-d6, δ in ppm) 171.2, 161.5, 157.3, 154.8, 154.4, 151.6, 151.2, 137.6, 128.4, 126.9, 
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126.5, 124.9, 122.3, 119.8, 119.6, 115.6, 115.0, 113.4, 112.3, 109.8, 108.2, 107.2, 107.0, 98.5, 
67.5, 56.7, 55.8, 45.4(2C), 31.8, 12.7(2C). MS (CI, NH3): m/z 541.30 [M+H]+, calcd mass for 
[C32H33N2O6]+: 541.23; HRMS (ES): m/z 541.2337 [M+H]+, calcd mass for [C32H33N2O6]+: 
541.2339. 
 
10.1.7 DMNB N-caged auxin (section 4.3.2) 
 
 
 
Methyl 2-(1-(4,5-dimethoxy-2-nitrobenzyl)-1H-indol-3-yl)acetate 
(DMNB-MeIAA) 6MeI  
 
 
Methyl 2-(1H-indol-3-yl) acetate (50 mg, 0.26 mmol) was added to a solution of NaH (60% 
suspension in mineral oil) (12 mg, 0.29 mmol, 1.1 eq.) in DMF (1 ml), and the mixture was 
stirred at room temperature for 15m. After being cooled to 0℃, 1-(bromomethyl)-4,5 
dimethoxy-2-nitrobenzene (80 mg, 0.29 mmol, 1.1 eq.) was added slowly. The solution was 
stirred for 2 hours at 0℃, then continued stirring at room temperature overnight and H2O (5 
ml) was added. the aqueous layer was separated and extracted with EtOAc (3×50 mL). The 
organic layer was washed with brine, dried over anhydrous MgSO4, filtered, and concentrated 
in vacuo. The residue was purified by flash chromatography on silica gel with 
dichloromethane which yielded to the desired 6MeI (10 mg, 10% yield) as brown oil. 1H 
NMR (300 MHz, CDCl3, δ in ppm): 7.77 (s, 1H), 7.63 (m, 1H), 7.16 (m, 4H), 5.75 (s, 2H), 
5.68 (s, 1H), 3.93 (s, 3H), 3.82 (s, 2H), 3.70 (s, 3H), 3.40 (s, 3H). MS (CI, NH3): m/z 
402.25[M+NH4]+, calcd mass for [C20H24N3O6]+: 402.17. 
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10.2 Biology part 
 
10.2.1 Cloning 
The plasmids used in this study are listed in table 10.1. pNHK60 (kind gift from M. 
Kanamaki) and derived plasmids IRES-containing bicistronic vector were used for co-
expression of Protein A: F-box-(NLS)-Myc (NLS: PKKKRKVPKKKRKV) and Protein 
B:EGFP-AID-NLS. Sequences were verified by sequencing. Sequences were verified by 
DNA sequencing. pcDNA5-FRT-TO-CyclinB-AID-YFP (kind gift from D. Cleveland) was 
used together with pAG122 for the co-expression of OsTIR1-Myc and CyclinB1-AID-YFP. 
Restriction enzymes were supplied by New England Biolabs. Phusion polymerase (New 
England Biolabs) was used for Polymerase Chain Reaction amplification. 
 
 
Plasmid Protein A Protein B from 
pNHK60 OsTIR1-9cMyc EGFP-AID-NLS (Nishimura, 2009) 
pAG1 OsTIR1-9cMyc HA-EGFP-AID-NLS pNHK60 
pAG36 mCherry-AID  pNHK60 
pAG38 OsTIR1-NLS-3cMyc HA-EGFP-AID-NLS pAG1 
pAG39 HsSKP1-OsTIR1-9cMyc HA-EGFP-AID-NLS pAG1 
pAG40 HsSKP1-OsTIR1-NLS-3cMyc HA-EGFP-AID-NLS pAG38 
pAG47 OsTIR1-NLS-3cMyc HA-EGFP-shAID-NLS pAG38 
pAG52 AtAFB2-NLS-9cMyc HA-EGFP-AID-NLS pAG1 
pAG53 OsAFB2-NLS-9cMyc HA-EGFP-AID-NLS pAG1 
pAG72 OsTIR1D170E-NLS-3cMyc HA-EGFP-AID-NLS pAG38 
pAG73 OsTIR1M473L-NLS-3cMyc HA-EGFP-AID-NLS pAG38 
pAG74 OsTIR1D170E/M473L-NLS-3cMyc HA-EGFP-AID-NLS pAG38 
pAG75 AtAFB2D170E-NLS-9cMyc HA-EGFP-AID-NLS pAG52 
pAG76 AtAFB2M473L-NLS-9cMyc HA-EGFP-AID-NLS pAG52 
pAG77 AtAFB2D170E/M473L-NLS-9cMyc HA-EGFP-AID-NLS pAG52 
pAG122 OsTIR1-9cMyc  pAG1 
 
Table 10.1:List of plasmids used in this study. 
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pAG1 was obtained from pNHK60. The IRES sequence was amplified with the primers 
ag7/ag2. The EGFP sequence was amplified with the primers ag3/ag4. The two fragments 
were then assembled by PCR using the primers ag7/ag4. The resulting fragment contained the 
sequence coding for an HA tag flanked by Pvu I and EcoR I upstream the sequence coding for 
EGFP. After digestion with Xma I and BsrG I, this fragment was inserted in pNHK60 
between Xma I and BsrG I restriction sites. 
pAG36 was obtained from a modified pIRES vector by inserting the sequence coding for 
mCherry-LYKGAGAGAGAGAGP-AID into Bgl II and Not I restriction sites. 
pAG38 was obtained from pAG1. The sequence coding for the 9×Myc-tag in pAG1 was 
replaced by a sequence coding for NLS-3×Myc (amplified from pAG1 using primers 
ag49/ag50) using Sal I and Xma I restriction sites. 
pAG39 and pAG40 were obtained respectively from pAG1 and pAG38. The sequence coding 
for HsSKPI-GGGSGGGSTR-OsTIR1(1-39) was synthesized by Eurofins, and subcloned into 
pAG1 and pAG38 using Eco47 III and Blp I. 
pAG47 was obtained from pAG38. The sequence encoding shortAID-NLS was generated by 
digesting pAG38 with Age I and Mfe I and subsequently inserting a synthetic sequence 
(obtained from Eurofins) containing (a) the coding sequences for the C-term of short-AID and 
the nuclear localization signal (NLS) and (b) a sequence identical to the 3’-UTR of pAG38 
located upstream Mfe I. 
pAG52 and pAG53 were obtained from pAG38. The sequence coding from respectively 
AtAFB2-NLS-9×Myc and OsAFB2-NLS-9×Myc were synthesized by Eurofins and subcloned 
into pAG38 using Bgl II and Xma I restriction sites. 
pAG72, pAG73, pAG74 were obtained from pAG38 by site-directed mutagenesis. 
pAG75, pAG76, pAG77 were obtained from pAG52 by site-directed mutagenesis. 
pAG122 was obtained from pAG1. The sequence coding for HA-EGFP-AID-NLS was 
removed by digestion using EcoR I and Mfe I restriction sites. Ligation of the digested vector 
gave pAG122 (Note: EcoR I and Mfe I have compatible cohesive ends). 
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Primer lists: 
ag2: aatctggaacatcgtatgggtacgatcgcatggttgtggccatattatc 
ag3: atacgatgttccagattacgctgaattcgtgagcaagggcgaggagctg 
ag4: ggaagaccaagacacagctcag 
ag7: ggaacgatcattcaagagatccc 
ag49:atcctactcgagggtgctggcgcccccaagaagaaaagaaaggtccctaaaaagaaacgtaaggtttccggttctgctgctagtg 
ag50: gcggatcccggggatctcttg 
 
10.2.2 Cell culture and protein quantification 
 
Mammalian cell culture Chinese Hamster Ovarian (CHO) cells were grown at 37°C in 5% 
CO2 atmosphere in DMEM (GIBCO) complemented with 10% fetal bovine serum (FBS, 
GIBCO), 1% non-essential amino-acids (GIBCO) and 1% penicillin / streptomycin (Life 
technologies). Human embryonic kidney 293 cells were grown at 37°C in 5% CO2 atmosphere 
in DMEM with GlutaMAX-1 (GIBCO) complemented with 10% fetal bovine serum (FBS, 
GIBCO) and 1% penicillin / streptomycin (Life technologies). Cells were transiently 
transfected with Genejuice (Merck) according to the manufacturer’s protocol.  
 
 
 
Fig. 10.1: Overview of transient expression protocol in mammalian culture cells. Cells are seeded on culture 
wells pre-coated with poly-lysine polymer and grown for 24 h, after which cells were transfected at 50-70% 
density for 24h. 
 
 
For experiments with auxins (or caged auxins in the dark), medium was replaced with fresh 
complete medium supplemented with the auxin at indicated concentration and incubated for 
the indicated duration. The supplemented medium contained 1% DMSO (Sigma). For the 
microscopy experiments with PA-IAA (4I), medium was replaced with serum-free 
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DMEM/OPTI-MEM (GIBCO) (1:1) supplemented with the photoactivatable auxin at the 
indicated concentration and incubated for 20 min in darkness before photolysis. The 
supplemented medium contained 1% DMSO. 
 
Immunoblotting.  
Cells were washed with ice-cold phosphate buffer saline (PBS, GIBCO), then lysed with ice-
cold lysis buffer (Sigma) supplemented with protease inhibitors cocktail (Roche). Samples 
were boiled with 2% β-mercaptoethanol-containing SDS-loading buffer (BioRad). Samples 
were then resolved using Novex Nupage 4-12% bis-Tris gels (Life technlogies) and 
transferred on nitrocellulose membrane (GE Healthcare). Membranes were blocked with 5% 
dried non-fat milk in TBS buffer containing 0.1% Tween-20 (Sigma), and then incubated with 
the appropriate antibodies for subsequent detection by standard chemoluminescence methods. 
For immunoblotting analysis, the following antibodies were supplied by Cell Signaling: actin 
(rabbit, 1:2,000), Myc (rabbit, 1:2,000), GFP (rabbit, 1:4,000, monoclonal (D5.1)). 
 
Immunostaining. Cells were washed with ice-cold phosphate buffer saline (PBS), and fixed 
with 5 % paraformaldehyde (PFA, Sigma) in PBS. Nuclear membrane was permeated through 
treatment with Triton X100 0.25%. Cells were incubated with 1% BSA in PBS for blocking, 
then incubated with a solution of rabbit anti-Myc antibody (1/50), washed, and incubated with 
the Alexa-633-conjugated secondary anti-rabbit antibody (1/50). 
 
 
10.2.3 Illumination protocols and microscopy imaging 
 
 
Global photolysis in cells 
Cells grown in 12-well plates and treated as described were globally illuminated at 365 nm 
(photon flux 100 μmol.m–2.s–1 or 3 mW.cm–2) with a hand lamp (Vilber Lourmat VL-6L 6W) 
placed above the plate for the indicated duration, then incubated in darkness at 37°C in 5% 
CO2 atmosphere for the indicated duration. Cells were then harvested for immunoblotting 
analysis. The photon flux was measured using a Nova II powermeter (Laser Measurement 
Instruments). 
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Live cell imaging 
Live cells grown in μ-Dish (Ibidi) were imaged at 37°C with an inverted Zeiss LSM 710 
Laser Scanning Microscope equipped with a Plan Apochromat 63 ×/1.4 oil immersion 
objective. EGFP and YFP were excited with a 488 nm argon laser, and emission was collected 
between 497-797 nm. The mean nuclear fluorescence intensities were quantified using ImageJ 
software. 
 
Photolysis with the metal halide lamp 
Photolysis was performed at a 63× magnification with an EXFO X-Cite 120 XL System 
employing a 120 W metal halide lamp with a UV filter (filter setting– excitation G 365, beam 
splitter FT 395, emission BP 445/50). The illumination area was 0.1 mm2. The photon flux in 
the specimen plane (100 mmol.m–2.s–1) was estimated using a Nova II powermeter (Laser 
Measurement Instruments). Pulses of 1s every 5 minutes were used in the presented 
experiments. 
 
Photolysis with the 405 nm laser diode 
Photolysis at the single cell level was performed at a 63× magnification using a 405 nm laser 
diode. Using the bleaching procedure of the Zeiss Zen Software, a rectangular region of 
interest (ROI) of 200 μm2 was defined and illuminated with 50 iterations using the 405 nm 
laser diode at 1% power. We adjusted roughly the photon flux by comparing with the photon 
flux enabling the photoswitching of KikGR, a fluorescent protein switching for green to red 
upon UV-violet excitation and possessing an action-cross section of photoswitching close to 
the action-cross section of PA-IAA photolysis. Pulses every 10 minutes were performed in the 
presented experiments. 
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Résumé 
La régulation de la protéolyse est un outil efficace pour le contrôle de la fonction d'une 
protéine dans des cellules. Nous présentons dans ce travail une stratégie générique permettant 
d'activer la protéolyse de façon conditionnelle par la lumière, améliorant ainsi la résolution 
spatio-temporelle. Notre approche repose sur un système de dégradation inductible par 
l'auxine (AID), mis au point en transposant des composants de la voie de dégradation 
contrôlée par l'auxine existant chez les plantes dans des cellules de mammifères. Nous 
présentons une version optimisée du système AID qui a permis de diminuer de façon 
significative la stabilité de protéines cibles en présence d'auxine. Nous avons en parallèle 
développé un déclencheur de dégradation photo-activable sous la forme d'une auxine cagée. 
Une illumination courte et locale permet la libération efficace de l'auxine dans les cellules et 
induit la dégradation de protéine d'intérêt avec un bon contrôle spatiotemporel. Cette méthode 
générique a été utilisée dans des contextes nucléaires et cytoplasmiques. 
 
Mots-clefs: molécules cagées, chemical biology, optogénetique, protéasome, ubiquitine. 
 
 
Abstract 
The regulation of proteolysis is an efficient way to control protein function in cells. Here, we 
present a general strategy enabling to increase the spatiotemporal resolution of conditional 
proteolysis by using light activation as trigger. Our approach relies on the auxin-inducible 
degradation (AID) system obtained by transposing components of the plant auxin-dependent 
degradation pathway in mammalian cells. We developed an optimized version of the AID 
which enables to significantly destabilize target proteins in presence of auxin. Parallely, we 
developed a photoactivatable auxin that acts as a photoactivatable inducer of degradation. 
Upon local and short light illumination, auxin is released in cells and triggers the degradation 
of a protein of interest with spatiotemporal control. This generic method was implemented in 
nuclear and cytoplasmic contexts. 
 
Keywords: caged molecule, chemical biology, optogenetics, proteasome, ubiquitin. 
 
